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Chapter I 
OUTLINE OF INVESTIGATION 

This study aimed to present the results of our own investigations on patients 
whose clinical and pathological features met the criteria for the diagnosis of 
congenital muscular dystrophy (CMD) and to compare these findings to those 
reported in the literature (Chapter II). 
Materials 
Clinical criteria that suggested the diagnosis of CMD were: (1) generalized 
congenital hypotonia ('floppy infant'), (2) congenital muscle weakness and (3) 
contractures ('arthrogryposis'). The diagnosis suspected on clinical grounds was 
confirmed by muscle biopsy, which showed dystrophic characteristics. 
Over the past 16 years, 3500 muscle biopsies have been examined at the 
neuromorphological department. CMD was found in 34 of them. Eighteen cases, 
including four with white matter hypodensity (type IB), had classical or 'pure' 
CMD without severe impairment of their intellectual development (type I). 
Structural brain abnormalities and mental retardation (Fukuyama type CMD, 
F-CMD, type II) were present in eight cases. Two exceptional cases were classi-
fied as F-CMD-like cases. Six cases had structural brain and eye abnormalities 
(the Walker-Warburg syndrome (WWS), type IV). Autopsy of the brain was 
performed on four cases with WWS, on two cases with F-CMD and on one of 
the patients with the F-CMD-like condition. We also added some cases with 
particular forms of muscle dystrophy to the series. 
Methods 
The study was primarily a clinico-morphological study on CMD. We compared 
the clinical and morphological aspects recorded in our patients to those reported 
in the literature. Some (semi)-quantitative examinations of morphological 
changes were performed on muscle biopsies. The results have been published in 
various articles (Chapters III and IV). In the final chapter (Chapter V), we 
discuss our results in the light of the most recent CMD classification from 1995. 
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Chapter II 
CONGENITAL MUSCULAR DYSTROPHY: 
A REVIEW OF THE LITERATURE 
Q.H. Leyten, F.J.M. Gabreëls, W.O. Renier, H.J. ter Laak 
Submitted for publication 
Abstract 
The name congenital muscular dystrophy (CMD) has been given for a condition 
in which there is already at birth marked hypotonia, generalized muscle weak-
ness and frequently multiple contractures. CMD has recently been classified into 
four categories: classical or 'pure' CMD without severe impairment of intellec-
tual development (CMD I), the Fukuyama type CMD with muscle and structural 
brain abnormalities (CMD II), CMD with muscle, eye and brain abnormalities: 
the Finnish type CMD (CMD III) and the more severe Walker-Warburg syn-
drome (CMD IV). Data of the literature concerning those different CMD types 
have been reviewed and are presented with emphasis on signs and symptoms, 
clinical course, laboratory, neurophysiological, radiological, morphological and 
genetic characteristics. 
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Historical aspects and recent classification 
Since Oppenheim [1] first described generalized muscle weakness in early child-
hood in 1900, calling it 'amyotonia congenita', many papers have appeared on a 
heterogeneity of disorders that not only include primary muscle atrophies, but 
also secondary and neurogenic muscle atrophies [2,3] 
In 1903, Batten [4] described a congenital muscle disorder in a boy that was 
characterized by proximal weakness, torticollis, flexion contractures at the knees, 
hips and elbows, scoliosis and kyphosis The boy died at the age of 7 years 
Neuropathological examination did not reveal any abnormalities in the central 
nervous system, but primary alterations were found in the muscles that corre-
sponded with muscular dystrophy 
The term congenital muscular dystrophy (CMD) was first used by Howard [5] 
in 1908 He described a neonate with dystrophic changes in the muscles and 
introduced the term 'dystrophia musculans congenita' Afterwards, several other 
cases of CMD were recorded [6-10] After the reports by Ullrich [9,10] in 1930, 
only a few cases have appeared in the literature, limited to Germany [11-13] and 
Japan [14-21] In 1954, Walton and Natrass [22] recognized CMD as a clinical-
ly and genetically distinctive entity with an autosomal recessive mode of 
transmission 
In the late fifties and early sixties, some CMD cases were described as 
myopathic cases of 'arthrogryposis multiplex' [23-29] 
In 1960, Fukuyama et al [30] described a distinctive type of CMD with 
cerebral malformations The incidence of this disorder in Japan is about half as 
frequent as Duchenne muscular dystrophy [31], but is fairly rare in countries 
outside Japan [32-41] 
Santavuon et al [42] and Raitta et al [43] introduced the term 'muscle, eye 
and brain disease' (MEB-D) in 1977 and 1978, respectively The term was used 
to represent another distinct type of congenital muscular dystrophy associated 
with central nervous system and eye anomalies Santavuon et al were not the 
first to describe an eye-brain syndrome In 1942, Walker [44] described a 
hydrocephalic child with hssencephaly and maldevelopment of both eyes, 
however, the muscles were not analyzed In 1978, Warburg [45,46] described 
cases with retinal nonattachment associated with hydrocephalus in her review of 
the literature Based on Warburg's clinical description of the disorder, Pagon et 
al [47] introduced the term HARD +/- E syndrome as a mnemonic for hydro-
cephalus, agyna and retinal dysplasia with or without encephalocele, but later 
[48,49] withdrew this mnemonic and suggested the name Warburg syndrome or, 
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according to Dobyns et al. [50], Walker-Warburg syndrome. When in 1984, 
Towfighi et al. [51] found typical dystrophic muscular changes in cases with the 
Walker-Warburg syndrome, Dobyns et al. [52,53] suggested that there was only 
a gradual distinction between the Walker-Warburg syndrome and MEB-D as 
described by Santavuori et al. [42] and Raitta et al. [43]. 
Since 1979, there have been reports on patients with CMD with normal or 
subnormal cognitive functioning whose CT scans and/or MRI images indicate 
marked hypodensity of the white matter [37,40,54-67]. Castro-Gago and Peña-
Guitián [57] and Topaloglu et al. [61,62] suggested that this type should be 
considered as an intermediate form between the 'pure' CMD and the Fukuyama 
type of CMD in 1988 and in 1990 and 1991, respectively. They proposed the 
term Occidental type cerebromuscular dystrophy'. The recent discovery of 
merosin (merosin M-chain or laminin-a2) deficiency, an extracellular matrix 
protein, in patients with 'pure' CMD and marked hypodensity of the white 
matter, has enabled the identification of two subgroups of 'pure' CMD patients 
according to the presence or the absence of merosin [68,69]. 
In order to delineate the different nosological entities, international workshops 
were organized by Dubowitz in 1993 and 1994 [67,70], which resulted in a 
general proposal for the classification of CMD (Table 1). 
Table 1. The 1995 CMD classification according to the literature and two ENMC sponsored 
workshops [67,70] 
CMD I Classical or 'pure' CMD without severe impairment of intellectual develop-
ment. 
A. Without white matter hypodensity and with normal normal merosin 
(merosin M-chain or laminin-aj expression (McKusick, no. 23667), 
B. With white matter hypodensity and with deficient merosin (merosin 
M-chain or lamina-o^) status. 
CMD II CMD with mental impairment due to structural brain abnormality: the 
Fukuyama type (McKusick, no. 253800) 
CMD III CMD with eye and brain abnormalities: the Finnish type (McKusick, no. 
253280) 
CMD IV CMD with eye and brain abnormalities: the Walker-Warburg syndrome 
(McKusick, no. 236670). 
18 
Common clinical characteristics and muscle pathology 
Clinical characteristics (Table 2) 
The name congenital muscular dystrophy (CMD) is given to an autosomal 
recessive condition in which marked hypotonia is already present at birth or has 
an onset during the first year of life, frequently multiple contractures (arthro-
gryposis) and more or less generalized muscular weakness. The muscles of the 
pelvic and shoulder girdles and of the proximal limbs are predominantly 
affected, but in many patients involvement of the neck and facial muscles is 
found [71,72]. Clinical course is non-progressive or slowly progressive [71,72]. 
Muscle pathology (Table 2) 
The myopathological changes in CMD are variable. They include variation in 
fibre size, an increased number of fibres with internal nuclei and a marked 
increase in interstitial connective tissue with or without an increase in interstitial 
adipose tissue (Fig. 1A). No marked fibre necrosis and regenerative activity are 
seen in comparison with other muscular dystrophies, such as Duchenne muscular 
dystrophy and limb-girdle dystrophy, and evidence may even be lacking in the 
biopsy. However, sometimes more pronounced dystrophic patterns are found 
with evident necrosis and regeneration. Both fibre types are affected, but not 
always equally. The pathological changes can vary in severity between muscles 
and even between fascicles [30,31,40,42,52,66,67,70-72]. 
CMD: characteristics of different types of congenital muscular dystrophy 
In the following paragraphs, signs, symptoms, clinical course, laboratory, neuro-
physiological, radiological, morphological and genetic characteristics of the 
different types of CMD are outlined. 
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Table 2. Diagnostic criteria for classic or 'pure' CMD 
Inclusion criteria 
Clinical features 
- onset at birth or during the first year of life, 
- hypotonia and generalized muscular weakness, 
- multiple joint contractures evident in the first year of life, 
- clinical course non-progressive or slowly progressive, 
- normal or subnormal mental development 
Muscle biopsy 
- dystrophic pattern 
- marked increase in interstitial connective tissue with or 
without increase in interstitial adipose tissue, 
- no marked fibre necrosis and regenerative activity, 
- sometimes more pronounced by dystrophic pattern, with 
evident necrosis and regeneration , dystrophin (both by 
immunocytochemical and Western-blot techniques) must be 
present and normal 
Exclusion criteria 
Clinical features 
- onset during childhood, 
- clinical course rapidly progressive, 
- muscular hypertrophy, 
- ptosis and/or ophthalmoplegia, 
- severe impairment of intellectual development (IQ <50), 
- structural ocular abnormalities 
Laboratory findings 
- EMG with 'neuropathic' pattern, 
- muscle biopsy normal, with neuropathic abnormalities or with 
structural abnormalities specific of other myopathies, 
- dystrophin absent or abnormal, 
- major CT or MRI abnormalities of CNS different from white 
matter hypodensity (major malformations, developmental 
and/or migration defects) 
CMD I. Classic or 'pure' form of congenital muscular dystrophy without 
severe impairment of intellectual development 
CMD IA. Classic or 'pure' form of congenital muscular dystrophy without 
severe impairment of intellectual development, without white 
matter hypodensity and with normal merosin (merosin M-chain 
or laminin-a,) expression 
Signs, symptoms and clinical course [40,67,70-72] (Table 2) 
In many patients, decreased antenatal movement is noted. Postnatal asphyxia can 
occur. Signs and symptoms are present at birth or become apparent during the 
first year of life. Most patients are hypotonic at birth with generalized weakness 
(Fig. 2A). In most patients, the proximal muscles are more affected than the 
distal ones and initially the arms are more impaired than the legs. Facial, neck 
and chest musculature is variably involved, while the sucking and swallowing 
musculature and extraocular muscles are spared. Ophthalmologic examination is 
normal. The tendon reflexes are usually depressed or absent. In all patients, 
motor development is significantly delayed. However, the clinical course is not 
usually very progressive and differs from case to case. In some patients, 
contractures occur at birth and in others at a later age. In some patients, kypho-
scoliosis of the thoracolumbar spine is present [40]. Also congenital subluxation 
or dislocation of the hips and clubfeet are common features. Mental develop-
ment is usually normal (or subnormal). The degree of impairment and the delay 
in passing motor milestones vary from case to case. Most patients are able to sit 
up and one in three is able to stand at 5 years of age [73,74]. Most patients do 
not reach adolescence and die from progressive muscle weakness and respiratory 
failure. In general, patients who lack the ability to handle their pulmonary 
secretions are prone to developing frequent pulmonary infections and many of 
them die as a result. The prevalence of CMD abroad is estimated at 1 : 60,000 
at birth and at 1 : 100,000 in the population [75]. 
Laboratory findings 
Serum creatine kinase (CK) values are usually normal or moderately increased. 
Increased values usually tend to return to normal with increasing age, but not 
always [71]. 
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Fig. 1. Muscle biopsies of 4 patients stained for HE (A), dystrophin (B) and merosin (C and D). In 'pure' 
CMD, dystrophin expression is normal (B), but merosin expression may be normal (C) or deficient (D). Patient 
ages: 3 (А, В and C) and 1 year (D). Biopsy from quadriceps muscel (А, С and D) or rectus abdominis muscle 
(B). Bar = 50 um. 
Fig. 2. (A) Infant with the 'pure' form of CMD and merosin positive muscle biopsy or CMD type IA. (B) Child with the 'pure' form of CMD and 
merosin negative muscle biopsy or CMD type IB. (C) Cerebral CT with diffuse hypodensity of white matter in CMD type IB. 
Neurophysiological examination 
In most cases, electromyographic (EMG) studies indicate a myopathic disorder 
with an increased number of brief polyphasic potentials with a small amplitude 
Motor nerve conduction velocities (MNCVs) are normal in all patients Electro­
encephalography (EEG) and somatosensory evoked potentials (SEPs) [69] are 
normal 
Radiological examination 
Cerebral CT and/or MRI scans do not reveal any abnormalities 
Morphological aspects 
Muscle biopsy Histological abnormalities of muscle biopsy specimens are variable and 
usually include increased muscle fibre diameters, an increase in endomysial and 
perimysial fat and connective tissue (Fig 1A), and some regeneration [66,67,70-72] 
Fibres are rounded and fibre necrosis, fibre splitting, phagocytosis, predominance of 
type I or type II fibres, selective hypertrophy and selective atrophy have been seen, 
but not consistently These dystrophic changes generally depend on the stage of the 
disorder and are usually progressive Morphological follow-up studies on individual 
cases with CMD have not been done until now 
Immunohistological staining with antibodies against laminin A, BI, B2, M, collagen 
IV, spectrin and dystrophin (Fig IB) [76-79] and dystrophin-associated glycoproteins 
[79] are normal or near-normal Merosin (merosin M-chain or laminin-otj) is a striated 
muscle specific basal lamina associated protein The locus for the merosin gene is on 
chromosome 6q2 [70,80] Mercuri et al studied the muscle merosin (merosin M-chain 
or larmnin-a2) status in 10 'pure' CMD patients without any white matter hypodensity 
[69] All had normal merosin expression (Fig 1С) 
Genetics 
There are sets of familial cases The disease may appear sporadically or be 
transmitted as an autosomal recessive trait [67,70-72] Only one publication on a 
family with CMD and minimal CNS involvement (ι e seizures and poor reading 
ability in the mother, and an abnormal EEG in the son) suggests an autosomal 
dominant pattern of inhentance [81] Therefore autosomal dominant or X-hnked 
inheritance is possible in this family 
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CMD IB. Classic or 'pure' form of congenital muscular dystrophy without 
severe impairment of intellectual development, with white 
matter hypodensity and deficient merosin (merosin M-chain or 
laminin-α,) status [82,83] 
Signs, symptoms and clinical course 
The clinical features are -in general- similar to those in CMD patients without 
any white matter hypodensity, except for (1) usually more severe clinical 
expression (including subnormal intelligence) and course and (2) some striking 
dysmorphic features, such as a large head, long and thin face, high arched palate 
and abnormalities of jaw articulation [58,66] Joint contractures are observed 
twice as frequently in CMD with white matter hypodensity than in patients with 
CMD without white matter hypodensity (Fig 2B) [66] In the literature [37,40, 
54-67], the occurrence of epilepsy was mentioned in 13 out of 64 patients A 
recent study demonstrated that perceptuo-motor difficulties and minor neurologi­
cal soft signs were a consistent feature in CMD children with diffuse MRI 
changes but not in those with normal MRI, irrespective of the seventy or the 
extent of the contractures and weakness [84] There are no structural ophthalmo-
logical abnormalities 
Laboratory findings 
CK levels are higher than in CMD without white matter hypodensity [66] No 
reference was made to findings of demyehnation when cerebrospinal fluid (CSF) 
was examined [65,66] 
Neurophysiological examination 
EMG studies are similar to those of CMD without white matter hypodensity 
EEG abnormalities are not uncommon [37,40,54-67] Spikes and slow waves, 
periodic complexes and focal spikes can be detected in routine EEG recordings 
[65,66] Patients with white matter changes on MRI have abnormalities in the 
somatosensory evoked potentials (SEPs) [69] Visual evoked potentials are less 
sensitive than SEPs for detecting abnormalities in children with white matter 
changes on MRI [69] 
Radiological abnormalities 
Cerebral CT and/or MRI indicates marked hypodensity of the white matter (Fig 
2C) The severity of this hypodensity differs from case to case Most patients 
have brain MRI changes of diffuse white matter involvement, resembling 
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leukodystrophy, usually sparing the internal capsule, basal ganglia, corpus 
callosum and brain stem [63,65,84]. There is a lack of progression of white 
matter hypodensities on successive CT/MRI scans [36,59,63], but long-term 
evaluation of the evolution of the hypodensities is needed. 
Morphological aspects 
Muscle biopsy. The histological appearance of muscle biopsies from CMD with 
white matter hypodensity are in general similar to those of CMD without white 
matter hypodensity, except that more necrosis was seen in 4 patients with CMD 
with white matter hypodensity [66]. Immunohistological staining with antibodies 
against laminin A, BI, B2, collagen IV, spectrin, dystrophin [69,76-78] and 
dystrophin-associated glycoproteins [78] were normal. In 1995, Mercuri et al. 
[69] described 8 patients with CMD and abnormal cerebral MRI who all had a 
negative merosin status (Fig. ID), in contrast with 10 patients with 'pure' CMD 
and normal cerebral MRI. 
Neuropathological examination of the brain. The nature and significance of 
the white matter changes remain obscure. Informative neuropathological data are 
scarce. Before the introduction of CT/MRI, some authors described demye-
lination in the brain in CMD [32]. There is only one report, in which two 
patients are described [36]. One patient showed moderate focal subpial gliosis 
and good preservation of the cortical architecture in a brain biopsy from the 
right frontal lobe. The myelin sheaths were intact in the core of the convolution. 
In the white matter, there was obvious astrocyte proliferation. In the other 
patient, microscopic examination showed patchy demyelination of the white 
matter of the centrum semiovale. The authors suggested that these neuropatho-
logical findings in themselves were not diagnostic, but that low density in the 
central areas of the brain on CT/MRI scans may indicate a demyelinating 
process. In one other case, the white matter had a spongy appearance on 
necropsy [56]. Malik et al. described a case with significantly decreased staining 
of myelin compared to age-matched, normal control brains [85]. From these few 
studies, no definitive conclusions can be drawn as to whether the neuropatholo-
gy of the white matter hypodensity is caused by de-, hypo- or dysmyelination. 
In all these patients, a normal cortical gyration was found. Recently, Voit et al. 
[86] postulated that the white matter hypodensities on CT/MRI are characteric 
of dysmyelination of the central nervous system. 
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Genetics 
The disease may appear sporadically or be transmitted as an autosomal recessive 
trait [67,70-72]. Recent studies suggest that in 'pure' CMD the cases with white 
matter changes on CT/MRI are all merosin-negative [69,84]. The merosin 
(merosin M-chain or laminin-otj) is linked to the LAMA 2 gene on chromosome 
6q2 [80,82,83], but no mutations of this gene in humans have been reported so 
far [80]. Until now, no direct relation has been demonstrated between the 
hypodensities of the white matter and the merosin (merosin M-chain or laminin-
ot2) deficient muscle status. 
CMD II. Fukuyama type CMD (F-CMD) with structural brain abnormal-
ities and associated mental retardation 
F-CMD consists of severe congenital muscular dystrophy, mental 
retardation and mild cobblestone (previously type II) lissencephaly. 
Signs, symptoms and clinical course [30,31,67,70] 
A high percentage (28.5%) of the mothers of patients with Fukuyama congenital 
muscular dystrophy have had spontaneous abortions. The mothers are often 
aware that fetal movements of affected infants are diminished. At birth, a 
number of clinical features are apparent. Weakness is generalized, but proximal 
muscles are affected more than distal ones. The infant sucks poorly and the cry 
is weak. The face lacks expression and the infant is usually hypotonic (Fig. 3). 
A funnel chest deformity is noted in about 30%. Pseudohypertrophy of muscle, 
particularly of the gastrocnemii, is seen in about half of the cases. Mild con-
tractures at the knees and elbows are often present or gradually develop and the 
tendon reflexes are decreased or absent. Motor development is greatly retarded; 
the infant supports his or her head poorly and is unable to sit up until almost 
one year of age. Although many children are able to sit and to crawl, only a 
small percentage can stand at 4 years of age. The distribution of the affected 
regions is generalized. Not much difference is found between the proximal and 
distal muscles or between the shoulder and hip girdles, but the proximal muscles 
are slightly more severely affected. Contractures at the knees, elbows and hips 
gradually develop. Exceptionally the child is able to take a few steps. Along 
with weakness of the facial musculature, the mouth assumes an inverted V-
shape. By 8 to 10 years of age, the limb muscles are atrophic and virtually 
paralyzed. The majority of these children die by 10 years of age. There is a high 
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association with seizures (37% have febrile seizures and 20% have persistent 
epilepsy). The most common type of seizure is a major, generalized tonic-clonic 
convulsion. Status epilepticus occurs occasionally and may result in death. 
During the first few years of life, it becomes evident that intellectual develop-
ment is also retarded. The child is unable to form sentences and can understand 
only the simplest commands. However, in Fukuyama's personal series of 83 
cases, the IQ varied from 20 to 90, which indicates that the intellectual deficit is 
not always severe. One of the clinical aspects that distinguishes the Fukuyama 
type CMD from the Finnish type of muscle-eye-brain disease and the Walker-
Warburg syndrome, is the absence of any major ocular involvement, although 
there are some reports of ocular abnormalities [31,67]. About half of the patients 
have minor eye anomalies, such as strabismus, abnormal eye movements or mild 
myopia. A few have severe myopia, cataracts, optic disc pallor or irregular 
greyish mottling of the retinal periphery [87]. Some patients have other minor 
congenital anomalies, such as brachycephaly, a high arched palate, hypertricho-
sis and protruding heels [88]. 
4 
Fig. 3. Infant with Fukuyama type of CMD (F-CMD) or CMD type II. 
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Prevalence. In Japan, the ratio of the Fukuyama form of CMD to Duchenne 
dystrophy is 1 : 2.1 [31]. Takeshita et al. [89] estimated that 1 in every 18,000 
Japanese children between the age of 5 and 19 years is affected by Fukuyama 
congenital muscular dystrophy. In countries other than Japan, Fukuyama CMD 
is very rare [32-41]. Dobyns et al. [88] believe that most non-Japanese patients 
diagnosed as having Fukuyama type of CMD have more severe anomalies 
typical of the Finnish type of muscle-eye-brain disease (F-MEB-D) or Walker-
Warburg syndrome (WWS). 
Laboratory findings 
Serum CK level is generally higher than in 'pure' CMD, but may decline from 
the age of 6 years. Also serum GOT, GPT, LDH and aldolase activities are 
found to be higher [31,67]. In CSF, no evidence has been found to indicate 
possible cell loss or demyelination [90]. 
Neurophysiological examination 
In most cases, EMG studies indicate a myopathic disorder with an increased 
number of brief polyphasic potentials with a small amplitude. EEGs often show 
focal paroxysmal discharges, abnormal background rhythms and other abnormal 
findings [30,31,67,70,91]. In infants and younger children, these focal spikes are 
mainly present in the fronto-centro-parietal region, while in older patients, they 
are also present in the centro-occipital region. Visual evoked potential (VEP) 
studies can show low amplitude of N2 waves, or prolongation of the peak 
latency of N2 waves. 
Radiological examination 
Cerebral CT/MRI examinations reveal asymmetry of the skull in 77%, mild de-
creased radiodensity of the white matter in 23% and marked hypodensity in 
18%. Some authors found hypomyelination in the temporoparietal and frontal 
white matter. This hypomyelination usually diminished at around one year of 
age and normalized as the child grew older [90,92]. There is dilatation of the 
lateral ventricles (59%), third ventricle (41%), fourth ventricle (28%), cortical 
sulci (50%), longitudinal cerebral fissure (45%), Sylvian fissure (91%) and 
incisura cerebelli posterior (25%). None of the patients showed cavum septi 
pellucidi [31]. Another characteristic revealed by MRI study is the presence of 
pachygyria [90,92]. 
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Morphological aspects 
Muscle biopsy Fukuyama et al [31] desenbed the spectrum of muscle abnor­
malities as follows In the skeletal muscle, advanced connective tissue infiltra­
tion into the endomysium and perimysium enlarges the interfibrillar space and 
the basic structure of the fibre bundle is destroyed Generally, fat infiltration 
tends to be less severe than connective tissue infiltration In the latter period of 
the pathological change, only small round fibres remain as islands or are 
scattered in the midst of a huge amount of connective tissue and fat Within 
each muscle fasciculus there is striking variation in fibre diameter Less hyper­
trophic fibres are found, with small-sized fibres being predominant Muscle 
fibres are observed in varying stages of necrosis Ultrastructural studies have not 
shown any specific identifying features [93] Some authors observed mild focal 
cellular infiltrates in the perimysium and endomysium as well as around blood 
vessels [94,95] 
In most cases, dystrophin distribution is normal or near-normal (occasional 
abnormally immunostained pattern) [76,78,79,96,97], although exceptionally 
dystrophin-negative patients have been observed (perhaps atypical Duchenne 
dystrophy cases9) The intensity of lmmunostaining for muscle-specific merosin 
(merosin M-chain or laminin-a2) was shown to be greatly reduced to 26% by 
quantitative immunofluorescence [78] However, merosin was normally ex­
pressed in intrafusal fibres, which suggests a secondary change [78,88] Greatly 
reduced staining for dystrophin-associated proteins -especially the 43 kDa 
component (43 DAG)- was found in 12 F-CMD patients [96] However, these 
proteins were excluded as candidates for the primary defect in F-CMD, because 
no positive linkages were found with loci in the 6q2 region containing the 
LAMA 2 gene and in the 3p21 region containing the 43 DAG gene [82,83,98] 
Neuromorphological studies on the peripheral nervous system, ι e spinal 
anterior roots and medullated nerve fibres, in F-CMD did not reveal any 
abnormalities [99,100] 
Neuropathologies examination of the brain [30,31,88,101,102] Cobblestone 
hssencephaly (previously type II lissencephaly) is a complex brain malformation 
which consists of cobblestone cortex, abnormal white matter, enlarged ventri­
cles, small brain stem and small cerebellum, especially vermis with cerebellar 
polymicrogyna The descriptive term 'cobblestone cortex' was proposed by 
Haltia [67,70,88] The cortical changes consist of mixed agyna, pachygyria and 
polymicrogyna with a pebbled surface The spectrum begins with widespread 
agyna (but with a pebbled surface) and probably ends with mixed frontal 
pachygyria and posterior polymicrogyna Leptomemngeal neuronal and glial 
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heterotopia partly obstruct the subarachnoid space and may fuse the hemi-
spheres. The white matter changes vary from simple myelin pallor to severe 
oedema and cystic degeneration [88]. 
F-CMD consists of cobblestone lissencephaly which is less severe than in 
F-MEB-D or WWS [31,88,103]. The cobblestone cortex consists of pachygyria 
and polymicrogyria with partial obstruction of the subarachnoid space and 
hemispheric fusion. Other abnormalities include white matter abnormalities 
which improve with age, mildly enlarged ventricles, mild cerebellar polymicro-
gyria and hypoplasia of the pyramidal tracts. However, the majority of cases did 
not show any remarkable abnormalities in the cerebral white matter [101,102]. 
Although the neuropathological changes are consistent with the loss of normal 
cortical cytoarchitecture from a histological point of view, the distribution and 
the degree of the pathological changes can differ considerably from one case to 
another [30,31,101,102]. 
Genetics 
F-CMD (or CMD type II) is transmitted as an autosomal recessive trait [30,31]. 
A 25% incidence of consanguineous marriages is found within these families. 
The sexes are almost equally affected and there is a high frequency of affected 
siblings. The gene responsible for the F-CMD has recently been localized on 
chromosome 9q31-33 [98]. 
CMD III Finnish type of muscle-eye-brain disease (F-MEB-D) 
F-MEB-D consists of congenital muscular dystrophy, mental retar-
dation, retinal hypoplasia and cobblestone lissencephaly [42,43,65, 
67,70,88,104]. 
Signs, symptoms and clinical course [42,43,65,67,70,104] 
Clinical manifestations include muscle weakness, hypotonia (often associated 
with distal spasticity) and ocular abnormalities, especially retinal hypoplasia. 
Muscle weakness is generalized, affecting especially the muscles of the trunk 
and the extremities. Muscular dystrophy appears before the age of 1 year. The 
head lag is extremely severe. In the extremities, muscle weakness is slightly 
more prominent in the proximal muscles. After the age of 5 years, slight 
spasticity develops in many patients especially in the legs, but can be difficult to 
recognize later on because of contractures. All the patients have weak or absent 
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reflexes until they develop spasticity, when brisk reflexes can again be found 
before the development of contractures Most patients have poor vision Eye 
signs are high myopia, congenital or infantile glaucoma associated with angle 
abnormalities, ins hypoplasia, cataracts, optic nerve pallor, choroidal hypoplasia, 
colobomas and retinal atrophy The eyes are hydrophthalmic during infancy in 
patients with glaucoma and become deepset later on Microphthalmia, typical 
retinal dysplasia and corneal opacity have not been observed All cases are 
mentally retarded, most of them severely but some only moderately, 10 out of 
the 20 (personal experience of Santavuon) achieved some speech Epilepsy is a 
common associated feature The facial appearance shows some similarities in 
most patients The head appears large with a high and prominent forehead and 
wide fontanelle The calvanum is narrow in the temporal region The palate is 
always narrow The midfacies is flat and the nose and the philtrum appear short 
The head size remains on the +1 to +2 SD curve in some patients after the age 
of 15 years, but is ultimately smaller than average in most cases Usually the 
head circumference grows too rapidly during the first year of life and a tense 
fontanelle is seen Although some die in childhood, most survive to 10-30 years 
and some even longer 
Laboratory findings 
CK values are elevated in all the patients, but some are normal during the first 
year, reaching the highest values between 5 and 15 years of age Examination of 
the CSF does not reveal any abnormalities [65] 
Neurophysiological examination 
The EMG can be normal initially, but after 1 to 2 years of age, it always shows 
a typical myopathic pattern with small and polyphasic motor unit potentials 
During the first 6 months of life, the EEG is normal but after the age of one 
year it becomes abnormal with a slow and irregular background, attenuated 
activity in the posterior regions, an excess of beta activity and exaggerated 
spindles in sleep Paroxysmal activity is found in half of the recordings Dunng 
early infancy, the ERG may be normal, but after the age of 1 year, the respon-
ses are absent or severely attenuated Visual evoked potentials (VEPs) are also 
normal during infancy, but usually change to unusual giant potentials after the 
age of 1-2 years The combination of low values on the electroretinogram and 
very high visual evoked potentials in most patients is a striking but not specific 
feature, because it has also been descnbed in late infantile ceroid lipofuscinosis 
[105,106] 
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Radiological examination 
Neuroimaging demonstrates enlargement of the lateral ventricles and fourth 
ventricle In some patients, the third ventricle is also enlarged, especially at the 
anterior part Also cortical atrophy can be present [104] There is -patchy- low 
density white matter in about half of the patients, while the white matter can 
appear quite normal in others, even on some high-quality MRI scans Examina-
tion of the brain of 10 patients with F-MEB-D using high-field MRI revealed a 
uniform pattern consisting of pachygyria, septal and corpus callosum defects and 
severe hypoplasia of the pons in 7 of them [107]. Some patients may have 
progressive hydrocephalus, apparent hydranencephaly, Dandy-Walker malforma-
tion and occipital cephaloceles [65,88]. 
Morphological aspects 
Muscle histology Muscle biopsy tissue obtained from patients of various ages 
(from a few months to 56 years) showed histological findings that varied from 
nearly normal to severely dystrophic. Muscular dystrophy appears before the age 
of 1 year. An increased number of internal nuclei and abnormal variation in the 
fibre size is common. There are more atrophic fibres than hypertrophic ones. 
Fibre splitting is also seen in a number of patients, but necrotic and regenerative 
fibres are rare. In the most severely affected patients, increased endo- and 
perimysial fat and connective tissue are obvious. The seventy of the changes 
increases with age, but the histological picture of burned-out myopathy is not 
seen even in the oldest patients [104]. No reports have appeared on the merosin 
(merosin M-chain or laminin-ctj) status of F-MEB-D patients. 
Neuropathological examination of the brain. Autopsy was performed on two 
patients with Finnish type MEB-D who died at the age of 15 and 34 years, 
respectively Both brains showed a global abnormality in the gyral pattern. The 
surface was covered by small nodules, the so-called 'cobblestone cortex', with 
pachygyria over the frontal region and polymicrogyna posteriorly. Histological-
ly, there was disruption of the normal cortical cytoarchitecture, with loss of the 
regular boundary between the neuroectodermal tissue and the pia arachnoid. The 
cerebellum showed the presence of the various normal elements but in a 
haphazard arrangement, comparable to a 'scrambled egg' [67]. Pihko described 
a severely mentally retarded boy with occipital encephalocele and a Dandy-
Walker cyst [65]. 
Pathological examination of the eyes. Eye pathology includes the loss of 
ganglion cells and a thick abnormal preretinal layer, abnormal retinal pigment 
epithelium, Peter's anomaly, anterior chamber malformations, cataract, persistent 
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hyperplastic primary vitreous (PHPV), abnormal vascularization and hypoplasia 
of the optic nerve [54,67,108-110]. 
Genetics 
Muscle-eye-brain disease has an autosomal recessive mode of inheritance. 
Recently, Ranta et al. demonstrated that Finnish type MEB-D and F-CMD are 
not allelic [111]. They excluded the F-MEB-D gene from the region of the F-
CMD gene on chromosome 9q31-33. The gene responsible for the Finnish type 
of MEB-D has not yet been detected. 
CMD IV Walker-Warburg syndrome (WWS) 
WWS consists of congenital muscular dystrophy, severe mental 
retardation, retinal abnormalities and severe cobblestone lissen-
cephaly [44-53,86,88] 
Signs, symptoms and clinical course [44-53,86,88] 
Pregnancy is often complicated by polyhydramnios and decreased fetal move-
ments. Delivery is often by Caesarian section because of fetal distress and/or 
cephalopelvic disproportion due to an enlarged fetal head. Many patients are 
stillborn or die during the perinatal period. The mean survival is only four 
months, although some patients may survive for more than five years [88]. 
Most children have severe or profound mental retardation, hypotonia and 
muscle weakness, mild distal spasticity and often poor vision. Muscular dystro-
phy appears before the age of 1 year. A few patients have only moderate mental 
retardation and are able to roll over and sit up. Seizures may occur during the 
neonatal period and are common at older ages; treatment may be difficult [52]. 
Congenital macrocephaly is due to hydrocephalus, but microcephaly is also 
encountered. The eye abnormalities consist of microphthalmia (Fig. 4A), iris 
coloboma, buphthalmos, glaucoma, Peter's anomaly, cataract, corneal opacities 
in the anterior chamber, microphthalmia, hypoplasia of the optic nerve, typical 
retinal dysplasia and detachment, vitreous haemorrhage and persistent vessels. 
Many other congenital anomalies have been reported in WWS patients: adrenal 
hypoplasia, cleft lip/palate, urogenital anomalies in males, hearing loss, renal 
dysplasia/hypoplasia [44-53,86,88]. 
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Laboratory findings 
All the patients showed an increased serum CK level, but there was great 
variation between the patients (3 to 60 times the upper limit of normal) or over 
time in an individual patient [52]. 
Neurophysiological examination 
EMG studies produced a severe myopathic trace, while motor nerve conduction 
velocities were normal [52,67,70]. EEG showed diffuse slowing and paroxysmal 
discharges. Visual evoked potentials (VEPs) and brainstem auditory evoked 
potentials (BAEPs) appeared to be severely disturbed. 
Radiological examination 
MRI mostly showed changes typical of cobblestone lissencephaly: agyria or 
pachygyria, usually combined with polymicrogyria, severe and diffuse white 
matter abnormalities. These consisted of radiolucency on CT scans or a bright 
signal on T2-weighted MRI, enlarged ventricles often severe enough for hydro-
cephalus, brain stem hypoplasia, cerebellar hypoplasia, especially vermis hypo-
plasia, with Dandy-Walker malformations, while one third of the patients had 
occipital encephalocele or meningocele (Fig. 4B) [50,52,67,70,88]. 
Fig. 4. (A) Child with the Walker-Warburg type of muscle-eye-brain disease (WWS) or CMD 
type IV. (B) Cerebral CT illustrating occipital encephalocele and ventricle dilatation in WWS 
(CMD type IV). 
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Morphological aspects 
Muscle histology. The histological and histochemical features are consistent with 
congenital muscular dystrophy [52]. CMD is often diagnosed before the age of 1 
year. The pathological changes can vary in severity between muscles and even 
between fascicles [52]. In some patients, the muscle changes are less severe and 
are then classified as unspecific myopathy. In a recent study, preserved merosin 
(merosin M-chain or laminin-a2) was reported consistently in 5 patients with 
WWS [86]. 
Neuropathological examination of the brain. Severe 'cobblestone cortex' is 
present in all patients [67]. The gross appearance is dominated by widespread 
agyria with scattered areas of pachygyria and/or poly microgyria [52]. The lepto-
meninges are thick and granular and may obliterate the interhemispheric fissure, 
effectively 'fusing' the cerebral hemispheres. Ventricles are enlarged. The cortex 
is abnormally thick with absent white matter interdigitations. The white matter is 
oedematous and sometimes shows cystic degeneration. The corpus callosum and 
septum pellucidum are very frequently absent or hypoplastic. Microscopically, 
the subarachnoid space is partially occluded by fibrous and heterotopic neurogli-
al tissue. The cortex is severely disorganized with no recognizable layers and 
widespread disruption by abnormal vascular channels and fibrous glial bands. 
The white matter is poorly myelinated with scattered heterotopic neurons. 
Cerebellar malformations comprise polymicrogyric or smooth (afoliar) 
surfaces, hemispheric and especially vermis hypoplasia and characteristic micro-
scopic changes reminiscent of those in the cerebrum. However, some cortical 
layers can usually be recognized and the white matter abnormalities are less 
severe. The vermis, especially the posterior vermis, is always hypoplastic. This 
is often associated with enlargement of the fourth ventricle to form a retrocere-
bellar cyst, usually referred to as Dandy-Walker malformation. 
Occipital cephaloceles, meningoceles and encephaloceles, have been 
described. In most cases, a cephalocele represents an extension of a retrocere-
bellar cyst through an occipital skull defect [50,52,67,70,88]. 
Pathological examination of the eyes. The ophthalmological signs include 
severe structural eye changes, such as microphthalmia and colobomas, cleavage 
defects of the anterior chamber resulting in congenital glaucoma, optic cup 
deformation resulting in severe myopia, cataract and retinal detachment second-
ary to retinal dysplasia. Also persistent hyperplastic primary vitreous (PHPV), 
retinal pigment epithelium abnormalities and Peter's anomaly have been described. 
Histologically, the inner retina is thin with abnormal gliovascular prolifera-
tion. The ganglion cells are decreased in number and poorly differentiated with 
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few axons and dendrites. The nerve fibre layer is secondarily thin or absent, 
resulting in small (hypoplastic) or absent optic nerves. Photoreceptors are 
present, but their outer segments are poorly formed or absent. There may be 
areas of abnormal differentiation with retinal folds and rosettes. The retinal 
pigment epithelium is usually irregularly pigmented and may have areas of 
hyperplasia with drusen formation. In the most severe cases, there is so-called 
PHPV in which the retina forms a mass of gliotic tissue extending from the 
posterior pole to the posterior surface of the lens. Microphthalmia commonly 
accompanies PHPV [52]. 
Genetics 
An autosomal recessive mode of inheritance is more or less certain on the 
grounds of the following observations: (1) normal sex ratio in affected children, 
(2) several families have multiple affected children of both sexes, (3) healthy 
parents and (4) several instances of parental consanguinity. In the review by 
Dobyns et al. [52], nine out of twenty-five sibs (36%) were affected. Parental 
consanguinity was documented in one of the twenty-eight families in the 
literature (third-cousins) [112] and in two out of nineteen families in the series 
described by Dobyns et al. [52]. No ethnic, racial, or geographic predilections 
are apparent [52]. 
Toda et al. [113] claimed genetic identity of F-CMD and WWS. Their 
findings were based on microsatellite marker analysis of two siblings: one 
presumed to be suffering from F-CMD and one from WWS. Both showed the 
same alleles for the flanking markers of the F-CMD locus on 9q31-33. How-
ever, no statistical analysis or lod score calculation were provided and no muta-
tion of the F-CMD gene was demonstrated. Various explanations can account 
for this observation [86]. 
Comparison between F-CMD, F-MEB-D and WWS (Table 3) 
While Fukuyama type CMD has clinical and neuropathological similarities with 
F-MEB-D and WWS concerning autosomal recessive inheritance, dystrophic 
changes in muscle, pachygyria or polymicrogyria of the brain and sometimes 
eye abnormalities, it has long been considered as distinct from F-MEB-D and 
WWS. The reasons are as follows: (1) the spectrum of gyral abnormalities is 
much less severe and does not typically extend to complete or near-complete 
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agyria, (2) there is a lack of major eye abnormalities, (3) major cerebellar 
abnormalities are rare [30,31,52,67,70] and (4) the immunostaining intensity of 
merosin (merosin M-chain or Іатіпіп-сц) is significantly reduced in F-CMD 
[78], but (in contrast) merosin expression in WWS is consistently preserved 
[86]. Yoshioka et al. [114] observed two sibs with discordant manifestations. 
The younger sib had severe WWS while the older had F-CMD. However, after 
reviewing the brain and eye abnormalities, Dobyns et al. [88] suggested that the 
latter actually had F-MEB-D or mild WWS. Toda et al. recently mentioned that 
F-CMD and WWS may in some cases be due to variable expression of the same 
genetic defect [113], but no statistical analysis or lod score calculation were 
provided and no mutation of the F-CMD gene was demonstrated [86]. Various 
explanations can account for this observation, e.g. a mutation of the F-CMD 
gene leading to unusually severe phenotypes, a combination of different muta­
tions present in one family, etc. [86]. 
The consistently preserved merosin (merosin M-chain or laminin-c^) expres­
sion in the skeletal muscle of 5 (all) WWS patients is in contrast with F-CMD 
[86]. Therefore, some authors believe that merosin can be used as an immuno-
cytochemical marker to distinguish WWS from F-CMD [86]. However, F-CMD 
(with reduced merosin expression) could theoretically be caused by different 
mutations of the same gene. Ultimately, this issue can only be solved by linkage 
and subsequent gene analysis [86]. Moreover, Ranta et al. demonstrated that F-
CMD and F-MEB-D are not allelic [111]. 
At present, there is considerable discussion among the consortium participants 
of the two ENMC sponsored International Workshops on CMD [67,70], as to 
whether F-MEB-D and WWS should be considered as one entity. Initially, 
muscular dystrophy was not detected in WWS; the muscle disease was probably 
overshadowed by the severe cerebro-ocular abnormalities. Later, however, 
Dobyns et al. [70] made a detailed comparison between F-MEB-D patients from 
Finland and WWS patients from the United States and elsewhere (Table 4). At 
the workshop, comparative MRI/CT studies on 20 patients with F-MEB-D or 
WWS demonstrated striking similarities [70]. Nevertheless, there were quantita­
tive differences between the F-MEB-D and WWS patients (Tables 3 and 4). In 
F-MEB-D patients, the gyral malformation most often consisted of pachygyria 
over the frontal region and polymicrogyria posteriorly. The white matter changes 
were present but patchy in about half of the F-MEB-D patients, while the white 
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Table 3. Comparison of F-CMD, F-MEB-D and WWS (adapted from Dobyns [52,88]) 
F-CMD F-MEB-D WWS 
Chromosome localization of 
responsible gene 
9q31-33 
Cobblestone (type II) lissencephaly 
Predominate agyna 
Predominate pachygyria 
Predominate polymicrogyria 
White matter lucency 
Cerebellar malformations 
Cortical dysplasia 
Vermis hypoplasia 
Dandy-Walker malformation 
Occipital cele 
Eye abnormalities 
Typical retinal dysplasia 
Optic nerve pallor 
Other retinal abnormality 
Anterior chamber malformation 
Persistent vessels 
Microphthalmia 
Muscle disease 
CMD 
Calf pseudohypertrophy 
Merosin reduced 
+++ 
0 
++ 
++ 
50% 
improving with age 
+++ 
+++ 
0 
0 
0 
± 
0 
± 
± 
± 
0 
0 
+++ 
+ 
++ 
+++ 
0 
+++ 
(frontal) 
+++ 
(posterior) 
50% 
(mild, patchy) 
+++ 
+++ 
++ 
± 
± 
+++ 
0 
++ 
+++ 
++ 
+ 
0 
+++ 
0 
•> 
+++ 
+++ 
++ 
+ 
+++ 
(severe, diffuse) 
+++ 
+-H-
+++ 
++ 
++ (30%) 
+++ 
++ 
+++ 
++ 
++ 
++ 
++ 
+++ 
0 
0 
Associated abnormalities 
Ventricular dilatation 
Hypoplastic corpus callosum 
Brain stem hypoplasia 
Congenital macrocephaly 
Congenital microcephaly 
(mild) 
+ 
0 
0 
++ 
++ 
+ 
+ 
± 
++ 
+++ 
++ 
± 
+++ = constant, ++ = frequent, + = occasional, ± = very rare, ? = unknown, 0 = not observed. 
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Table 4. Differences between Finnish type of muscle-eye-brain disease (F-MEB-D) and Walker-Warburg syndrome (WWS), modified according to 
Dobyns [52,88]. 
F-MEB-D WWS 
Mental retardation; mild to severe 
Structural eye abnormalities 
a) absent microphthalmia 
b) absent typical retinal dysplasia 
c) absent corneal opacities 
Cobblestone lissencephaly with 
a) primarily frontal pachygyria and occipital polymicrogyna 
b) absent or patchy white matter changes 
c) very rare occipital cele 
Mental retardation; always severe 
Structural eye abnormalities 
a) microphthalmia 
b) typical retinal dysplasia 
c) corneal opacities 
Cobblestone lissencephaly with 
a) agyna with pachygyria and polymicrogyna 
b) diffuse white matter changes; cortex lacks white matter interdigilations 
c) frequent occipital cele 
matter appeared to be quite normal in the others, even in some with high-quality 
MRI scans. Most WWS patients had severe gyral changes that consisted of 
agyria or mixed agyria-pachygyria with some areas of polymicrogyria. All the 
WWS patients had severe and diffuse white matter changes and severe to 
profound mental retardation, which made them more severely handicapped than 
most of the F-MEB-D patients [70]. All the differences appeared to be quantita-
tive, especially the severity of the gyral malformation and the white matter 
changes. The cerebellar malformations may have been somewhat more severe in 
WWS. This is supported by the frequency of occipital celes, which occur in 
about 30% of patients with WWS but have only been reported sporadically in 
patients with F-MEB-D. The eye abnormalities in the two disorders also differ 
quantitatively. However, microphthalmia, typical retinal dysplasia and corneal 
opacities have not been observed in F-MEB-D [88]. According to Dobyns et al., 
the similarities far outweigh the differences, making it likely that WWS and F-
MEB-D are allelic [88]. Thus, the question must be left open as to whether 
WWS and the clinically milder but phenotypically similar F-MEB-D are allelic 
disorders [86,88,115]. 
In conclusion, the classification of CMD as presented in Table 1 is the most 
actual, but it is possible that this classification will be changed after new genetic 
research findings become available. For definite delineation of the nosological 
entities of CMD, further molecular genetic research is necessary. 
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Chapter III 
COMMON TYPES OF CONGENITAL MUSCULAR DYSTROPHY 

Ill 1 
CLINICAL STUDIES 

Ill 1.1 
Congenital muscular dystrophy 
Q. H. Leyten, F.J.M. Gabreëls, W.O. Renier, 
H.J. ter Laak, R.C.A. Sengers, R.A. Mullaart 
The Journal of Pediatrics 1989;115:214-221 
Abstract 
We report the cases of 18 patients with congenital muscular dystrophy, six of 
whom also have involvement of the central nervous system, corresponding to 
the Fukuyama type of congenital muscular dystrophy. In four patients, both the 
central nervous system and the eyes are involved, and the diagnosis of "muscle, 
eye and brain disease" was made. A comparative study of these patients with 
those whose cases were recently reported indicates that there is a wide varia-
bility of clinical and laboratory expression of the dystrophy, but a constant 
feature in all patients is a progression of motor disability. The association of 
congenital muscular dystrophy with brain abnormalities indicates a poor clinical 
prognosis. At present it remains an open question whether the three variants of 
the disease are separate diseases or only different expressions of the same 
syndrome, but our study tends to support the latter hypothesis. 
58 
Congenital muscular dystrophy (CMD) is a rare and ill-defined muscular 
disorder characterized by generalized weakness and hypotonia at birth, joint 
contractures, delayed motor development, and features of dystrophy on muscle 
biopsy. The disorder is slowly progressive, although rapid evolution has been 
noted occasionally. The clinical severity of CMD and the delay in motor devel-
opment can differ substantially. Initially the patient's arms are more severely 
affected than his legs, and proximal muscles more than distal ones. Joint con-
tractures may be restricted to talipes or may constitute a severe form of arthro-
gryposis multiplex congenita.'"16 Creatine kinase levels vary and sometimes are 
only moderately raised at the onset of the disease.4"'6 In general, an autosomal 
recessive mode of inheritance is accepted,'0'7'9 although some reports describe 
an autosomal dominant mode of inheritance in "pure" CMD.20,21 
Apart from the "pure" form of CMD, there are two types of CMD with 
involvement of the central nervous system: (1) the Fukuyama type10 and (2) 
"muscle, eye, and brain disease" (Santavuori et al.22), "congenital cerebro-ocular-
myopathy syndrome" (Pavone et al.23), or "cerebro-ocular dysplasia-muscular 
dystrophy syndrome" (Towfighi et al.17). The neuromorphologic alterations of 
the CNS are nonspecific and consist of malformations that appear at different 
stages of brain development, ranging from the fourth week (agenesis of olfacto-
ry bulbs) to the final months of gestation (cortical polymicrogyria).23 The 
ophthalmologic signs in MEB disease include both functional disturbances, such 
as nystagmus and uncontrolled eye movements of central origin, and structural 
eye changes, such as microphthalmia, cleavage defects of the anterior chamber 
resulting in congenital glaucoma, optic cup deformation resulting in severe 
myopia, cataract, and retinal changes such as retinal dysplasia and detach-
„ , „ „ • 17.24 
ment. 
We report the cases of 18 patients with CMD, of whom six have the 
Fukuyama type and four the MEB disease type. The purpose of this report is to 
describe the broad clinical spectrum and to discuss the different nosologic 
entities. 
Methods 
In a period of about 15 years we examined and followed 18 patients with CMD 
from a consecutive series of 1980 patients who had muscle biopsies. All patients 
with generalized weakness and hypotonia at birth or a severely delayed motor 
development, or both, underwent muscle biopsy of the quadriceps. Two speci-
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mens were taken from the biopsy; the one used for enzyme histochemical proce-
dures was frozen in isopenthane cooled in liquid nitrogen and was cut and 
stained according to standard procedures, and the other was taken for bio-
chemical measurements. The final diagnosis of CMD was based on histologic 
signs of muscular dystrophy. 
CMD 
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Fig. 1. Motor development of eight patients with CMD, six with Fukuyama-CMD, and four 
with MEB disease. Age of ambulation at the end of follow-up or at death (t). 
Results 
Clinical features (Table, Fig. 1) 
Decreased antenatal movement was noted in five patients. Three patients were 
born by breech delivery. Mild postnatal asphyxia occurred in five patients. All 
patients had hypotonia and generalized weakness from birth. In most patients, 
proximal muscles were more affected than distal ones and, in general, the arms 
were more impaired than the legs. Contractures were present at birth in four 
patients and developed between the ages of 3 and 7 years in seven others, 
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necessitating tendon-lengthening procedures in two patients. Kyphoscoliosis of 
the thoracolumbar spine occurred in seven of the patients with "pure" CMD, six 
of whom also had a congenital subluxation or a dislocation of the hips. 
The CNS was involved in 10 patients and the eyes in four of them. Mental 
retardation occurred in all ten of these patients and varied from mild in two 
patients with Fukuyama-CMD to severe in the other eight patients. Two patients 
had tonic-clonic seizures. The four patients with MEB disease had either 
microcephaly or macrocephaly. Two of the six patients with Fukuyama-CMD 
had microcephaly. Either encephalocele or meningocele occurred in three 
patients. 
Ocular involvement included microphthalmos, blepharophimosis, corneal 
clouding, and fetal anterior chamber angle in two patients; corneal clouding, 
fetal anterior chamber angle, iris atrophy, and cataract in one; and uncontrolled 
eye movements, horizontal rotatory nystagmus, severe myopia, and macular 
atrophy in the fourth. 
In all patients, motor development was significantly delayed (Fig. 1); the 
patients with CNS involvement did not reach any motor milestones. In the CMD 
patients without CNS involvement, three patients were able to walk without 
support and one walked from the age of 3 to 12 years. Two patients with "pure" 
CMD died at the ages of 9.5 and 35 years, three patients with Fukuyama-CMD 
at the ages of 3, 0.8, and 0.3 years, and two patients with MEB disease at the 
ages of 3 months and 2 days, respectively. 
Genetic aspects 
The male/female ratio was 7:11. There were four sets of familial cases: two 
sisters in two families, a father and daughter, and a brother and sister. In only 
one case consanguinity was proved. 
Biochemistry 
Results of the following laboratory tests were normal: complete blood cell count 
and urinalysis, renal function tests, and determinations of serum electrolyte 
levels, serum protein content and electrophoretic pattern, serum lipid spectrum, 
serum pH, carbon dioxide tension and bicarbonate value, ceruloplasmin, copper, 
ammonia, amino acid, and organic acid levels in plasma and urine, and lyso-
somal enzyme activities in leukocytes. Appropriate studies ruled out endocrino-
logie, immunologic, and chronic infectious diseases, vitamin deficiencies, and 
disorders caused by toxic agents. 
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Table. Signs, symptoms, and laboratory, radiologic, and neurophysiologic characteristics of 18 
patients with CMD 
"Pure" CMD patient No 
Age at examination (yr) 
Sex 
Consanguinity 
Delivery, position 
Asphyxia in neonatal period 
Congenital hypotonia 
Joint contractures 
At birth 
At later stages 
Rapidly progressive course 
CK activity (normal <90 U/L) 
Lactate in serum 
Myogenic pattern of EMG 
OFC 
CNS involvement 
Mental retardation 
Convulsions 
CSF abnormalities 
EEG abnormalities 
Hydrocephalus 
Hypomyehnation 
Encephalocele 
1 
0 5 
F 
-
N 
+ 
+ 
+ 
-
+ 
+ 
288 
N 
+ 
N 
-
-
-
np 
np 
-
-
-
2 
3 
M 
-
N 
-
+ 
-
-
-
-
134 
N 
+ 
N 
-
-
-
np 
np 
-
-
-
3 
1 
F 
-
В 
-
+ 
-
-
-
-
Ν 
Ν 
+ 
Ν 
-
-
-
-
-
-
-
-
4 
3 
F 
-
В 
-
+ 
+ 
+ 
+ 
+ 
128 
Ν 
+ 
Ν 
-
-
-
np 
np 
-
-
-
5 
35 
M 
-
Ν 
-
+ 
+ 
+ 
+ 
-
Ν 
np 
+ 
Ν 
-
-
-
np 
np 
-
-
-
6 
0 7 
F 
-
N 
-
+ 
+ 
-
+ 
-
N 
N 
+ 
N 
-
-
-
-
np 
-
-
-
7 
6 
M 
-
N 
+ 
+ 
+ 
-
+ 
-
282 
N 
+ 
N 
-
-
-
np 
np 
-
-
-
8 
6 
M 
-
N 
-
+ 
+ 
+ 
+ 
-
143 
N 
+ 
>P97 5 
-
-
-
np 
-
-
-
-
Ophthalmologic disorder 
+, Present, -, not present, EMG, electromyography, OFC, occipitofrontal circumference, N, 
normal, B, breech delivery, np, not performed, EEG, electroencephalography, P, percentile 
•Increased protein 
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Fukuyama-CMD: patient No. MEB disease: patient No. 
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+ 
+ 
-
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14 
0 
F 
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-
-
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-
-
15 
0.3 
F 
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-
-
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-
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Lactate and pyruvate levels in serum and cerebrospinal fluid were determined 
in 10 patients, and were within normal ranges; 24-hour lactate excretion in urine 
was normal. Further studies of CSF showed normal leukocyte count, normal 
protein electrophoresis and Immunoelectrophoresis, and normal concentrations of 
ketone bodies; an elevated CSF protein content (1576 mg/L) was found in only 
one child with MEB disease. 
Five patients had normal CK activity and nine slightly increased CK activity; 
in the latter, CK activity decreased during progress of the disorder. The activity 
of CK was markedly increased in the patients with MEB disease. 
Neurophysiology and radiologic examinations (Table) 
Electroencephalography showed diffuse slowing in the patients with CNS 
involvement, and paroxysmal discharges in two patients. The visual evoked 
potentials and brain-stem auditory evoked potentials were severely disturbed in 
two patients with CNS involvement. In all patients, electromyographic studies 
indicated a myopathic disorder by an increased number of brief polyphasic 
potentials with small amplitude; motor nerve conduction velocities were normal 
in all patients. In one patient with Fukuyama-CMD, somatosensory evoked 
potentials could not be elicited with normal sensory action potentials of peri-
pheral nerves, and in another they indicated diffuse involvement of the CNS. On 
CT scan the third and lateral ventricles were significantly enlarged in all but one 
patient with combined CNS and ocular involvement. Cerebral and cerebellar 
atrophy or hypoplasia was observed in five patients. In one patient with the 
Fukuyama type and one with MEB disease, a hypodense area was present in the 
left temporooccipital lobe and the frontal lobe, respectively. 
Muscle biopsies (Fig. 2) 
Light microscopy. In all cases there was an increased variation in fiber diameter 
caused by the presence of atrophic and hypertrophic fibers. All biopsy speci-
mens were characterized by rounded muscle fibers surrounded by increased 
quantities of collagen. In all biopsy specimens except one, basophilic fibers 
were also present. Fatty infiltration was seen in 10 cases and an increased 
number of fibers with internal nuclei occurred in eight. Necrotic fibers were 
present in four cases. Small numbers of hyalin fibers were found in 13 cases. 
The terminal innervation ratio was normal in all patients. 
Biochemical studies. Pyruvate oxidation and fatty acid oxidation were in the 
normal range. Carnitine content was examined in five cases; no abnormalities 
were found. 
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Fig. 2. Transverse section of quadriceps muscle biopsy specimen from patient 1. There is a 
considerable variation in muscle fiber diameter. Between the rounded muscle fibers, increased 
quantities of connective tissue can be seen (Hematoxylin-eosin stain; bar, 50 μχή). 
Pathologic examination 
Pathologic findings in two patients with Fukuyama-CMD (Nos. 13 and 14) have 
been described by Krijgsman et al.25 
Two patients with MEB disease are still alive; in the other two patients (Nos. 
15 and 16, who were sisters) autopsy was performed. Brain examination 
revealed agyria, polymicrogyria and pachygyria, thickened arachnoidea, hydro­
cephalus, agenesis of the olfactory bulbs, optic chiasm and septum pellucidum, 
cerebellar hypoplasia, and an encephalocele above the cerebellum. On light 
microscopic examination, we observed a stratification disorder, hypomyelination 
of cerebral white matter, diffuse leptomeningeal and marginal glial proliferation, 
and vessel hypertrophy. Both eyes had malformations consisting of diffuse 
disruption of laminar order and dysplastic and dysgenetic changes. 
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Discussion 
According to the criteria of Banker,13 the clinical and pathologic features of our 
18 patients fit the diagnosis of CMD. Ten of these patients also have CNS 
involvement, and four of them have additional ocular involvement. 
Many clinical data in our study are in accordance with those of the litera-
ture.6"9 All patients had generalized hypotonia and generalized muscle weakness 
at birth, indicating that the disease starts during intrauterine life, but contractures 
were not always present.5,8·14·15 A prolonged delivery time810 could not be 
confirmed; there was a high incidence of breech deliveries, and, in four cases, 
perinatal cyanosis and drinking or sucking problems were noted.51012 Progres-
sion is rapid and prognosis is worse in MEB disease compared with "pure" 
CMD.7,8 In the studies of Donner et al.8 and McMenamin et al.,7 2 of 15 and 8 
of 24 patients, respectively, died before the age of 16 years. 
In countries other than Japan, Fukuyama-CMD is very rare.2531 The CNS 
manifestations in Fukuyama-CMD include moderate to severe mental retarda-
tion, microcephaly, and convulsions. The most common pathologic changes in 
the CNS are polymicrogyria and agyria (lissencephaly) caused by a defect in the 
migration of neurons.10,34 Other neuropathologic changes are hypomyelination of 
the cerebral white matter,35 adhesions between the hemispheres, sometimes mild 
hydrocephalus, and an aberrant pathway of the pyramidal tract. Ophthalmologic 
involvement does not usually occur.10,36,37 Among our six patients, one has 
generalized convulsions, and two, who have microcephaly and severe mental 
retardation, have enlarged ventricles. Such pronounced hydrocephalus is excep-
tional in Fukuyama-CMD.10 One of our patients has a decrease of radiodensity 
in the white matter, suggesting hypomyelination, as described by Egger el al.,29 
Echenne et al.,35 and Mukoyama et al.38 
Santavuori et al.22 and Raitta et al.24 first introduced the term "muscle, eye, 
and brain disease," representing a rare disorder characterized by varying but 
usually severe mental retardation, macrocephaly, often severe hydrocephalus, 
hypotonia, and visual failure. Some authors have described encephaloceles.17·39,40 
All but one of our patients had severe hydrocephalus with agyria, and three had 
encephaloceles. 
According to Williams et al.,41 Towfighi et al.,17 and Dobyns et al.,42 many 
neuropathologic similarities exist in Fukuyama-CMD and MEB disease, 
although there are some differences; in general, most patients with Fukuyama-
CMD have microcephaly with hypomyelination of the cerebral white matter, and 
they have no or mild dilation of the ventricles, no encephaloceles, and no ocular 
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involvement, in contrast, patients with MEB disease generally have macrocepha-
ly, and they have hydrocephalus and encephaloceles with severe ophthalmologic 
involvement Our data support these observations, confirming that on clinical 
and neuropathologic grounds a distinction between Fukuyama-CMD and MEB 
disease can be made However, clinical overlap does exist, for instance, two of 
our patients with typical Fukuyama-CMD had severe hydrocephalus 
In 1978, Warburg41 reported thirteen patients with hydrocephalus, microph-
thalmos and congenital retinal nonattachment Pagon et al44 described two 
siblings with autosomal recessive eye and brain anomalies, of whom one also 
had an occipital encephalocele, and suggested the term "Warburg syndrome " 
Initially, muscular dystrophy was not detected in the Warburg syndrome, the 
muscle disease was probably overshadowed by severe cerebroocular abnormali-
ties Later, however, Towfighi et al '7 and Dobyns et al42 found typical dystro-
phic muscular changes, and we share their opinion that there is probably no 
distinction between the Warburg syndrome and MEB disease 
Most of our patients have normal or moderately increased CK activity, as 
described previously,78 l22"l'i whereas CK values in MEB disease are higher than 
in other types of CMD In all cases, CK activity decreased with progression of 
the disorder ' n Considering that lactate and pyruvate levels in serum and CSF, 
and pyruvate oxidation, fatty acid oxidation, and carnitine levels in muscle, are 
normal in the examined patients, mitochondrial dysfunction is unlikely 
Mitochondrial abnormalities such as crystalline inclusions and contorted cnstae, 
as found in patient 5,21 can be interpreted as a secondary phenomenon4*^8 
Except for a difference in serum CK activities in "pure" CMD and Fukuyama-
CMD on the one hand and in MEB disease on the other, differentiation of the 
subtypes cannot be made on biochemical grounds 
Histologic characteristics of muscle biopsy specimens in "pure" CMD, 
Fukuyama-CMD, and MEB disease are variable' '74° Dystrophic characteristics 
generally depend on the stage of the disorder and are usually progressive 8 In 
our series there was no correlation between age and degree of seventy of 
abnormality Histologic differences between patients with and those without 
CNS or ophthalmologic involvement could not be found, which is in accordance 
with the literature '° '7 We found an inflammatory infiltrate in muscle, as 
described by Towfighi et al '7 in some MEB disease cases, in only one patient 
with "pure" CMD 
The cause of the syndrome of CMD is not known Because of the high inci-
dence of the disorder among siblings, a genetic determination must be consid-
ered However, in cerebroocular dysgenesis and in Fukuyama-CMD, some 
67 
authors41,49,50 have suggested a viral meningoencephalitis, presumably of low 
virulence, as the cause of the proliferative, sclerosing process of the lepto-
meninges that eventually leads to an internal hydrocephalus. Thickening of the 
arachnoid with diffuse leptomeningeal and marginal gliodermal proliferation 
occurred in two of our patients with MEB disease, but antibodies against Toxo-
plasma, cytomegalovirus, herpesvirus, and rubella virus were not increased. 
Regarding the slight, diffuse mononuclear cell infiltration in patient 1, several 
authors'7·34·40,51 also observed mild, focal cellular infiltrates in the perimysium 
and endomysium and around blood vessels. Although the histopathologic 
findings might suggest a chronic meningoencephalitis active through the second 
and third trimesters of pregnancy and leading to oculocerebral malformation, the 
fact that siblings also can be affected indicates a genetic influence. The possibil-
ity remains of a nongenetic cause in sporadic cases. 
Recently we reported a family (patients 4 and 5) in which the "pure" CMD 
had an autosomal dominant mode of inheritance.21 These different modes of 
inheritance in CMD indicate the likelihood of genetic heterogeneity. Except for 
reports of this and one other20 "pure" CMD family with a likely autosomal 
dominant mode of inheritance, all other reports of "pure" CMD and "CMD plus" 
in patients mention an autosomal recessive inheritance.'017"'9,42 Interfamilial 
differences are more pronounced than intrafamilial ones, which also suggests 
genetic heterogeneity; the existence of allelic mutations in autosomal recessive 
CMD, Fukuyama-CMD, and MEB disease is possible. 
The question arises whether three different nosologic entities exist in CMD, 
or whether there is a single entity with variable expression ("pure" CMD, 
Fukuyama-CMD, and MEB disease).36 An argument for the latter hypothesis is 
the fact that the clinical course varies in CMD from mild to severe, the disease 
severity being generally more pronounced in Fukuyama-CMD and greatest in 
MEB disease with early death. Because of the higher values of CK activity in 
these latter patients, disuse of muscles cannot be the cause. Neuropathologic 
abnormalities are more pronounced in MEB disease than in Fukuyama-CMD, 
but no truly specific abnormality is found in these syndromes, with the possible 
exception of encephaloceles in MEB disease. However, the sibling of a patient 
with encephaloceles in this series had the typical brain and eye malformations of 
MEB disease but no encephalocele. The apparent intrafamilial concordance for 
severity and the fact that sibling pairs are always in the same general category 
indicate true genetic heterogeneity, as is also suggested by the differences in the 
incidence of Fukuyama-CMD in different gene pools. Whether this etiologic 
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heterogeneity is caused by allelic mutations or by mutations in different genes 
remains to be elucidated. 
On the basis of this study and the literature, we suggest that patients with 
CMD can be classified as having "pure" CMD of the autosomal recessive type, 
"pure" CMD of the autosomal dominant type, Fukuyama-CMD, or MEB 
disease, as defined by the apparent mode of inheritance and the presence of 
brain abnormalities with or without ophthalmologic abnormalities. Brain abnor-
malities in patients with CMD make the prognosis worse. 
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Ill 1.2 
White matter abnormalities in congenital muscular dystrophy 
Q.H. Leyten, F.J.M. Gabreëls, W.O. Renier, B.G.M, van Engelen, 
H.J. ter Laak, R.C.A. Sengers, H.O.M. Thijssen 
Journal of the Neurological Sciences 1995;129:162-169 
Abstract 
Central nervous system (CNS) characteristics were examined in seventeen 
patients with autosomal recessive classic or "pure" congenital muscular dys-
trophy (CMD). In three patients, neuroradiological examination (CT/MRI) 
indicated hypodense white matter areas. Two out of these three patients had 
epilepsy (seizures and epileptic discharges on their EEG). Only two of the 
remaining patients had epileptic EEG discharges, but without clinical seizures. 
By comparing our results to data in the literature, we could conclude that the 
classic or "pure" form of CMD can be subdivided into two subtypes, i.e. those 
with and those without white matter hypodensities. A mild form of epilepsy or 
an epileptic predisposition on EEG can be part of the subtype with white matter 
hypodensities. 
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Congenital muscular dystrophy (CMD) has been used to describe a group of 
neuromuscular disorders characterized by autosomal recessive inheritance, onset 
at birth or during the first year of life, hypotonia and generalized muscular 
weakness, multiple joint contractures evident in the first year of life, non-
progressive or slowly progressive clinical course, (sub)normal mental develop-
ment, and muscle biopsies which show striking pathological changes similar to 
muscular dystrophy and a normal distribution of dystrophin (Fukuyama et al., 
1960, 1981; Gubbay et al., 1966; Vassella et al., 1970; Donner et al., 1975; 
Lázaro et al., 1979; Serratrice et al., 1980; McMenamin et al., 1982; Banker, 
1986; Dubowitz, 1994). CMD has been classified into three separate entities 
(Dubowitz, 1994): classic or "pure" CMD with (sub)normal intelligence, 
Fukuyama type of CMD (F-CMD) with cerebral abnormalities and severe 
mental retardation (Fukuyama et al., 1960, 1981), and "muscle-eye-brain 
disease" (MEB-D) (Raitta et al., 1978; Santavuori et al., 1989; Leyten et al., 
1991, 1992) or the "cerebro-ocular dysplasia-muscular dystrophy syndrome" 
(COD-MD) (Towfighi et al., 1984; Heggie et al., 1987; Federico et al., 1988) 
with severe mental retardation and ocular malformations. The Walker-Warburg 
syndrome (WWS) is an autosomal recessive disorder characterized by type II 
lissencephaly, cerebellar malformation, characteristic eye malformations and 
congenital muscular dystrophy (McKusick, 1988). At present, there is still no 
consensus about whether MEB-D and WWS are separate entities (Dubowitz, 
1994). Some authors consider that MEB-D and WWS only differ in severity 
rather than in any fundamental feature (Dobyns et al., 1985; Leyten et al., 
1989). 
Recently, there have been 14 reports on 64 patients with a "pure" CMD and 
(sub)normal intelligence, whose CT/MRI scans indicated marked hypodensity of 
the white matter (Bernier et al., 1979; Nogen, 1980; Egger et al., 1983; Echenne 
et al., 1986; Martinelli et al., 1987; Yoshioka et al., 1987; Castro-Gago and 
Peña-Guitián, 1988; Streib and Lucking, 1989; Tanaka et al., 1990; Cook et al., 
1992; Kacinski et al., 1992; Pihko et al., 1992; Donner [see Dubowitz, 1994]; 
Topaloglu et al., 1994). Topaloglu et al. (1994) suggested that this type should 
be considered as an intermediate form between the "pure" form of CMD and the 
Fukuyama type of CMD, referred to by them as "occidental type cerebro-
muscular dystrophy". At present, cases with a (sub)normal intelligence quotient 
(IQ) who show white matter hypodensity on CT or MRI examination are 
included into the "pure" form of CMD (Dubowitz, 1994). 
We analyzed the CT/MRI of our 17 patients with "pure" CMD and found 3 
cases with white matter hypodensities. The clinical, electrophysiological and 
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neuroradiological data of these patients were compared to those reported in the 
literature. 
Materials and Methods 
In a retrospective study on a consecutive series of 2010 patients who underwent 
muscle biopsy because of muscle weakness, we found 17 patients with CMD. 
The final diagnosis was based on diagnostic criteria for classic or "pure" CMD 
(see Table 1) (Dubowitz, 1994). CNS characteristics of these patients were 
analyzed, including the clinical signs and symptoms, IQ, cerebrospinal fluid 
(CSF) (9 patients), especially myelin basic protein (MBP), EEG, and neuroradio-
logical findings (CT/MRI). DNA analysis including examination of the Xp21 
dystrophy gen was performed on all of the boys with a serum creatine kinase 
(CK) level of above 150 U/l (normal, <100 U/l), on some of the boys with a 
normal CK level and on two of the girls. 
Reports of 3 CMD cases with white matter hypodensities 
Case 15 
This 21-year-old man was the only child of healthy non-consanguineous parents. 
Family history did not mention neuromuscular disorders. Pregnancy was 
uneventful with normal intrauterine movements. Birth weight was 2870 g. At 
birth, generalized weakness and hypotonia, facies myopathica and contractures 
of the hips were found. Respiration was poor during the neonatal period. Motor 
development was delayed; the patient sat without support at 36 months and 
pulled himself upright at 40 months. He did not learn to stand and walk without 
support. Intellectual development was normal. 
On admission at 3 years of age, muscle weakness and hypotonia were severe 
and diffuse, but muscle wasting was not obvious. His face was without expres-
sion. Flexion contractures of the elbow, knee, hip and ankle joints were present. 
Right concave scoliosis was found. The only abnormal neurological signs 
comprised absent tendon reflexes, while the plantar responses were flexor. There 
were no dysmorphic features and the head circumference was on the 50th 
percentile. His mental development was considered to be above average until the 
age of 3 years. 
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Table 1. Diagnostic criteria for classic or "pure" CMD 
Inclusion criteria 
Clinical features: 
- onset at birth or during the first year of life, 
- hypotonia and generalized muscular weakness, 
- multiple joint contractures evident in the first year of life, 
- clinical course non-progressive or slowly progressive, 
- normal or subnormal mental development. 
Muscle biopsy: 
- dystrophic pattern 
- marked increase in interstitial connective tissue with or 
without increase in interstitial adipose tissue, 
- no marked fibre necrosis and regenerative activity, 
- sometimes more pronounced by dystrophic pattern, with 
evident necrosis and regeneration; dystrophin (both by 
immunocytochemical and Western-blot techniques) must be 
present and normal. 
Exclusion criteria 
Clinical features: 
- onset during childhood, 
- clinical course rapidly progressive, 
- muscular hypertrophy, 
- ptosis and/or ophthalmoplegia, 
- severe impairment of intellectual development (IQ <50), 
- structural ocular abnormalities. 
Laboratory findings: 
- EMG with "neuropathic" pattern, 
- muscle biopsy normal, with neuropathic abnormalities or with 
structural abnormalities specific of other myopathies, 
- dystrophin absent or abnormal, 
- major CT or MRI abnormalities of CNS different from white 
matter hypodensity (major malformations, developmental 
and/or migration defects). 
On examination at the age of 13 years, there was no evidence of progression 
of the muscle weakness. The Wechsler Intelligence Scale for Children-Revised 
(WISC-R) revealed a full scale IQ score of 115. 
At the age of 20 years, muscle weakness was static. He did not show 
deterioration in intelligence and behaviour. At this age, he had suffered two 
generalized tonic-clonic grand mal epileptic seizures. Over the last four years he 
developed progressive thoracic scoliosis. 
Biochemical investigations of serum and urine gave normal values except for 
a serum CK of 400 U/l (normal, <100 U/l). Full blood count, electrolytes, 
lactate and pyruvate levels in serum and CSF, blood and urine amino acids, 
copper, long chain fatty acids, white cell lysosomal enzymes and organic acids 
were normal. Microbiological examination excluded infections such as toxoplas-
ma, cytomegalovirus, herpes or rubella virus. Chromosome analysis revealed a 
normal 46.XY karyotype. Rearrangements of the dystrophy gen at Xp21 were 
not found. 
Electromyography (EMG) revealed an increased number of brief polyphasic 
potentials with a small amplitude. Motor nerve conduction velocities were 
normal. EEG showed rhythmic activity which was poor for his age and multi-
focal discharges. VEP and SSEP were normal. 
A biopsy from the quadriceps muscle at the age of 3 years showed a wide 
variation in fibre diameters; many of the fibres were larger than normal. 
Degenerative changes were present with central nuclei and fibre splitting. There 
was an increase in the interstitial connective tissue and some fat replacement. 
Cerebral CT at the age of 13 years showed marked hypodensity of the white 
matter of both hemispheres, which could also be seen on MRI. There has been 
no progression in white matter hypodensities on CT/MRI during the past 5 
years. 
Case 16 
A boy, the third child of healthy consanguineous parents (second cousins), was 
born after an uneventful pregnancy and normal intrauterine movements. Family 
history did not mention any neuromuscular disorders. Birth weight was 3925 g. 
Postpartum period was not complicated by asphyxia. At birth, generalized 
weakness and hypotonia, facies myopathica and contractures were found. Since 
the age of 2 years, he has been receiving (successful) treatment with antiepilep-
tic drugs for partial complex epileptic seizures, sometimes with secondary 
generalization. 
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On examination at the age of 6 years, his head circumference was 55 cm 
(>P90) and strabismus divergens was noted, without any structural ocular 
malformations. Generalized hypotonia and muscle weakness, which affected the 
proximal and distal muscles equally, were present with "facies myopathica". 
Deep tendon reflexes could not be elicited. Examination of the feet revealed 
"pedes equinovarus adducti" with toe-walking. Further development was charac-
terized by motor retardation and contractures of the achules tendons which 
necessitated tendon lengthening procedures. At the age of 7 years, he became 
wheelchair-dependent. Over the past 8 years he has developed progressive 
thoracolumbar scoliosis which required spondylodesis. At present he is 22 years 
old and wheelchair-dependent. He did not show any deterioration in intelligence 
and behaviour. 
Fig. 1. Cerebral CT scan of case 16 showing diffuse hypodensity of the white matter. 
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Biochemical investigations of serum and urine gave normal values (CK, 67 
U/l). Full blood count, electrolytes, lactate and pyruvate levels in serum and 
CSF, blood and urine amino acids, copper, long chain fatty acids, white cell 
lysosomal enzymes and organic acids were normal. Microbiological examination 
excluded infections such as toxoplasma, cytomegalovirus, herpes or rubella 
virus. Chromosome analysis revealed a normal 46,XY karyotype. Rearrange-
ments of the dystrophy gen at Xp21 were not found. 
EMG revealed an increased number of brief polyphasic potentials with a 
small amplitude. Motor nerve conduction velocities were normal. EEG showed 
diffuse slowing of the background and paroxysmal epileptic discharges. 
A biopsy from the quadriceps muscle at the age of six years revealed 
dystrophic changes, such as increased variability of muscle fibre size, severe 
increase of fat cells, basophilic fibres and fibres with internal nuclei and an 
increased amount of interstitial connective tissue. 
Cerebral CT at the age of 12 years showed diffuse hypodensity of the white 
matter (Fig. 1). MRI of the brain was not performed. No progression of the 
white matter hypodensities has been seen on CT during the past 3 years. 
Case 17 
A girl, the third child of healthy non-consanguineous parents was born after an 
uneventful pregnancy with normal intrauterine movements. Family history did 
not mention any neuromuscular disorders. Birth weight was 3360 grams and the 
Apgar scores were 9 and 10. Postpartum period was not complicated by 
asphyxia. At birth, generalized weakness and hypotonia, facies myopathica and 
slight dysplasia of the left hip were found. Deep tendon reflexes were absent. 
Head circumference was normal for her age. Ophthalmological examination did 
not reveal any structural malformations. At the age of 3 months, torticollis was 
noted, which necessitated operative correction at the age of 7 months. By the 
age of 18 months she was able to crawl, but could not stand. Generalized 
areflexia, hypotonia and muscle weakness were obvious, especially in the 
proximal musculature. Contractures did not occur. Mental development was 
normal. The following examinations were performed at this age of 18 months. 
Biochemical investigations of serum and urine gave normal values, except for 
increased CK (1178 U/l; normal, <90). Full blood count, electrolytes, lactate and 
pyruvate levels in serum and CSF, blood and urine amino acids, copper, long 
chain fatty acids, white cell lysosomal enzymes and organic acids were normal. 
Microbiological examination excluded infections such as toxoplasma, cytomega-
lovirus, herpes or rubella virus. Chromosome analysis revealed a normal 46,XX 
82 
karyotype. Rearrangements of the dystrophy gen at Xp21 were not found. 
EMG revealed an increased number of brief polyphasic potentials with a 
small amplitude. Nerve conduction velocity was normal. EEG, VEP and BAEP 
were normal. 
A »i 
Fig. 2. Biopsy of quadriceps muscle stained with HE (A) and dystrophin antibody (B). Note the 
wide variation of muscle fibre diameters and the even distribution of dystrophin. Bar = 50 pm. 
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Table 2. Signs and symptoms, laboratory, genetica!, radiological, and neurophysiological 
characteristics of 17 patients with "pure" congenital muscular dystrophy, 3 of whom had white 
matter hypodensities 
Case No 
Age at muscle biopsy (yr) 
Sex 
Consanguinity 
Congenital hypotonia 
Joint contractures 
Rapidly progressive course 
(motor retardation) 
CK activity 
(normal <90 U/l) 
DNA analysis 
Dystrophic muscular biopsy 
CNS involvement 
- CSF abnormalities 
- EEG abnormalities 
- Convulsions / epilepsy 
- White matter hypodensity 
(CT/MRI) 
- Intelligence * 
"Pure" CMD 
Without white 
hypodensity 
1 
0 
F 
-
+ 
+ 
+ 
288 
np 
+ 
np 
-
-
np 
N 
2 
0 
M 
-
+ 
-
-
N 
np 
+ 
np 
-
-
-
N 
matter 
3 
1 
F 
-
+ 
-
-
N 
np 
+ 
N 
-
-
-
N 
4 
1 
F 
-
+ 
+ 
-
N 
N 
+ 
np 
np 
-
-
N 
5 
1 
F 
+ 
+ 
+ 
-
N 
np 
+ 
N 
-
-
-
N 
6 
2 
M 
-
+ 
-
+ 
N 
np 
+ 
N 
-
-
-
N 
7 
3 
M 
-
+ 
-
-
N 
N 
+ 
N 
-
-
-
N 
N = normal, np = not performed, - = absent, + = present * Normal intelligence = IQ >70 
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8 
3 
M 
+ 
+ 
_ 
9 
3 
M 
+ 
-
_ 
10 
3 
M 
+ 
-
_ 
11 
4 
M 
+ 
-
_ 
12 
5 
M 
+ 
-
+ 
13 
6 
M 
+ 
-
-
14 
14 
M 
+ 
+ 
-
With white matter 
hypodensity 
15 
3 
M 
+ 
+ 
+ 
16 
6 
M 
+ 
+ 
+ 
-
17 
1 
F 
+ 
-
_ 
143 Ν N 134 153 392 N 400 N 1178 
np 
+ 
np 
+ 
np 
+ 
N 
+ 
N 
+ 
N 
-
np 
+ 
np 
-
N 
+ 
np 
-
N 
+ 
N 
-
np 
+ 
np 
-
N 
+ 
np 
+ 
+ 
+ 
N 
+ 
N 
+ 
+ 
+ 
N 
+ 
N 
-
+ 
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A biopsy from the quadriceps muscle at the age of 18 months revealed dys-
trophic changes, such as rounded fibres, a wide variation in the fibre diameter 
and an increased amount of interstitial connective tissue (Fig 2A) There was no 
marked evidence of fibre necrosis and regenerative activity Immunohisto-
chemistry with dystrophin antibodies showed a normal expression pattern (Fig 
2B) 
Cerebral CT at the age of 18 months showed hypodensities in the white 
matter At this age, MRI revealed hypodensities in the periventricular areas of 
both occipital horns (Tl, sagittal) and hypenntensity of the white matter (T2) 
No progression in white matter hypodensities has been seen on CT/MRI during 
the past 3 years 
Clinical course was characterized by motor retardation, but with normal 
mental development 
Analysis of the data on 17 patients with CMD (Table 2) 
Neuroradiological findings 
Thirteen patients did not show abnormalities on their CT or MRI of the brain In 
the 3 patients (cases 15, 16 and 17) with white matter hypodensity on cerebral 
CT, the hypodensity was diffuse and could be confirmed in 2 of the 3 cases by 
MRI, in one patient, MRI was not available (case 16) The first neuroimaging 
occurred at the age of 15, 13 and 16 years, respectively Follow-up was 
performed 3, 5 and 3 years later, respectively There was no change or progres-
sion 
Clinical features 
There were no clinical differences between CMD with and without white matter 
abnormalities 
EEG and epilepsy 
In cases 8 and 9, generalized spike-wave paroxysms occurred during sleep In 
case 8, there were also some spikes of short duration in the central regions, 
while in case 9, paroxysmal sharp theta waves were found, but these electrical 
phenomena were not associated with seizures 
Two patients with white matter hypodensities (cases 16 and 17) had poor 
rhythmic background activity for their age In cases 16 and 17, the following 
were noted multifocal discharges, diffuse slowing of the background activity 
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and paroxysmal epileptic discharges, such as bilateral irregular sharp theta 
waves which were sometimes mingled with spikes. Both patients had clinical 
seizures. Case 16 had suffered from two generalized tonic-clonic epileptic 
seizures at the age of 20 years, while case 17 had suffered partial complex 
seizures sometimes with secondary generalization from the age of 2 years 
onwards. Seizures could be treated successfully using conventional antiepileptic 
drugs. 
Laboratory findings 
In 16 out of our 17 patients, serum CK activity appeared to be normal or 
slightly increased. One case (case 17) with cerebral white matter hypodensity 
had markedly increased CK activity. 
All the CSF parameters, including cell count, protein content, protein electro-
phoresis, immuno-electrophoresis, myelin basic protein, lactate and pyruvate 
levels, were within normal ranges. 
Genetics 
The male/female ratio was 12:5. In 2 patients, consanguinity could be proved 
(case 5, 8'h-9'h generation; case 16, second cousins). 
DNA analysis was performed on 6 boys and 2 girls. Rearrangements of the 
dystrophy gen at Xp21 were not found. 
Discussion 
Congenital muscular dystrophy may be associated with more or less marked 
disorders of cerebral development. There are three subtypes (Dubowitz, 1994): 
classic or "pure" CMD, F-CMD and MEB-D. Topaloglu et al. (1994) believe 
that CMD with only white matter hypodensities on CT or MRI examination 
should be considered as an intermediate form. However, according to the 
opinion of most of the participants in a workshop on this topic (Dubowitz, 
1994), cases with a (sub)normal IQ who show white matter hypodensities on CT 
or MRI, without major malformations, developmental and/or migration defects 
of CNS, should be included in the classic or "pure" form of CMD (see Table 1). 
Table 2 shows a summary of the clinical data published in the literature on 
patients with CMD, (sub)normal intelligence, and low density areas in the white 
matter. All 17 patients with CMD in our series showed normal intellectual 
development. Three had marked, diffuse hypodensity of the white matter on CT 
and/or MRI examination. There were no dysmorphic features and no pyramidal 
signs. Some reports mentioned dysmorphic features, such as a long and thin 
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Table 3. Review of previously reported cases (64) and our cases (3) of congenital muscular dystrophy with (sub)normal intelligence and low density 
areas in the white matter 
Number of cases 
Male : female ratio 
Weakness 
- nonprogressive 
- progressive 
Epilepsy 
IQ>70 
50-70 
Other clinical signs 
- dysmorphic features * 
- pyramidal syndrome 
Epileptic EEG 
(First) author (year of publication) 
Bemier 
(1979) 
5 
3 : 2 
5/5 
0/5 
1/5 
5/5 
0/5 
0/5 
0/5 
1/5 
Nogen 
(1980) 
2 
0 : 2 
2/2 
0/2 
0/2 
0/2 
2/2 
0/2 
0/2 
0/2 
Egger 
(1983) 
3 
1 : 2 
2/3 
1/3 
1/3 
3/3 
0/3 
0/3 
0/3 
1/3 
Echenne 
(1986) 
6 
4 : 2 
4/6 
2/6 
2/6 
1/6 
5/6 
0/6 
0/6 
2/4 
Martinelli 
(1987) 
1 
1 :0 
0/1 
1/1 
l/l 
1/1 
0/1 
0/1 
0/1 
1/1 
Yoshioka 
(1987) 
1 
1 : 0 
1/1 
0/1 
0/1 
1/1 
0/1 
1/1 
0/1 
0/1 
Castro-Gago 
(1988) 
1 
1 : 0 
1/1 
0/1 
0/1 
1/1 
0/1 
0/1 
0/1 
0/1 
F = female; M = male; nm = not mentioned, * Dysmorphic features, such as (long and) thin face, high arched palate, abnormalities of jaw articula-
tion, and pigeon chest. 
Table 3. (continued) 
Number of cases 
Male female ratio 
Weakness 
- nonprogressive 
- progressive 
Epilepsy 
IQ>70 
50-70 
Other clinical signs 
- dysmorphic features * 
- pyramidal syndrome 
Epileptic EEG 
(First) author (year of 
Streib 
(1989) 
2 
1 1 
2/2 
0/2 
2/2 
2/2 
0/2 
0/2 
1/2 
2/2 
Tanaka 
(1990) 
1 
1 0 
1/1 
0/1 
0/1 
1/1 
0/1 
0/1 
0/1 
0/1 
publication) 
Kacinski 
(1992) 
1 
0 1 
1/1 
0/1 
0/1 
1/1 
0/1 
0/1 
0/1 
0/1 
Cook 
(1992) 
11 
4 7 
2/11 
9/11 
0/11 
9/11 
2/11 
0/11 
0/11 
1/4 
Pihko 
(1992) 
5 
3 2 
5/5 
0/5 
2/5 
5/5 
0/5 
0/5 
0/5 
5/5 
Donner ** 
5 
nm 
nm 
nm 
3/5 
5/5 
0/5 
nm 
nm 
nm 
Topalo|lu 
(1994) 
20 
12 8 
3/20 
17/20 
1/20 
11/13 
2/13 
8/20·? 
0/20 
8/20·? 
Our cases 
3 
2 1 
2/3 
1/3 
2/3 
3/3 
0/3 
0/3 
0/3 
2/3 
Total 
67 
34 28 
31/62 
31/62 
15/67 
49/60 
11/60 
9/62 
1/62 
25/53 
** See Dubowitz 1994 
face, abnormalities of jaw articulation and a high arched palate (Yoshioka et al., 
1987; Topaloglu et al., 1994). Although the authors of these reports suggested 
that these clinical aspects are specific, we believe that the facial dysmorphic 
features and high arched palate are not specific for this group, but they are 
frequently seen in myopathic children (Leyten et al., 1990). Topaloglu et al. 
(1994) reported clinical findings in 18 cases with "pure" CMD and 20 cases 
with (sub)normal IQ which show white matter hypodensity. The last group may 
tend to run a more severe course in the presence of significantly higher CK 
levels. This is in agreement with our findings. 
EEG abnormalities are not uncommon in "pure" CMD. Spikes and slow 
waves, periodic complexes and focal spikes can be detected in the routine EEG 
recordings (Pihko et al., 1992, Topaloglu et al., 1994). In literature 21 of 50 
studies cases with hypodensity of the white matter had abnormal recordings (see 
Table 3). Two of our three patients (cases 15 and 16) had seizures and epileptic 
discharges on their EEG. In contrast, only 2 of the 14 remaining CMD cases 
(cases 8 and 9) had epileptic EEG discharges without any seizures. However, 
only CT but no MRI examination of the brain had been performed on these 
patients, so we cannot exclude minor CNS deficit which can only be visualized 
using MRI. 
The occurrence of epilepsy was mentioned in 13 out of 64 patients in the 
literature (Table 3). Based on the data presented in Table 3, it can be concluded 
that there is a significantly higher epilepsy ratio (1 : 4.5) in CMD patients with 
(sub)normal intelligence and associated white matter hypodensities than in the 
normal population (1 : 150). This phenomenon cannot be explained by other 
neurological pathology. Therefore we believe that a mild form of epilepsy can 
be part of CMD with white matter hypodensities. 
The nature and significance of the white matter changes remain obscure. 
Informative neuropathological data are scarce. There is only one report (Egger et 
al., 1983) which described two patients. One patient showed moderate focal 
subpial gliosis and good preservation of the cortical architecture in a brain 
biopsy from the right frontal lobe. The myelin sheaths were intact in the core of 
the convolution. In the white matter, there was obvious astrocytic proliferation. 
This patient had a WISC-IQ of 135 at the age of 8 years, but this had fallen to 
90 at the age of 10 years. In the other patient in the report, microscopical 
examination showed patchy demyelination of the white matter of the centrum 
semiovale. The authors suggest that these neuropathological findings in them-
selves were not diagnostic, but the low density in the central areas of the brain 
on the CT scans may indicate a demyelinating process. One other case had 
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spongy appearance of white matter on necropsy (Echenne et al., 1986). Malik et 
al. (1990) described a case with significant decrease in staining of myelin as 
compared with age-matched, normal control brains. Before the introduction of 
CT/MRI, other authors also found demyelination of the brain in congenital 
muscular dystrophy (Fowler and Manson, 1973). However, the lack of progres-
sion of white matter hypodensities on successive CT/MRI scans (Egger et al., 
1983; Streib and Lucking, 1989; Cook et al., 1992; our study), the absence of 
progressive neurological signs and symptoms, and the normal MBP findings in 
CSF in our patients, are all arguments in favour of a non-progressive cerebral 
white matter disorder. However, long-term follow-up studies and neuropatho-
logical studies will be necessary to have more insight in this topic. 
The histological findings in the muscle biopsy specimens from CMD patients 
with (sub)normal intelligence and low density areas in the white matter reported 
in the literature and the findings in our series (Table 3) did not differ essentially 
from those described in "pure" CMD, F-CMD and MEB-D (Leyten et al., 1993). 
In their series, Topaloglu et al. (1994) found necrosis in 4 patients with white 
matter hypodensity and not in "pure" CMD. In our series, only fat cell infiltra-
tion was found to be increased with increasing age in "pure" CMD (Leyten et 
al., 1993). Therefore, muscle biopsies cannot discriminate between the subtypes 
of CMD. 
In conclusion, the data published in the literature (Table 3) and our findings 
support the hypothesis that the "pure" form of CMD with (sub)normal mental 
development can be subdivided into two subtypes, i.e. those with and those 
without white matter hypodensities. However, considerable overlap is evident in 
clinical and pathological presentations. The subtype with white matter hypodens-
ities tend to be clinically more severe (Topaloglu et al., 1994) and a mild form 
of epilepsy can be part of the clinical picture. The features are not sufficient to 
consider this subtype of CMD as a separate entity between the "pure" form of 
CMD and the Fukuyama type of CMD (Dubowitz, 1994). 
Further research should aim to perform more MRI in a prospective longitudi-
nal way, at different ages and on larger groups of children with CMD, and 
should include neuropathological examination of the hypodense white matter 
areas. Molecular genetic studies ("genetic mapping") should help to clarify 
whether the possible etiologic heterogeneity in the three subtypes of CMD is 
caused by allelic mutations of the same gene or by mutations in different genes. 
The responsible gene for the Fukuyama type of CMD has been localized at 
chromosome 9q31-33 (Toda et al., 1993) and we are probably now reaching the 
stage with CMD having clearly defined basic syndromes. 
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Ill 1.3 
Congenital muscular dystrophy with eye and brain 
malformations in six Dutch patients 
Q.H. Leyten, F.J.M. Gabreëls, W.O. Renier, 
К. Renkawek, H.J. ter Laak, R.A. Mullaart 
Neuropediatrics 1992;23:316-320 
Abstract 
From four Dutch families six patients, who have congenital muscular dystrophy, 
involvement of the central nervous system and of the eyes, or the so-called 
"muscle, eye and brain disease" (MEB-D), are reported. Two patients are still 
alive, in four autopsy could be performed. The clinical and morphological data 
of our patients are compared to those described in recent literature. The progres-
sion of the disease was rapid in five of our six patients. Our study supports the 
idea that within the MEB-D syndrome there are at least two different types of 
clinical expression, one with a rapid progression as described by Dobyns et al 
(1989) and one with a slower progression as described in most patients of 
Santavuori et al (1989). The study also confirms the autosomal recessive mode 
of inheritance of MEB-D. 
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The term "muscle, eye and brain disease" (MEB-D) was first introduced by 
Santavuori et al (22) and Rauta et al (21), representing a гаге autosomal 
recessive disorder characterized by muscular dystrophy, visual failure, mental 
retardation, macrocephaly and often severe hydrocephalus 
After the discovery of muscle involvement in the Walker-Warburg syndrome, 
previously known to consist of hydrocephalus, severe mental retardation and 
ocular malformation (15, 26), most authors actually agree that both conditions 
form one and the same entity (9, 10, 17, 18, 20-25) A consensus of this opinion 
was recently accepted at the VII International Congress on Neuromuscular 
Disease, Munich, FRG, 16-22 September 1990 
Dobyns et al (9) have proposed four diagnostic criteria for "muscle, eye and 
brain disease" (1) congenital muscular dystrophy, (2) retinal malformation, (3) 
cerebral malformation, type II hssencephaly or variants, and (4) cerebellar 
malformation Hydrocephalus and anterior chamber malformation of the eye are 
two other major abnormalities, which are not constant but very frequent 
In this paper we describe six Dutch patients with MEB-D Four patients have 
yet been mentioned in a previous survey of congenital muscular dystrophy 
(CMD) (17) Two new cases are added The clinical expression, follow-up and 
morphological data of these six patients are compared with recent descriptions 
of MEB-D in the literature (1-9, 12-16, 23, 26-30) 
Clinical features (Table 1) 
Two children were born by breech delivery Mild postnatal asphyxia occurred in 
three cases All had hypotonia and generalized weakness from birth In most 
cases, proximal muscles were more affected than distal ones and, in general, the 
arms were more impaired than the legs Contractures were present at birth in 
two cases All patients had severe involvement of the central nervous system 
(CNS) and the eyes, and appeared profoundly retarded One patient had left-
sided hemiconvulsions, which were treated successfully with anticonvulsive 
therapy Three patients had microcephaly and the other three had macrocephaly 
In three patients, an occipital encephalocele was present 
Ophfhalmological examination revealed microphthalmia and blepharophimosis 
of the right eye (Fig 1) and clouding of the cornea in Cases 1 and 2, who were 
sisters, of whom one also had choreoid atrophy and retinal detachment of the 
left eye and of whom the other had fetal anterior chamber angle of the left eye 
Case 3 had an antimongoloid position of the eyes with cataract and ins atrophy, 
and the cornea of the right eye had an opaque area in the central part Ocular 
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Table 1. Diagnostic criteria, signs and symptoms, laboratory, radiological and neurophysio-
logical characteristics of six Dutch cases with "muscle, eye and brain disease" compared to the 
data of the cases of Dobyns (9) and of Santavuori (23) 
Clinical expression 
Perinatal asphyxia 
Congenital hypotonia 
Early pyramidal signs 
Early joint contractures 
Age at death 
Age of survivors 
Muscle 
Increased CK activity 
Myogenic pattern of EMG 
Dystrophic muscular biopsy 
Normal distribution 
of dystrophin 
Our 
(n = 
3/6 
6/6 
4/6 
2/6 
2d-
cases 
6) 
5yr 
(4 cases) 
4 yr. 
6/6 
6/6 
5/5 
2/2 
, И yr 
Dobyns' cases 
(n = 21) 
often 
21/21 
-
7/20 
mean 2 mo 
( 19 cases) 
5-10% >5 yr 
8/8 
2/2 
14/14 
-
Santavuori's cases 
(n = 19) 
0/19 
10/19 (19/19)a 
>5 yr 
0/19 
6-16 yr 
(4 cases) 
(2.5)-46 yr 
0/19 (19/19)" 
14/14' 
16/16d 
-
OFC = occipital frontal circumference 
d
 initially 10/19, after 6 months 19/19 
b
 initially normal, later increased in 19/19 
c
 initially normal, after 1-2 years myopathic in 14/14 
d
 initially normal, after 6 months dystrophic in 16/16 
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Table 1. (continued) 
Eye 
Ophthalmological disorder 
Brain 
CNS involvement 
- mental retardation 
- mild 
- severe 
- O F C 
- congenital macrocephaly 
- congenital microcephaly 
- encephalocele 
- hydrocephalus 
- hypomyelination 
- cerebellar malformation 
Our 
(n = 
6/6 
6/6 
-
6/6 
3/6 
3/6 
3/6 
5/6 
1/6 
4/6 
cases 
6) 
Dobyns' cases 
(η = 21) 
21/21 
21/21 
-
21/21 
11/19 
3/19 
5/21 
20/21 
11/21 
20/20 
Santavuori's cases 
(η = 19) 
19/19 
19/19 
2/19 
17/19 
-
-
0/19 
11/19 
7/21 
slight atrophy in 
11/19 
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Fig. 1. Case 1. Microphthalmia and blepharophimosis of the right eye. 
Fig. 2. Case 4. Enlarged lateral ventricles and occipital encephalocele. 
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involvement in Case 4 revealed fetal anterior chamber angle in the left eye, 
cataract in the right eye, oblique implantation of the papil with excavation as 
seen in glaucoma. Case 5 had pendicular horizontally nystagmus and uncon-
trolled eye movements of central origin. The fundus showed a white coloured 
retina and a white coloured atrophic macula with pigmentation. In Case 6 a 
subcapsular and polaris posterior cataract in both eyes and strabismus con-
vergens appeared to be present. 
No patient did reach any motor milestones. Four patients died at the ages of 2 
days, 2 months, 3 months and 5 years, respectively. 
Genetical aspects 
In our series there are four girls and two boys. There are two sets of familial 
cases: two sisters (Cases 1 and 2), and a brother and sister (Cases 3 and 4). In 
only one case (Case 5) consanguinity was proved. In all cases chromosomal 
examination revealed a normal pattern. 
Laboratory investigations 
Appropriate studies ruled out inborn errors of metabolism, endocrinological, 
immunological and chronic infectious diseases, vitamin deficiencies, and 
disorders caused by toxic agents. All six patients had increased CK activity 
(between 990 U/l and 1540 U/l, normal < 90 U/l). 
Neurophysiological investigations 
Electroencephalography in the examined cases showed diffuse slowing and 
paroxysmal discharges. Visual evoked potentials and brain stem auditory evoked 
potentials were examined in two cases and appeared severely disturbed. Electro-
myographic studies indicated a severe myopathic trace in all patients, while 
motor nerve conduction velocities were normal. 
Radiological investigations 
Computerized tomography of the brain could be performed in five of the six 
children and showed lissencephaly and enlarged third and lateral ventricles 
(hydrocephaly) in all five. In Case 6 irregular porencephaly was present in the 
left frontal lobe. Three had an occipital encephalocele (Fig. 2). 
Muscle biopsies 
Light microscopical examination of muscle biopsy or autopsy samples from five 
out of six patients was performed and revealed dystrophic changes ranging from 
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slight to very severe. The least affected biopsy showed a slight increase of fat 
cells and connective tissue, and a slightly increased variability of muscle fibre 
size. In the most affected specimen, almost all muscle fibres were replaced by 
fat cells. In all specimens, rounded fibres were present and in all cases there 
was an increased variation in fibre size diameter caused by the presence of 
atrophic and hypertrophic fibres (Fig. 3). Fibres with internal nuclei were 
observed in one case, basophilic fibres in two cases, some hyaline fibres in three 
cases and sporadic necrotic fibres in one case. In two cases, immunohistochemi-
cal investigations for the presence of dystrophin could be performed; normal 
distribution patterns were found. 
Biochemical studies 
Pyruvate oxidation and fatty acid oxidation were in the normal range. Carnitine 
content was examined in three cases and revealed no abnormalities. 
Fig. 3. Dystrophic picture of the soleus muscle with rounded muscle fibres of varying diameter 
and clear increase of connective tissue, Haematoxylin and Eosin, χ 400. 
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Neuropathologies examination 
In four cases autopsy has been performed immediately after death. It concerns 
Case 1 and her sister (Case 2), Case 3 and her brother (Case 4). Two of our 
patients are still alive. Macroscopical and microscopical examination showed 
similar picture of brain abnormalities in all cases examined. There was lissen-
cephaly, hydrocephalus, agenesis of the olfactory bulbs, optic chiasma and 
septum pellucidum, cerebellar hypoplasia, agenesis of vermis and cystic malfor-
mation. Light microscopical examination revealed a type II lissencephaly, 
hypomyelination of cerebral white matter, diffuse leptomeningeal and glial 
proliferation, disorganization of the cerebral and cerebellar lamination and 
heterotopia of Purkinje cells (Figs. 4 and 5). 
Examination of the eyes showed malformations consisting of diffuse disruption 
of laminar disorder and apparently dysplastic changes due to defective fetal 
development. Detailed examination of neuropathological and ophthalmological 
abnormalities of Cases 1 and 2 has been described in our previous publication 
(18). 
Pathological examination 
General autopsy of Case 1 revealed several small follicle cysts in the right 
ovarium. In the adrenals some nodular hyperplasia occurred. Histological 
examination of the skin excluded ectodermal dysplasia. In Case 2, autopsy of 
the body revealed slight splenomegaly of the weight (250 g, normal 160 g) and 
infectious changes in the spleen. In Cases 3 and 4, the lungs and heart were of 
normal weight and of normal appearance. Cardiomyopathy was not found. 
Especially renal dysplasia and imperforate anus did not occur. 
Discussion 
The six Dutch patients manifest the association of congenital cerebro-ocular 
malformations and dystrophic changes of the muscles, the so-called "muscle, eye 
and brain disease" (MEB-D) (9, 17, 18, 20-23, 25). 
In the literature, two large series on MEB-D have recently been published, one 
by Dobyns et al (9), the other by Santavuori et al (23). The former series 
contains a large survey of the literature (1-8, 12-16, 26-30). 
Considering the clinical data in our study, the high rate of respiratory difficul-
ties in half of our cases is remarkable and is also found in Dobyns' study (9). In 
general, the clinical expression of the disease at birth (as perinatal asphyxia, 
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Fig. 4. Disorder of cortical lamination and neural orientation, nest of cells divided by acellular 
tissue. Klüver-Barrera, χ 200. 
. * * 1 Й « , " . - . Й ^ 
Fig. 5. Disarrangement of cerebellar architecture, proliferation of mesenchymal tissue. 
Haematoxylin and Eosin, χ 120. 
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congenital hypotonia, early pyramidal signs and early joint contractures) is more 
severe in our group and in most patients of Dobyns (9) compared to those of 
Santavuori (23). Progression of the disease was rapid in five of our six patients, 
in all patients described by Dobyns et al (9) and in most of the patients de-
scribed in the literature (1-8, 12-16, 26-30). In contrast, patients in Santavuori's 
study show a slow progression (23). In our study only one patient has a mild 
course. From the literature study one can expect that 5-10% of the MEB-D 
patients will have a slow progression (1-9, 12-16, 26-30). Our patients are 
profoundly retarded, as most in the literature (9). However, mental retardation is 
mild in two patients of Santavuori (23). The initially normal and later increasing 
CK values in Santavuori's patients (23) contrast with the initially increased CK 
values in our study and in Dobyns' report (9). 
Dystrophic characteristics of the muscle generally depend on the stage of the 
disorder and are usually progressive (11, 17). The dystrophic changes of muscle 
biopsy in the cases of Santavuori's study (23) seem less severe than in the cases 
of Dobyns (9) and in ours. The histological findings described in Santavuori's 
study (23) were very variable, ranging from nearly normal to severely dystro-
phic and the histological picture of a burned out myopathy was not seen even in 
the oldest patients. 
The ophthalmological signs in MEB-D include both functional disturbances, 
such as nystagmus and uncontrolled eye movements of central origin, and 
structural eye changes, such as microphthalmia, cleavage defects of the anterior 
chamber resulting in congenital glaucoma, optic cup deformation resulting in 
severe myopia, cataract, and retinal changes, such as retinal dysplasia and 
detachment (9, 17, 20-23, 25). Comparing the ophthalmological characteristics 
between the three studies (ours, 9, 23) and the other reports from the literature 
(1-8, 12-16, 26-30) no essential differences have been noticed. 
Regarding the neuropathological findings, no essential pathological differences 
can be found between the patients of Dobyns' report (9) and our patients. 
Encephalocele, cerebellar malformation and hydrocephalus are observed more 
often in our and in Dobyns' study (9), and not or less frequently in the study of 
Santavuori (23). Microscopical data have scarcely been described, but the 
cerebral gyral anomalies are more widespread in Dobyns' group (10). 
Considering the clinical expression and progression, and the laboratory, radio-
logical and morphological characteristics in the different studies, we conclude 
that within the spectrum of "muscle, eye and brain disease" different severities 
of the disease exist, ranging from a more milder type in the Finnish group (23) 
to a more severe type in Dobyns' group (9) and in most of our patients. Besides 
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the clinical spectrum of MEB-D our study also confirms the autosomal recessive 
inheritance of MEB-D (19). 
Regarding genetic aspects of MEB-D in our cases and in literature (1-8, 12-16, 
26-30), interfamilial differences are more pronounced than intrafamilial, which 
is compatible with genetic heterogeneity and the possible existence of allelic 
mutations. Whether this possible etiologic heterogeneity is caused by allelic 
mutations or by mutations in different genes remains to be elucidated (10, 17, 
18). 
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Ill 2 
MORPHOLOGICAL STUDIES 

Ill 2.1 
Congenital muscular dystrophy 
A study on the variability of morphological 
changes and dystrophin distribution in muscle biopsies 
Q.H. Leyten, H.J. ter Laak, F.J.M. Gabreëls, 
W.O. Renier, К. Renkawek, R.C.Α. Sengers 
Acta Neuropathologica 1993;86:386-392 
Abstract 
Histomorphological and histochemical variability was studied in muscle speci-
mens from 30 patients with congenital muscular dystrophy (CMD). We found 
involvement of the central nervous system in 8 patients (Fukuyama CMD, 
F-CMD), involvement of the brain and the eyes in 5 patients (muscle, eye and 
brain disease, MEB-D) and hypodense white matter on the CT scans of 2 
patients with (sub)normal intelligence (occidental-type cerebromuscular dystro-
phy, O-CMD). No morphological hallmarks were found to differentiate these 
subgroups. Only fat cell infiltration was found to be increased with increasing 
age in 'pure' CMD (pure-CMD). The morphological data did not appear to be 
correlated with the clinical severity or type of dystrophy (pure-CMD, F-CMD, 
MEB-D and O-CMD). Immunohistochemistry with dystrophin, vimentin and 
desmin antibodies in 14 patients (6 pure-CMD, 5 F-CMD, 2 MEB-D and 1 
O-CMD) showed a normal expression pattern. 
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Congenital muscular dystrophy (CMD) encompasses several groups of congeni-
tal degenerative muscle diseases with great variation in clinical appearance [2, 4, 
7-14, 17-20, 22, 28, 30-33, 35, 38]. We can distinguish 'pure' CMD (pure-
CMD), CMD with normal (or subnormal) intelligence and hypodense white 
matter on CT scans, also called 'Occidental-type CMD' (O-CMD) [34], CMD 
with malformation of the central nervous system or 'Fukuyama-CMD' (F-CMD) 
and CMD with involvement of the central nervous system and the eyes, so-
called 'muscle, eye and brain disease' (MEB-D) [9, 30-33, 35]. 
Dystrophin distribution has been described in a few cases of pure-CMD [1, 
24, 29, 36, 37] and F-CMD [1, 27]. As the distribution was found to be dis-
turbed in some of the studies on F-CMD [1, 27], we compared our results to 
those studies. 
The aim of this study was (i) to investigate whether there are any qualitative 
and/or quantitative morphological differences between the muscle biopsies of 
patients suffering from pure-CMD, O-CMD, F-CMD and MEB-D, (ii) to present 
and discuss the results of dystrophin, desmin, and vimentin distribution in these 
patients, and (iii) to investigate whether there is a possible relation between 
muscle pathology and the clinical severity of the disease. 
Material and Methods 
From the 2010 muscle biopsies (performed and stained according to standard 
procedures) examined at the neuromorphological department over the past 18 
years, 30 were diagnosed as having CMD. The final clinical diagnosis of 
pure-CMD, O-CMD, F-CMD or MEB-D was based on clinical data and 
CT/magnetic resonance imaging. The clinical severity of CMD was expressed 
by the individual motor development of the patients (Fig. 1). 
Clinical data (Table 1, Fig. 1 ) 
Some patients showed mild postnatal asphyxia. Generalized hypotonia and 
weakness from birth with significantly delayed motor development (Fig. 1) was 
noted in all patients. In most patients, proximal muscles were more affected than 
distal ones and generally the arms were more impaired than the legs. 
Contractures were often observed (at birth or later). CNS involvement included 
mild or severe mental retardation, epilepsy, microcephaly, macrocephaly, 
encephalocele, meningocele, and hydrocephalus. Ophthalmological involvement 
included microphthalmus, corneal clouding, fetal anterior chamber angle, 
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Table 1. Diagnostic entena, signs, symptoms, laboratory, radiological, and neurophysiological characteristics of 30 patients with congenital muscular 
dystrophy (CMD) 
Pure-CMD 
n= 15 
Occidental 
n = 2 
0/2 
2/2 
1/2 
1/2 
1/2 
2/2 
2/2 
1/1 
-type CMD Fukuyama-CMD 
n = 8 
2/8 
8/8 
4/8 
4/8 
4/8 
7/7 
8/8 
5/5 
Muscle-eye-brain disease 
n = 5 
Clinical expression 
Perinatal ashyxia 
Congenital hypotonia 
Joint contractures 
Rapidly progressive course 
Muscle 
Increased CK level 
Myogenic pattern of EMG 
Dystrophic muscular biopsy 
Normal distribution of dystrophin 
Eye 
Ophthal mological disorders 
Brain 
CNS involvement 
Mental retardation 
Congenital macrocephaly 
Congenital microcephaly 
Encephalocele 
Hydrocephalus 
Hypomyelination 
Cerebellar malformation 
3/15 
15/15 
10/15 
4/15 
6/15 
15/15 
15/15 
6/6 
0/15 
0/15 
0/15 
0/15 
0/15 
0/15 
0/15 
0/15 
0/15 
0/2 
2/2 
0/2 
0/2 
0/2 
0/2 
0/2 
2/2 
0/2 
0/8 
8/8 
8/8 
0/8 
3/8 
0/8 
4/8 
2/8 
3/8 
2/5 
5/5 
2/5 
4/5 
5/5 
5/5 
5/5 
2/2 
5/5 
5/5 
5/5 
2/5 
2/5 
3/5 
4/5 
1/5 
3/5 
macular atrophy, severe myopia, and uncontrolled eye movements. All our 
patients had normal or moderately increased CK levels, the highest ones being 
present in the MEB-D group (see Table 2). For more details we refer to our 
papers on congenital muscular dystrophy [19] and on neuropathological findings 
in "muscle-eye-brain disease" [20]. 
Postmortem examination 
Seven patients have died (see Fig. 1). Five brains were available for postmortem 
examination (two F-CMD and three MEB-D). The data of one F-CMD patient 
(no. 20) and two MEB-D patients (no. 26 and 27, who were sisters) have 
already been described, [17] and [20], respectively. Generally, neuropathology 
was characterized by severe hydrocephalus and defective brain development; 
low density of the cerebral white matter in CT scan was common. 
One F-CMD brain (no. 20) revealed a lissencephalic and partly polymicro-
gyric neocortex, absent corpus callosum and a bridge of gray matter linking both 
hemispheres, absence of cerebral cortex lamination with subcortical neuronal 
heterotopic masses, white matter gliosis, a polymicrogyric cerebellum and a true 
hydrocephalus presumably due to aqueductal stenosis. The other F-CMD brain 
(no. 19) was microcephalic and showed severe depletion of neurons, demyelin-
ation and neuronal migration defect. Cortical layering was absent, and gray and 
white matter were poorly delineated. Further, this brain showed a thin corpus 
callosum, hydrocephalus and diffuse poverty of myelin fibers. 
The pathological findings in MEB-D (no. 26, 27 and 30) were lissencephaly, 
hydrocephalus, absence of cerebral cortex lamination, hypomyelination, heteroto-
pia, Dandy-Walker cysts, and agenesis of olfactory and optic tracts, septum, 
corpus callosum, and vermis. Examination of the eyes was performed in one 
patient (no. 26) and revealed changes due to defective eye development of fetal 
origin. Both eyes were microphthalmic and among others revealed retinal 
dysplasia, fetal chamber, coloboma, and cataract. 
Morphological biopsy parameters 
In all of the muscle biopsies (mostly taken from the quadriceps muscle), the 
following parameters were semiquantitatively examined and expressed in rela-
tion to their severity (-, normal or absent; +/-, present; +, increased; ++, 
marked; and +++, extensive): the presence of fat cell infiltration, endomysial 
connective tissue, fibers with internal nuclei, basophilic fibers, necrotizing or 
necrotic fibers, atrophy of type I fibers and type II fibers and hypertrophy of 
type I and type II fibers; the presence of type I and type IIC fibers was also expressed. 
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CMD 
O-CMD 
F-CMD 
MEB-D 
Age (years) 
Fig. 1. Motor development of 15 patients with pure congenital muscular dystrophy (CMD), 2 
with occidental type (O)-CMD, 8 with Fukuyama (F)-CMD, and 5 with muscle-eye-brain 
disease (MEB-D). Age of ambulation at the end of follow-up or at death (f). 
Immunohistochemical labelling of dystrophin, desmin, and vimentin 
Immunohistochemical labelling of dystrophin, vimentin and desmin was carried 
out on six pure-CMD patients, five F-CMD patients, two MEB-D patients and 
one O-CMD patient. Unfixed frozen sections, 8 um thick, were cut using a 
cryostat microtome. These sections were mounted directly onto microscope 
coverslips and stored at -30°C until required. Immunolabelling was done by 
incubating (1 h) sections with primary monoclonal antibody against the С 
terminus of dystrophin (DYS 2, Novocastra Laboratories) diluted with phos­
phate-buffered saline (PBS 1:2). After rinsing in PBS ( 3 x 3 min), peroxidase-
conjugated rabbit anti-mouse immunoglobulins (Dakopatts) were added and left 
for 1 h (dilution 1:10). Immunohistochemical labelling of desmin and vimentin 
was also performed by incubating sections with diluted (1:40) polyclonal 
antibodies against desmin and vimentin (both from Euro-diagnostics) for 1 h; for 
these antibodies peroxidase-conjugated goat anti-rabbit immunoglobulins 
(Nordic) were used. Sections were washed again in PBS ( 3 x 3 min) prior to 
evaluation of the peroxidase label by using a solution with 3-amino-9-ethyl-
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Fig. 2. Dystrophin immunostain of case 9 (pure-CMD). Note the even distribution on both 
small and hypertrophic muscle fibers. Bar = 50 μπ\. 
carbazole (for dystrophin) or 3,3'-diaminobenzidine tetrahydrochloride (for 
desmin and vimentin) for 5 min. To avoid misinterpretation, immunolabelling of 
control tissue sections from other patients - of the same age and stored for the 
same period - was also performed simultaneously. 
Statistical analysis 
Wilcoxon's test (or modifications of this test) or exact calculation of the results 
was performed to determine Ρ values (a value smaller than 0.05 or exceeding 
0.95 was considered to be significant). 
Results 
Histometry 
Patients were classified according to their final clinical diagnosis and arranged 
according to their age (Table 2). From this table it can be seen that there was 
considerable variability in the observed parameters. After statistical testing no 
significant differences were found between pure-CMD, O-CMD, F-CMD and 
MEB-D, except for the increase in fat cell infiltration with age in pure-CMD. 
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Table 2. Morphological parameters in pure-CMD, occidental type CMD, Fukuyama-CMD and muscle-eye-brain disease 
Patient no 
Age of examination (years) 
Sex 
Biopsy location 
CK activity (normal <90 U/l) 
Fat 
Connective tissue 
Internal nuclei 
Basophilic fibers 
Necrotic fibers 
Hyaline fibers 
Percentage type I fibers 
Type IIC fibers 
Atrophic fibers 
- type I 
- type II 
Hypertrophic fibers 
- type I 
- type II 
Dystrophin distribution 
Desmin/Vimentin 
Pure-CMD in 
age 
1 2 
0 
F 
Q 
288 
+ 
++ 
-
+ 
-
-
NO 
NO 
++ 
1 
NO 
NO 
0 
M 
Q 
N 
-
+ 
-
-
-
-
48 
-
+++ 
+++ 
2 
+++ 
N 
N 
patients up to 
3 4 
1 
F 
Q 
N 
-
+ 
-
+ 
-
+/-
34 
-
++ 
++ 
3 
-
NO 
NO 
1 
F 
Q 
N 
-
+ 
-
+ 
-
+/-
55 
+ 
++ 
++ 
4 
++ 
++ 
NO 
NO 
3 years 
5 
1 
F 
Q 
33 
-
-
-
-
-
-
67 
-
++ 
+ 
5 
+ 
+ 
N 
N 
of 
6 
2 
M 
Q 
N 
-
++ 
++ 
-
-
-
99 
-
+ 
+ 
6 
++ 
-
NO 
NO 
Pure-CMD in 
7 
3 
M 
Sol 
18 
+++ 
++ 
++ 
++ 
-
+/-
87 
+ 
++ 
+ 
7 
+ 
++ 
N 
N 
8 
3 
M 
Q 
143 
+++ 
++ 
-
+ 
-
+/-
30 
-
+ 
+ 
8 
+ 
+ 
NO 
NO 
patients of 3 
9 
3 
M 
RA 
Ν 
-
++ 
-
-
-
-
70 
-
+ 
+ 
9 
+ 
+ 
Ν 
Ν 
10 
3 
Μ 
Q 
Ν 
+ 
+ 
-
+ 
+ 
-
55 
+ 
+ 
+++ 
10 
+++ 
+ 
Ν 
Ν 
years of 
11 
4 
M 
Q 
134 
++ 
+ 
+ 
++ 
+ 
+/-
42 
+++ 
+++ 
+++ 
11 
++ 
++ 
NO 
NO 
age and 
12 
5 
M 
Q 
153 
++ 
+ 
-
+ 
-
-
82 
++ 
+ 
+ 
12 
-
N 
N 
older 
13 
6 
M 
Q 
392 
+ 
++ 
+ 
-
+ 
-
54 
-
-
-
13 
++ 
++ 
NO 
NO 
14 
7 
M 
Q 
282 
-H-
++ 
++ 
+ 
+ 
+/-
51 
++ 
+ 
+ 
14 
++ 
++ 
NO 
NO 
15 
14 
M 
Q 
N 
+++ 
++ 
++ 
-
-
-
50 
-
-
+++ 
15 
+++ 
-
NO 
NO 
Occi 
type 
16 
1 
F 
Q 
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+ 
++ 
+ 
-
+ 
-
76 
+ 
+ 
-
16 
++ 
++ 
N 
N 
dental 
CMD 
17 
6 
M 
Q 
4O0 
+++ 
+ 
+ 
+ 
+ 
-
77 
+ 
+ 
-
17 
+++ 
+++ 
NO 
NO 
Table 2. (continued) 
Patient no 
Age of examination (years) 
Sex 
Biopsy location 
CK activity (normal <90 U/l) 
Fat 
Connective tissue 
Internal nuclei 
Basophilic Tibers 
Necrotic fibers 
Hyaline fibers 
Percentage type I fibers 
Type IIC fibers 
Atrophic fibers 
- t y p e I 
- type II 
Hypertrophic fibers 
- type I 
- type II 
Dystrophin distribution 
Desmin/Vimentin 
Fukuya 
18Aa 
0 
Q 
-
+ 
-
++ 
+ 
+/-
90 
-
+ 
+ 
+ 
+ 
NO 
NO 
ima-CMD 
18B" 
1 
F 
Sol 
590 
+++ 
++ 
+ 
+ 
-
-
40 
+ 
+ 
+ 
-
N 
N 
18C' 
1 
Q 
+++ 
+ 
+ 
+ 
-
-
77 
-
+ 
+ 
+ 
N 
N 
19 
0 
F 
Q 
527 
-
+ 
-
+ 
-
-
40 
++ 
+ 
+ 
+ 
N 
N 
20 
0 
M 
Q 
690 
-
++ 
+ 
+ 
+ 
++ 
30 
+++ 
++ 
++ 
++ 
++ 
NO 
NO 
21 
1 
F 
Sol 
37 
+ 
+ 
-
-
-
-
97 
-
+ 
+ 
-
N 
N 
22 
2 
M 
Q 
N 
++ 
+++ 
+ 
+ 
-
+/-
36 
+++ 
++ 
++ 
+ 
+ 
NO 
NO 
23 
3 
M 
Q 
60 
+++ 
+++ 
++ 
-
-
-
100 
-
++ 
+++ 
NO 
NO 
N 
N 
24 
4 
F 
Q 
192 
-
+ 
-
-
-
-
53 
-
_ 
-
+ 
+ 
N 
N 
25 
10 
M 
Q 
N 
++ 
+ 
+ 
-
-
-
64 
-
+ 
+ 
++ 
++ 
NO 
NO 
Muscle 
26 
0 
F 
Q 
1130 
+ 
+ 
-
NO 
-
+/-
NO 
NO 
+ 
++ 
NO 
NO 
-eye-brain disease 
27 
0 
F 
Q 
1540 
+ 
+ 
-
NO 
-
+/ -
NO 
NO 
+ 
++ 
NO 
NO 
28 
0 
F 
Sol 
1495 
+ 
++ 
-
++ 
-
+ / -
40 
-
+ 
+ 
+ 
+ 
NO 
NO 
29 
5 
M 
Q 
900 
+ 
+ 
-
+ 
+/-
-
59 
-
+ 
-
: 
N 
N 
30 
5 
F 
Q 
990 
++ 
++ 
+ 
-
-
-
40 
NO 
+ 
+ 
+ 
N 
NO 
F, female; M, male; N, normal; A, abnormal; NO, not observed or not performed, Q, quadriceps muscle; Sol, soleus muscle, RA, rectus abdominis muscle; 
- , normal or absent; +/-, present; +, increased; ++, marked, +++, extensive 
1
 Biopsies from the same patient 
Table 3. Studies of dystrophin in patients with pure-CMD, Fukuyama-CMD, occidental type CMD, and muscle-eye-brain disease 
CMD type 
Method 
Pure-CMD 
WB IH 
Occidental-type CMD 
WB IH 
Fukuyama-CMD 
WB IH 
Muscle-eye-brain disease 
WB IH 
Arikawaetal [1] (л = 51) 15/15: N 15/15: N 
Morandi et al [24] (η = 11) 7/11 : Ν 7/11 : Ν 
4/11: Α, 4/11: Α, 
Nomura et al [27] (я = 4) 
29/36: Ν 
5/36: А, 
2/36: А, 
34/36: А, 
2/36: А, 
2/4: N 
1/4: А, 
1/4: А, 
Patel et al [29] (η = 5) 
Uchino et al [36] (л = 3) 
Voit et al [37] (π = 1) 
Our study (л = 14) 
5/5: Ν 
3/3: Ν 
1/1: Α, 
-
-
-
1/1: Α, 
6/6: Ν 1/1: Ν 5/5: Ν 2/2: Ν 
WB, Western blot analysis; IH, immunohistochemistry; Ν, normal content and/or distribution of dystrophin; A, abnormal; A,, abnormality in WB or 
presence of fibers without dystrophin (and/or abnormally distributed dystrophin); A2, absence of dystrophin. 
Dystrophin, desmin and vimentin 
The dystrophin distribution was normal in all types of CMD (Fig. 2). Immuno-
histochemical desmin distribution was essentially the same as in the controls. 
Vimentin was present in the interstitial tissue in the patients and controls, but 
the muscle fibers were unstained. 
Discussion 
Histological characteristics were studied in all 30 patients. Our results with 
respect to morphological changes in muscle biopsies from pure-CMD, O-CMD, 
F-CMD and MEB-D patients indicated that there were no morphological hall-
marks to differentiate these four CMD types. Very few reports are available in 
the literature, especially on MEB-D, probably because, initially, muscular 
dystrophy was overshadowed by severe cerebral and ocular malformations [9, 
19]. Similar localization of MEB-D changes might be found in mitochondrial 
encephalomyopathy. However, we did not have any indication for the latter 
because increase of lipid and presence of ragged-red fibers were not observed in 
the biopsies. Furthermore, lactate and pyruvate levels were normal in both 
serum and CSF. Reports have indicated that muscle changes in CMD do not 
differ from those observed in patients reported to have O-CMD, F-CMD, or 
MEB-D [9, 14, 19, 34]. 
It is known that large numbers of hyaline fibers and groups of basophilic 
fibers are indicative of Duchenne muscular dystrophy, while ring fibers, fiber 
splitting and internal nuclei may indicate limb girdle dystrophy. Although these 
pathological characteristics are indicative of a particular type of dystrophy, they 
are not pathognomonic. In CMD, these pathognomonic characteristics are also 
lacking. Although the pattern was clearly dystrophic (fibrosis, diameter varia-
bility, and rounded muscle fibers), there was great variability between the 
parameters studied in each group. Even per patient, this histological variability 
was often considerable: the first biopsy of patient no. 18 did not show many fat 
cells, but in the second and third biopsies, the fat cell infiltration was extensive. 
It should be realized that the dystrophic characteristics in muscle biopsy 
specimens of all types of CMD vary considerably and generally depend on the 
stage of the disorder and are usually progressive. In fact, no significant differ-
ences were found between the groups. However, fat cell infiltration was found 
to increase with increasing age in pure-CMD. Owing to the lack of biopsies 
from patients in the higher age categories and the small number of patients with 
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0-CMD, F-CMD and MEB-D in our study, age-related conclusions could not be 
drawn from the data on these groups. Finally, no relation was found between 
muscle pathology and the clinical severity of the disease. 
In 14 patients, comprising 6 pure-CMD, 1 O-CMD, 5 F-CMD and 2 MEB-D, 
immunohistochemistry with dystrophin antibody staining could be performed. In 
the literature only a few reports are available on dystrophin in CMD with or 
without involvement of the central nervous system [1, 24, 29, 36, 37]. The data 
from the literature and our data are summarized in Table 3. In contrast to some 
of the references in this table, the distribution pattern of dystrophin in all of our 
cases was normal. Although our patients were carefully matched with controls, 
it might be possible that our patients with a normal dystrophin distribution 
contained lower quantities of this molecule or that the type of dystrophin 
(smaller or larger molecules) was different from normal. Western blot analysis 
has been proposed to resolve this problem. However, in a recent study [37] the 
results of Western blot analysis were found to be largely compatible with those 
from immunofluorescence. It is doubtful whether some of the publications in 
Table 3 represent typical CMD [1, 27]. CK values were not always mentioned 
[15, 26] and DNA-gen analysis was not performed in most cases. Therefore, 
more atypical cases or clinical variants of other dystrophies may have been 
present in these cases. Our data indicate a more homogeneous population: CK 
values were normal or only slightly increased and the findings in muscle 
biopsies were different from those generally found in Duchenne or Becker 
muscular dystrophy [3, 5, 6, 15, 16, 23, 25, 26]. 
Recently [21], a greatly reduced staining for dystrophin-associated proteins 
was found for F-CMD patients, but not for non-F-CMD patients. Both groups 
showed normal or almost normal dystrophin distributions, which is in agreement 
with our results. 
In conclusion, our study on morphological parameters of muscle biopsies 
from 30 patients with congenital muscular dystrophy, 8 with involvement of the 
central nervous system, 5 with involvement of both the brain and the eyes and 2 
occidental types, did not reveal any differences between the subdivided groups 
except for a statistically significant higher amount of fat in the pure-CMD 
patients who were older than 2 years of age. Moreover, the cytoskeletal proteins 
vimentin and desmin showed a normal distribution in all of the patients exam-
ined, including O-CMD, F-CMD, and MEB-D. 
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Ill 2.2 
Neuropathological findings in muscle-eye-brain disease (MEB-D) 
Neuropathological delineation of MEB-D from 
congenital muscular dystrophy of the Fukuyama type 
Q.H. Leyten, K. Renkawek, W.O. Renier, F.J.M. Gabreëls, 
C.M. Mooy, H.J. ter Laak, R.A. Mullaart 
Acta Neuropathologica 1991;83:55-60 
Abstract 
Congenital muscular dystrophy (CMD) associated with cerebro-ocular dysplasia 
named muscle-eye-brain disease (MEB-D) is described in two sisters. Progres-
sive hypotonia, mental retardation and severe visual failure appeared immedi-
ately after birth. Pathological examination demonstrated muscular dystrophy, 
hydrocephalus, type II lissencephaly and defective eye development of foetal 
origin. The great similarity of the clinical and neuropathological picture of both 
sisters is in agreement with an autosomal recessive inheritance. Neuropatholog-
ical distinction between Fukuyama-CMD and MEB-D is a more severe and 
earlier cerebral developmental defect and the association with ocular dysplasia 
in MEB-D. 
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Congenital muscular dystrophy (CMD) appears to be a heterogeneous group of 
disorders. CMD can be the only pathology, but can also be associated with 
cerebral abnormalities (Fukuyama-CMD [7]) or with cerebral and ocular dys-
genetic changes (muscle-eye-brain disease, MEB-D [12, 14] or congenital 
cerebro-ocular-muscle dysgenesis, COD-MD [6, 8, 18]). MEB-D and COD-MD 
have to be considered identical [4]. In the majority of the cases of Fukuyama-
CMD and MEB-D brain abnormalities consist of hydrocephalus, lissencephaly, 
polymicrogyria and gliomesodermal proliferation. In MEB-D, ophthalmic mal­
formations are associated, such as immature anterior chamber angle, cataract, 
retinal dysplasia, retinal detachment, abnormal retinal pigment epithelium and 
microphthalmia, persistent hyperplastic primary vitreous (PHPV) and hypoplasia 
of the optic nerve [7, 14, 16, 18]. 
On clinical grounds, Fukuyama-CMD can be differentiated from MEB-D 
[14]. Concerning the pathological aspects, it remains an unresolved problem 
whether they are separate entities or different expressions of the same disease. 
Brain anomalies are present in both instances, but eye changes are rarely found 
in Fukuyama-CMD [2, 19]. 
In this article we describe the clinical and neuropathological findings in two 
sisters with MEB-D. The results are compared with neuropathological data in 
the literature concerning MEB-D and Fukuyama-CMD, and the differences are 
discussed. 
Clinical and pathological findings 
Case I 
A girl, the first child of healthy, non-consanguineous parents was born after an 
uneventful pregnancy of 37 weeks. Postpartum the child did not breath sponta­
neously and artificial respiration was used. From birth generalised hypotonia and 
head lag were present. Deep tendon reflexes were absent. There was a macro-
cephaly (occipito-frontal circumference (OFC) Ρ > 97.5) with frontal bossing. 
The girl appeared profoundly retarded, reacting to auditory and tactile stimuli 
but not to visual ones. Ophthalmological examination revealed microphthalmia 
and blepharophimosis of the right eye, clouding of the cornea, choroid atrophy 
and retinal detachment of the left eye. On the 2nd day after birth hemiconvul-
sions occurred, which were treated successfully with phénobarbital and diphe-
nylhydantoin. At the age of 2 months the girl suddenly died. A brother of the 
mother had a child with microphthalmia of the right eye. 
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Fig. 1. Cerebral cortex, complete lack of Fig. 4. Section of left eye demonstrating in 
lamination. Clustered neurons, hazardly dis- the chamber angle anterior insertion of the 
tributed in the cortical ribbon. H&E, χ 20. iris root on trabecular meshwork (¿) and 
elongated ciliary processes with attachment to 
the posterior iris (Ü). H&E, χ 50. 
Fig. 2. Spatial disarray and abnormal position Fig. 5. Non-attached retina with atrophy of 
of the neurons. Klüver-Barrera, χ 100. the photoreceptor layer and glial proliferation 
of the inner retina. H&E, χ 100. 
Fig. 6. Muscle section from the quadriceps 
Fig. 3. Completely distorted architecture of biopsy. Note the rounded fibres and increased 
the cerebellum; the various layers are inter- diameter variability. Toluidine blue, Epon, χ 
mingled inextricably. H&E, χ 50. 500. 
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Biochemical investigations of serum and urine gave normal values except 
from increased creatine kinase (CK: ИЗО U/l, normal <90 U/l) and glutamate-
oxytransferase (GOT: 70 U/l, normal <40 U/l). Cerebrospinal fluid (CSF) had 
increased protein content (2400 mg/1). Microbiological examination excluded 
infections such as toxoplasma, cytomegalovirus, herpes or rubella virus. Chro­
mosomal examination revealed a normal pattern (46 XX). Muscle biopsy was 
refused. EEG showed a normal background pattern but with spike and wave 
paroxysms over the right hemisphere. EMG revealed an increased number of 
brief polyphasic potentials with small amplitude. Echo scan of the brain was 
normal. 
Pathological examination. General autopsy revealed small follicle cysts in the 
right ovarium. In the adrenals some nodular hyperplasia occurred. Histological 
examination of the skin excluded ectodermal dysplasia. 
Neuropathological examination. The brain weighted 410 g, was fixed in 10% 
formalin, embedded in paraffin and sections were stained with H&E, Kliiver-
Barrera, Bodian and Hölzer methods. 
Gross examination of the brain revealed a type II lissencephaly. Only a few 
poorly marked grooves were seen in the frontal lobes. The meninges were 
thickened. The olfactory bulbs, optic tracts and chiasma were missing. The 
cerebellum was hypoplastic, with absence of the vermis. Cerebellar surface was 
smooth with poorly developed foliae. Above the cerebellum a thin wall cyst 
expanding out of the fourth ventricle through the midline of the cerebellum was 
found, corresponding to Dandy-Walker malformation. The brain stem and spinal 
cord appeared normal. 
Coronal sections showed lacking septum pellucidum, a very thin corpus callo-
sum and enormously dilated ventricular system. The border between white and 
grey matter was obliterated, the basal ganglia and thalami were present. In both 
cerebellar hemispheres dentate nucleus was visible. 
Microscopical examination revealed complete absence of cerebral cortex 
lamination (Fig. 1). Neurons of various size were either scattered or clustered 
into glomerular or columnar formations at different cortical depths. Spatial 
disarray and abnormal position of the neurons were seen (Fig. 2). Multiple 
heterotopias were visible under the ependyma of both lateral ventricles. In the 
cortex diffuse spongiosis and gliomesodermal proliferation in the superficial 
cortical area was evident. The meninges showed an abundant number of vessels 
and marked proliferation of the mesenchymal meshwork. Myelinated fibres were 
visible only in the subcortical areas. 
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The architecture of the cerebellum was markedly destroyed. The foliae were 
fused. Neither granular layer nor Purkinje cells layer were normally formed. 
Dispersed islands of accumulated granular cells with admission of Purkinje cells 
or clusters of molecular layer incorporated into granular cells were seen (Fig. 3). 
Heterotopic foci of neurons in the white matter were noted. 
The basal ganglia, hippocampus, brain stem and spinal cord were unremark-
able. The vessels of the meninges and the brain exhibited advanced proliferative 
changes of their walls. 
Examination of the eyes. Both eyes were microphthalmic. In the left eye fetal 
configuration of the chamber angle and anterior polar cataract was noted. In 
addition elongated fused ciliary processes with attachment to the posterior iris 
were present (Fig. 4). The retina was detached with atrophy of the photoreceptor 
layer and glial proliferation of the inner retina. Incomplete retinal vascularisation 
and irregular pigmentation of the retinal pigment epithelium were present (Fig. 
5). Neuroectodermal dérivâtes, like the sphincter and dilator pupillary muscle 
were poorly developed; the iris pigment epithelium was double layered and 
irregularly pigmented. The right eye revealed a vascularised corneal stroma, 
breaks in Descemet's layer and loss of endothelium, agenesis of trabecular 
meshwork, iris coloboma and partly hypoplastic ciliary body. In addition, 
agenesis of iris pigment epithelium and ciliary body epithelium, agenesis of 
lens, vitreous, retina, choroid and optic nerve were found. 
Case 2 
The youngest sister of patient 1, was born after an uneventful pregnancy 
terminated by vacuum extraction. At birth generalised hypotonia was present. 
Deep tendon reflexes were absent. Contractures were lacking. There was a 
macrocephaly (OFC Ρ > 97.5) with frontal bossing. The girl appeared 
profoundly retarded, reacting to auditory and tactile stimuli but not to visual 
ones. Ophthalmological examination revealed microphthalmia and blepharo-
phimosis of the right eye, clouding of the cornea and fetal anterior chamber 
angle of the left eye. Cerebral CT scanning showed agyria and a large cyst 
above the cerebellum with aplasia of the inferior vermis and supratentorial 
hydrocephalus (Dandy-Walker variant). Increased intracranial pressure required 
ventriculoperitoneal drainage, and at the age of 4 months the girl died because 
of purulent meningitis caused by Klebsiella pneumoniae and Escherichia coli. 
Biochemical investigation of serum revealed an increased CK activity (973 
and 1540 U/l). GOT, calcium, phosphate, myoglobulin, lactate and pyruvate as 
well as fatty acids, dicarbon acid and myoglobin were normal. CSF protein 
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content was elevated (1576 mg/1). Microbiological examination excluded viral 
infection. Chromosomal examination revealed a normal pattern (46 XX). EEG 
showed a diffuse slowing of the background pattern without epileptic discharges. 
EMG revealed increased number of brief polyphasic potentials with small 
amplitude. Motor nerve conduction velocity was normal. 
Muscle biopsy. A muscle biopsy from the quadriceps was performed at the 
age of 2 months and revealed rounded muscle fibres and clearly increased 
diameter variability (Fig. 6). There was a moderate lipomatosis and a moderate 
endomysial and perimysial fibrosis. Fibres with internal nuclei were scarce. 
Opaque fibres were sometimes found and atrophic fibres often showed hyalin-
isation. One relatively large fibre filled with some swollen nuclei with clearly 
visible nucleoli was also observed. 
The above-mentioned findings correspond to muscular dystrophy. 
Pathological examination. Autopsy of the body revealed slight splenomegaly 
of the weight (250 g, normal 160 g) and infectious changes in the spleen. 
Neuropathological examination. Brain, weighting 770 g, was fixed in 10% 
formalin. Brain surface was devoid of gyri and sulci (lissencephaly). The 
meninges were severely thickened and massive purulent exsudate was present. 
The olfactory tracts and optic chiasma were absent. The cerebellum was 
hypoplastic, the vermis was residual. The brain stem and spinal cord appeared 
normal. Above the cerebellar surface a large cyst with a wall of about 3-mm 
thickness filled with purulent mass was found. Supratentorial hydrocephalus and 
enormously dilated ventricle system were present. 
Microscopical examination showed similar changes as have been described in 
the first child. Severely disorganised cortical lamination without horizontal 
pattern was seen. Massive gliomesodermal proliferation was present. The 
neurons were randomly distributed, some were placed in a rotated position. The 
vessels showed enormous proliferation of their walls. In the meninges, in the 
cortex and white matter the vessels were surrounded by massive monocyte 
infiltrations. In the white matter of the parietal lobe dispersed foci of necrosis 
were present. 
In the white matter only single fibres were myelinated. In the basal ganglia, 
hippocampus, brain stem and spinal cord, the intensity of the inflammation was 
less pronounced and white and grey substance were well developed. 
The cerebellar structure was severely abnormal. No developed foliae or 
cortical layers were recognisable. Most of the cerebellar cortex was composed of 
granular neurons which formed small groups of cells lying between hazardly 
mounted Purkinje cells. In the vicinity of the fourth ventricle proliferation of the 
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Table 1. Brain, eye and muscle findings in muscle-eye-brain disease (MEB-D) cases 
Clinical data 
1 Williams et al. [21] Hypotonia, 3 cases, 
2 siblings 
2 Towfìghi et al [18] Hypotonia, 7 cases 
in 4 families 
3 Heggie et al [8] Hypotonia, 2 siblings 
4 Pavone et al [11] Hypotonia, 3 cases 
in 1 family 
5 Federico et al. [6] Hypotonia, 2 cases 
6 Dambska et al. [3] Hypotonia, 3 siblings 
7 Chijiiwa et al [2] Hypotonia, 2 cases 
8. Our case Hypotonia, mental 
retardation, 
2 siblings 
PHPV Persistent hyperplastic primary vitreous; 
Brain 
Hydrocephalus, occipital encephalocele, agenesis 
of olfactory and optic tract, corpus callosum, 
hypoplasia of vermis and cerebellum, lissen-
cephaly, cerebellar micropolygyria, gliomeso-
dermal proliferation, heterotopia 
Hydrocephalus, cysts, hypoplasia of olfactory and 
optic tract, vermis and brain stem, 
lissencephaly, micropolygyria, ghomesodermal 
proliferation, heterotopia 
Hydrocephalus, meningoencephalocele, hypo-
plasia of vermis and brain stem, lissencephaly, 
cortical dysplasia, heterotopia 
Hydrocephalus, lissencephaly, arhinencephaly, 
cerebral and cerebellar agyna, pachygyria 
and/or micropolygyria, heterotopia, hypoplasia of 
pyramidal tracts and cerebellum, Dandy-Walker 
cyst 
Hydrocephalus, lissencephaly, agenesis of 
corpus callosum, optic nerve, chiasma and olfac-
tory bulb and lobe, aplasia of pyramides, 
spongiotic white matter, heterotopia, absence of 
cerebellar vermis 
Hydrocephalus, lissencephaly, agenesis of the 
olfactory bulbs, corpus callosum and of anterior 
commissure, hypoplasia of optic nerves, fossa 
posterior cyst, absence of the cerebellar vermis, 
cerebral and cerebellar micropolygyria with corti-
cal disorganisation 
No histology, only clinical findings, i e. mental 
retardation and neuroradiological findings (CT), 
i.e. atrophy of the white matter and hydro-
cephalus 
Hydrocephalus, Dandy-Walker cyst, agenesis of 
olfactory and optic tracts, septum, corpus 
callosum and vermis, lissencephaly without corti-
cal lamination, heterotopia 
E: retinal pigment epithelium. 
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Eye Muscle 
Microphthalmia, retinal dysplasia, anterior chamber 
malformations, cataract 
Microphthalmia, retinal detachment and dysplasia, 
fetal chamber angle, cataract, PHPV, abnormal 
RPE, abnormal vascularisation and hypoplasia of 
the optic nerve 
Microphthalmia, retinal detachment and dysplasia, 
cataract, immature anterior chamber angle, PHPV, 
optic nerve hypoplasia and coloboma 
No histology, only clinical Findings, ι e. shortened 
anterior chamber, fixed pupils and corticonuclear 
opacities in the lens 
Mesodermal dysgenesis of the anterior chamber of 
the left eye, Peter's anomaly 
Microphthalmia, retinal dysplasia, fetal chamber, 
coloboma, cataract 
Variability in fibre size, fibrosis, focal 
necrosis with regeneration (found in 1 case) 
Variability in fibre size, endomysial fibrosis, 
basophilic fibres, necrosis 
Variability in fibre size, adipose and fibrotic 
degeneration 
Severe degeneration of muscle fibres, 
fibrosis, lipomatosis 
Severe intrafascicular fibrosis, necrotic fibres, 
foci of regeneration, variability in fibre size, 
swollen hyalinised fibres 
Variability in fibre size, round fibres, 
basophilic fibres, adipose and fibrotic 
degeneration 
No histology, only clinical findings, ι e Variability in fibre size, fibrosis, central nuclei 
microphthalmia, corneal opacities, Peter's anomaly, 
central leukoma, RPE abnormalities, malformation 
of optic disc 
No histology, only clinical findings and fluorescein Random variation in fibre size, marked 
angiography, high myopia with astigmatism, entro- decrease in the amount of muscle fibre 
pion of lower lids, optic nerve palor, capillary 
nonperfusion, dilated and irregular capillaries 
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ependyma and inflammatory process, growing above ependymal layer, were 
seen. 
Discussion 
The simultaneous occurrence of muscle, eye and brain developmental defects 
(MEB-D) is a rare combination. Cases with complete pathological description 
have infrequently been documented (Table 1). Similar cerebral neuropathological 
features in different cases suggest an identical clinico-pathological entity [3]. 
MEB-D can be considered as part of a larger spectrum of CMD. Other entities 
of the spectrum are the pure form of CMD and a Fukuyama type of CMD. 
Pathological criteria of the brain, eye and muscle changes can have additional 
diagnostic value in the classification of these entities. 
The muscle pathology represents changes commonly described in the three 
entities of CMD [5]. The neuropathological features as has been described 
earlier in the Walker-Warburg syndrome (WWS) [20], such as congenital 
hydrocephalus, agyria, absence of cortical lamination, congenital retinal dyspla-
sia, retinal detachment, and abnormalities of eye chambers [1], are also found in 
our cases. The WWS is now to be considered identical to MEB-D [4, 9, 15], 
although in WWS muscular dystrophy is not described in detail. Other neuro-
pathological features as agenesis of optic chiasma, olfactory bulb, corpus 
callosum, dysplasia of the cerebellum, agenesis of vermis or cystic degeneration 
have been found in both MEB-D and in WWS. In the particular cases of Pavone 
et al. [11], Dambska et al. [3], Chijiiwa et al. [2] and Federico et al. [6], 
pathological brain and muscle findings similar to our cases have been detected, 
but ocular pathology was restricted to clinical ophthalmological examination. 
Also the two siblings described by Heggie et al. [8] as cerebro-ocular 
dysplasia-muscular dystrophy syndrome do not differ essentially from our cases. 
The neuromorphological malformations in MEB-D are different from those 
described in Fukuyama-CMD. Most Fukuyama-CMD patients are microcephalic 
with hypomyelination of the white matter, have no or mild ventricle dilatation, 
no encephalocele and only exceptionally an ocular involvement. Polymicrogyria 
is frequently present in Fukuyama-CMD, while type II Hssencephaly is prevalent 
in MEB-D [2]. Thus, MEB-D could be considered a more severe neurodevelop-
mental disturbance than Fukuyama-CMD. 
Several aetiologies are possible. In Fukuyama-CMD, brain pathology can 
appear at different stages of development and even can precede muscle dystro-
140 
phic changes [17]. A viral infection, probably of low virulence has been 
suggested as the cause of the proliferative, sclerosing process of the meninges, 
eventually leading to an internal hydrocephalus [21]. Eye damage might be 
explained by a local trauma early in the embryogenesis, or to local failure of the 
neural crest to develop a primary optic vesicle. As a unifying hypothesis 
explaining the malformation, a form of "neurocristopathy" has been suggested 
[13]. A deficiency in the number of crest cells, abnormal differentiation or a 
disturbance in the migration of the neural crest cells, may play a role in the 
malformation of the eyes [10]. Abnormalities in the neural crest may have 
occurred at any stage from their initial appearance to their final differentiation. 
This neural crest hypothesis does not rule out the theory of an intrauterine 
infection. 
However, the high incidence of this disorder among siblings suggests a 
genetic determination. All known reports of MEB-D have an autosomal reces-
sive inheritance [1-3, 5-8, 11, 14, 16, 18, 19, 21]. Because interfamilial differ-
ences are more pronounced than intrafamilial, genetic heterogeneity and the 
existence of allelic mutations within MEB-D is possible. This aetiological 
heterogeneity might be caused by allelic mutations in different genes. 
Our cases of two siblings being similarly affected imply a genetic influence. 
In the same family another child had microphthalmia, but normal intelligence. It 
is tempting to hypothesise that the genetic factor in the family has a variable 
expression. 
In conclusion, our study suggests that in Fukuyama-CMD and in MEB-D, 
although the muscular dystrophy pattern seems comparable, the neuropathologi-
cal data are clearly different. MEB-D is a more severe developmental distur-
bance than Fukuyama-CMD. The genetic influences seem to have their expres-
sion at different stages of the neural crest development. 
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Ill 2.3 
Abnormal merosin (or laminin-ot2) expression 
in congenital muscular dystrophies 
An immunohistochemical study 
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Abstract 
Muscle biopsies of 13 congenital muscular dystrophy (CMD) patients were 
investigated for the presence of merosin (the heavy chain protein of laminin M 
or in new nomenclature laminin-otj). Merosin levels were normal in 6 out of the 
8 patients with pure-CMD, in the 3 patients considered to have Fukuyama-CMD 
(F-CMD) and in the 2 patients with the Walker-Warburg syndrome (WWS). The 
2 pure-CMD patients with white matter hypodensity showed severely decreased 
merosin expression and contrary to the literature on Japanese F-CMD, we did 
not find any marked deficiency of merosin in our F-CMD. As the merosin gene 
and the gene for Japanese F-CMD are located on different chromosomes (6 and 
9, respectively), merosin deficiency in Japanese F-CMD is probably secondary 
to another as yet unknown defect. 
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According to two European Neuromuscular Centre (ENMC) workshops [5, 6], 
the congenital muscular dystrophies (CMDs) can be classified into classical or 
pure-CMD with only muscle involvement, Fukuyama type CMD (F-CMD) with 
both muscle and structural brain abnormalities, and into CMD with muscle, eye 
and brain abnormalities or muscle-eye-brain disease (MEB-D), including the 
Finnish type (F-MEB-D) and the Walker-Warburg syndrome (WWS), a more 
severe variant of MEB-D. 
Muscle fibres are surrounded by a specialized extracellular matrix -the base­
ment membrane (BM)- that contains laminin M, type IV collagen, fibronectin 
and heparin-sulphate proteoglycan. The BM plays a major role in muscle 
development and regeneration, in signal transmission, nerve adhesion and in the 
distribution and transmission of force. Laminin M is a cross-shaped protein with 
one large chain (the M-chain or merosin in postnatal muscle) and two smaller 
side chains (Bl and B2); these chains are encoded by chromosomes 6 [23], 7 
[16] and 1 [14], respectively. 
Besides laminin M, laminin A isoform may be discerned. Laminin A also 
contains one large chain (the Α-chain, encoded by chromosome 18) and the two 
smaller chains, Bl and B2. In muscle, laminin A is found in the small blood 
vessels and in regenerating muscle fibres [7]. 
According to new nomenclature [3], the terms laminin A, laminin M, 
Α-chain, M-chain or merosin, В1-chain and B2-chain have been replaced by the 
terms laminin-1, laminin-2, laminin-α,, laminin-aj, laminin-ß, and laminin-y,, 
respectively. 
The extracellular BM is linked to subsarcolemmal dystrophin via a transmem-
brane glycoprotein complex. This complex is composed of various tightly bound 
dystrophin-associated proteins (DAPs or DAGs) with different molecular 
weights (25, 35, 43, 50, 59 and 156 kDa). The 43 (transmembrane) and 156 
(extracellular) kDa DAGs represent products of the same gene [9] located on 
chromosome 3 [10]. Laminin, especially merosin, is bound to 156 kDa DAG [9, 
18] on the outer side of the sarcolemma. Apparently, an intact dystrophin-DAG/ 
DAP-laminin complex is an essential condition for normal muscular function. 
Dystrophin absence and abnormalities cause X-linked recessive Duchenne dys-
trophy and Becker type dystrophy; absence of 50 kDa DAG or adhalin is found 
in severe childhood autosomal recessive muscular dystrophy or SCARMD [13]. 
Recently, 13 merosin-negative pure-CMD patients (out of 20) have been 
described [21]. With MRI, white matter abnormalities were seen in 8 merosin 
deficient pure-CMD patients (seven patients described by Mercuri et al. [15] and 
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Table 1. Signs and symptoms, genetic, laboratory, radiological and neurophysiological characteristics in congenital muscular dystrophy (CMD) 
Patient No. 
Age at muscle biopsy (yr) 
Sex 
Consanguinity 
Congenital hypotonia 
Joint contractures at birth 
Rapid progressive course 
(motor retardation) 
DNA analysis 
CNS involvement 
- CSF abnormalities 
- EEG abnormalities 
- Convulsions / epilepsy 
- White matter hypodensity 
(CT/MRI) 
- Encephalocele 
- Intelligence * 
Opthalmological disorder 
1 
0 
M 
-
+ 
+ 
-
N 
N 
-
-
-
-
N 
-
2 
0 
M 
-
+ 
-
-
np 
np 
-
-
-
-
N 
-
Classical 
3 
1 
F 
+ 
+ 
+ 
-
np 
N 
-
-
-
-
N 
-
4 
3 
M 
-
+ 
-
-
np 
N 
+ 
-
-
-
N 
-
or pure 
5 
3 
M 
-
+ 
-
-
N 
N 
-
-
-
-
N 
-
Congenital 
:-CMD 
6 
5 
M 
-
+ 
-
+ 
N 
np 
-
-
-
-
N 
-
7 
1 
F 
-
+ 
-
-
N 
N 
-
-
+ 
-
N 
-
muscular 
8 
8 
F 
-
+ 
+ 
-
N 
N 
+ 
-
+ 
-
N 
-
dystrophy (CMD) 
9 
1 
F 
+ 
+ 
-
-
N 
N 
+ 
+ 
+ 
-
-
-
F-CMD 
10 
3 
M 
-
+ 
+ 
-
np 
N 
+ 
+ 
+ 
-
-
-
11 
4 
F 
+ 
+ 
+ 
-
np 
N 
+ 
+ 
+ 
-
-
-
12 
0 
M 
-
+ 
+ 
-
np 
N 
+ 
+ 
+ 
+ 
-
+ 
wws 
13 
5 
M 
-
+ 
+ 
-
np 
N 
+ 
+ 
+ 
-
-
+ 
F-CMD, Fukuyama CMD; WWS, Walker-Warburg syndrome; M, male; F, female; N, normal; np, not performed; -, absent; +, present; * normal 
intelligence: IQ > 70. 
Table 2. Morphological parameters of muscle biopsy in congenital muscular dystrophy (CMD) 
Patient No. 
Biopsy location 
CK activity (normal < 90 Ш ) 
Fat 
Connective tissue 
Internal nuclei 
Basophilic fibres 
Necrotic fibres 
Hyaline fibres 
Percentage type I fibres 
Type IIC fibres 
Atrophic fibres 
-type I 
- type II 
Hypertrophic fibres 
-type I 
- type II 
Immuno-expression 
- dystrophin 
- desmin 
- vimentin 
- laminin 
- merosin 
1 
Q 
88 
-
+ 
-
-
-
-
33 
+ 
++ 
++ 
-
N 
N 
N 
N 
N 
2 
Q 
N 
-
+ 
-
-
-
-
48 
-
+++ 
+++ 
+++ 
N 
N 
N 
N 
N 
3 
Q 
33 
-
-
-
-
-
-
67 
-
++ 
+ 
+ 
+ 
N 
N 
N 
N 
N 
Classical 
4 
RA 
N 
-
++ 
-
-
-
-
70 
-
+ 
+ 
+ 
+ 
N 
N 
N 
N 
N 
or pure 
5 
Q 
N 
+ 
+ 
-
+ 
+ 
-
55 
+ 
+ 
+++ 
+++ 
+ 
N 
N 
N 
N 
N 
Congenital 
CMD 
6 
Q 
153 
++ 
+ 
-
+ 
-
-
82 
++ 
+ 
+ 
-
N 
N 
N 
N 
N 
7 
Q 
117 
+ 
++ 
+ 
-
+ 
-
76 
+ 
+ 
-
++ 
++ 
N 
N 
N 
N 
D 
muscular 
8 
Q 
860 
+ 
++ 
+ 
-
-
-
40 
-
+ 
+ 
++ 
++ 
N 
N 
N 
N 
D 
dystrophy (CMD) 
9 
Sol 
737 
+ 
+ 
-
-
-
-
97 
-
+ 
+ 
-
N 
N 
N 
N 
N 
I 
F-CMD 
10 
Q 
60 
+++ 
+++ 
++ 
-
-
-
100 
NO 
++ 
NO 
+++ 
NO 
N 
N 
N 
N 
N 
11 
Q 
1192 
-
+ 
-
-
-
-
53 
-
_ 
-
+ 
+ 
N 
N 
N 
N 
N 
12 
Q 
wws 
13 
Q 
1050 900 
-
+ 
-
-
-
+/-
41 
-
+ 
+ 
-
N 
N 
N 
N 
N 
+ 
+ 
-
+ 
+/-
-
59 
-
+ 
-
-
N 
N 
N 
N 
N 
F-CMD, Fukuyama-CMD; WWS, Walker-Warburg syndrome; N, normal, D, deficient, NO, not observed, Q, quadriceps muscle, Sol, soleus muscle, RA, rectus 
abdominis muscle; -, normal or absent, +/-, present, +, increased; ++, marked, +++, extensive 
ι 
^ " * ν 
s 
Fig 1. Quadriceps muscle. Decreased (A) and normal (B) merosin staining in "pure" CMD 
with white matter hypodensity (patient 7) and Fukuyama type CMD (patient 10). Normal 
basement membrane ultrastructure (arrows, C) in patient 7. Bars represent 50 pm (A and B) 
and 1 pm (С). 
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one by Voit et al. [22]). Furthermore, a severe reduction in merosin was 
observed in F-CMD [7]. 
In this study, we present and discuss our results concerning the immunodetec-
tion of laminin and merosin in 13 patients with various types of CMD. 
Patients and Methods 
The muscle biopsies of 13 patients were investigated; these 13 CMD patients 
comprised 8 pure-CMD patients (6 patients without and 2 with white matter 
hypodensities), 3 F-CMD patients and 2 patients with WWS. The clinical and 
morphological data are summarized in Tables 1 and 2. 
Unfixed frozen sections of the biopsies were immunohistochemically stained 
for the presence of dystrophin, vimentin, desmin, laminin and merosin according 
to Leyten et al. [11]. For laminin and merosin detection, polyclonal rabbit 
antilaminin (Sanbio, dilution 1:50) and monoclonal anti-human merosin (Gibco, 
dilution 1:100) were used, respectively. 
The polyclonal rabbit antibody was raised against amnion BM and showed a 
distinct band at 200-220 kDa in immunoblots (probably Bl or B2 side chains). 
The monoclonal anti-human merosin antibodies reacted with an 80 kDa frag-
ment of the M-chain of human merosin. 
To avoid misinterpretations, immunolabelling of control tissue sections from 
13 other patients -of the same age and stored for the same length of time- was 
also performed simultaneously. 
Results 
Intensity and distribution of polyclonal laminin staining of the intra- and 
extrafusai muscle fibres (including the spindle capsules), capillaries and small 
blood vessels, nerves and perineuria (if present) were slightly variable in the 
CMD and control patients. No significant differences were present. 
Merosin expression was limited to muscle fibres (the sarcolemma) and nerves 
(the Schwann cells, if present). The staining was regular and intense in 6 out of 
the 8 pure-CMD patients; in the 2 other pure-CMD patients (patients 7 and 8, 
the patients with white matter hypodensity) merosin staining was markedly 
decreased (Table 2, Fig. 1A). Merosin staining was normal in the 3 F-CMD 
patients (Fig. IB) and in the 2 WWS patients (Table 2). 
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Dystrophin, vimentin and desmin staining were basically normal in all the 
patients; vimentin positive fibres were only found occasionally; these represent 
basophilic fibres in HE staining. 
The basement membranes of the muscle fibres in the two patients with 
decreased merosin were normal (Fig. 1С) and could not be distinguished in any 
way from controls by electron microscopy. 
Discussion 
Our merosin deficient patients were classified clinically (by CT/MRI) as "pure" 
CMD with diffuse white matter abnormalities. A similar correlation was found 
by Mercuri et al. in 7 patients [15] and by Voit et al. [22] in 1 patient. 
Our data on polyclonal laminin were slightly variable in the patients and 
controls. This could be ascribed to the storage time of the muscle sections, 
because the longer the sections were stored, the poorer the staining. 
The results with respect to normal polyclonal laminin and the low level of 
monoclonal merosin staining suggested abnormal merosin, but normal В1 and/or 
B2 chains. The latter is in agreement with (i) the location of Bl and B2 coding 
genes on chromosomes other than chromosome 6 (viz. 7 and 1), (ii) the normal 
presence of Bl and B2 laminin subunits in merosin-negative patients as was 
shown by monoclonal antibodies [21], (iii) the probable B2 specificity of 
polyclonal laminin antibodies [7], (iv) the self-assembly of laminin by the short 
arm (Bl and B2) globular domains as demonstrated in vitro [24] and (v) our 
normal ultrastructural findings in the basement membrane. 
Merosin has recently [1] been found to be missing in the dy/dy mouse (a 
strain that suffers from progressive fatal muscular dystrophy). Inheritance in 
these animals follows an autosomal recessive pattern and both the disease and 
the merosin locus were shown to be localized within the same region on 
chromosome 10 [18]. These animals showed an ultrastructurally abnormal base­
ment membrane [1]. The human merosin-negative patients showed an 
over-expression of laminin A [21]. A possible lack of this compensation 
mechanism in the animal model might contribute to the abnormal appearance of 
the basement membrane in the dy/dy mouse. 
Merosin gene locus and merosin deficient CMD are closely linked [8], which 
strongly suggests that merosin deficiency is the primary cause of this type of 
dystrophy. 
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In this study, normal merosin expression was found in the 3 F-CMD patients. 
These merosin findings contrast with the findings in 17 Japanese F-CMD 
patients [7]. On average, there was a 74% reduction in these patients. As the 
gene for Japanese F-CMD is localized on chromosome 9 [19] while the merosin 
gene is localized on chromosome 6, these low levels of merosin are probably 
secondary to another as yet unknown defect. Thus, our results show that 
phenotypic heterogeneity is present in F-CMD with regard to merosin expres-
sion. A similar condition was found in SCARMD for 50 kDa DAG or adhalin 
expression; adhalin positive and adhalin negative patients were found in a 
Brazilian study [25]. Furthermore, adhalin deficiency in SCARMD was shown 
to be linked to chromosome 13ql2 [2], while in another family linkage to 
chromosome 17ql2-21.33 -the adhalin locus- was found [17]. The differences 
between Japanese and non-Japanese F-CMD with regard to merosin expression 
may be based on genotypic heterogeneity, as is also the case in SCARMD. 
The normal merosin results in our non-Japanese F-CMD are in agreement 
with a normally functioning merosin gene. Our findings indicate that different 
primary defects may be involved in F-CMD. However, according to Dobyns et 
al. [4], another explanation for the merosin discrepancy might be that most of 
the non-Japanese F-CMD patients had to be diagnosed as F-MEB-D or WWS 
because of their more severe typical anomalies. Gene localization studies in 
non-Japanese F-CMD families are needed to clarify this. 
The merosin status in 2 WWS patients was normal, which agrees with the 
normal merosin findings in another 5 WWS cases [22]. 
As genetic identity has been stated for Japanese F-CMD and WWS in the 
Fukuyama gene region [20], WWS patients can also be expected to show 
merosin deficiency just as the Japanese F-CMD cases, but this was not the case 
[22]. 
Thus, while Toda et al. [20] claimed that F-CMD and WWS were genetically 
identical, Voit et al. [22] concluded that (based on merosin expression) WWS is 
a separate disease entity from Japanese F-CMD and also from pure-CMD with 
merosin deficiency. 
Our merosin findings also exclude WWS from being allelic to the latter type 
of CMD, but they do not exclude genetic identity of WWS and F-CMD. 
The question must be left open as to whether WWS and the clinically milder 
but phenotypically similar Finnish type of MEB-D are allelic disorders. The 
merosin status of the Finnish type patients has not yet been reported. 
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IV 1.1 
Λη autosomal dominant type of congenital muscular dystrophy 
Q.H. Leyten, F.J.M. Gabreëls, E.M.G. Joosten, W.O. Renier, 
H.J. ter Laak, В.G.A. ter Haar, A.M. Stadhouders 
Brain & Development 1986;8:533-537 
Abstract 
A family with an autosomal dominant type of congenital muscular dystrophy 
(CMD) will be reported. In general, an autosomal recessive mode of inheritance 
is accepted for CMD. In 1980, Kalyanaraman et al reported another family with 
an autosomal dominant CMD with possible involvement of the central nervous 
system (CNS). Our report concerns a father and daughter suffering from CMD 
without CNS involvement. The histological findings, especially some mitochon-
drial abnormalities in the muscle biopsy were remarkable. 
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Congenital muscular dystrophy (CMD) is a rare muscular disorder, characterized 
by generalized weakness and hypotonia at birth, often with joint contractures 
and delayed motor development [1-12]. The term CMD was introduced by 
Howard [2] in 1908. The joint contractures may be limited to talipes or consti-
tute a severe form of arthrogryposis multiplex congenita [1-12]. The onset of 
this slowly or rapidly progressive muscle weakness occurs in uterine life. 
Fukuyama et al [6, 13, 14] differentiate CMD in one type with and one 
without involvement of the central nervous system (CNS). The type with CNS 
involvement is also called the Fukuyama type (F-CMD). 
In general, an autosomal recessive pattern of inheritance in CMD is suggested 
[13, 15, 16]. Kalyanaraman et al [17] are the only authors who have reported a 
family with CMD and possible CNS involvement, suggesting an autosomal 
dominant pattern of inheritance. 
Recently, we had the opportunity to examine a family with CMD without 
CNS involvement and likely an autosomal dominant mode of inheritance. 
Case reports (Fig. 1) 
Case J (proband) 
Patient 1 was a 6-year-old daughter of patient 2, born to unrelated parents, after 
a normal pregnancy and a delivery by Caesarian section. Birth weight was 3,480 
g. Neonatal period was normal. At birth, generalized weakness, hypotonia, 
flexion contractures of the knees and clubfeet were present. 
Further development was characterized by a progressive motor retardation 
without any mental retardation. At age 3, the girl was able to walk without aid, 
but fell frequently. At age 5, she was confined to a wheelchair. 
At age 6, examination revealed an alert, intelligent thin girl. Extraocular 
muscles were intact, but there was a mild facial weakness. There was general-
ized loss of muscle strength in the trunk and limbs. Proximal and distal muscles 
were affected equally. Tendon reflexes were absent. Bilateral flexion contrac-
tures of the elbows, hips, knees and ankles, and a kyphoscoliosis were obvious. 
Sensory functions were intact. 
Biochemical investigations of serum, urine and cerebrospinal fluid (CSF) 
showed apart from a slightly elevated serum CK (128 U/l, normal <90) no other 
abnormalities. Lactate and pyruvate levels in serum and CSF were normal as 
well as blood gas analysis. 24-Hour lactate excretion was in the normal range. 
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Fig. 2. Transverse sections (HE-stain) of quadriceps muscle biopsy specimens from case 1 
(top, χ 500) and case 2 (bottom, χ 300). In both biopsies there is a considerable variation in 
muscle fiber diameter. Between the rounded muscle fibers increased quantities of connective 
tissue can be seen. Note the presence of many muscle fibers with internal nuclei (case 2). 
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Electromyography (EMG) revealed an increased number of brief polyphasic 
potentials with small amplitude. Nerve conduction velocities (NCVs) were nor­
mal. Electroencephalography (EEG), somatosensory evoked potentials (SSEP), 
cerebral CT scan, electrocardiography (ECG) and echocardiography revealed no 
abnormalities. 
Case 2 
Patient 2 was the father of patient 1, a 36-year-old man, born to unrelated 
parents after an uncomplicated pregnancy and delivery. Since birth, a general­
ized hypotonia and gracile musculature was noticed, and wry neck was present. 
At age З'/г years, he started walking, but generalized hypotonia and muscular 
atrophy without proximal or distal predominance were present. Gradually, 
bilateral flexion contractures of the elbows, hips, knees and ankles developed. 
He was able to walk until the age of 12, when he was confined to a wheelchair. 
Examination at age 35 revealed a generalized hypotonia and muscular 
atrophy. There were severe bilateral flexion contractures of the elbows, hips, 
knees and ankles with kyphoscoliosis. Sensory functions were normal. Tendon 
reflexes were absent. There was mild facial weakness. He had a normal intelli­
gence. At age 38, he died because of bilateral bronchopneumonia. 
Biochemical investigations of serum (including CK), urine and CSF showed 
no abnormalities. 
EMG revealed an increase in the number of brief polyphasic potentials with a 
small amplitude. NCVs were normal. EEG, SSEP, cerebral CT scan, ECG and 
echocardiography revealed no abnormalities. 
Muscle biopsies 
Case 1 (at age 3 years) 
Light microscopy (Fig. 2). A biopsy from quadriceps muscle revealed both 
increased fat and connective tissue. The ratio of the number of type I and type 
II fibers (type I/type II) was 2.13. Both types HA and IIB fibers were observed; 
6% of the total number of fibers represented type IIC fibers, most of these were 
basophilic fibers. Mean diameters of type I and II fibers were about the same 
(type I: 26 um ± 9 urn; type II: 25 um ± 10 um). Two percent of the fibers, 
both type I and type II, contained internal nuclei, especially the small type IIC 
fibers. Phagocytosis was not observed. Isolated basophilic fibers with swollen 
nuclei were frequently seen. Ragged-red fibers were not observed. The checker­
board pattern was normal and the terminal innervation ratio was also normal. 
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Table 1. Signs and symptoms in (F-)CMD 
CMD F-CMD Cases of Our cases 
Kalyanaraman et al [17] Case I Case 2 
Early onset hypotonia 
Involvement of facial muscles 
Joint contractures 
Slowly or rapidly progressive course 
Increased CK activity 
Myogenic pattern of EMG 
Dystrophic abnormalities in muscle biopsy 
CNS involvement 
+ 
+ 
+ 
+ 
++ 
+ 
++ 
+ 
+ 
+ 
+ 
++ 
+ 
++ 
+ 
+ 
+ 
+ 
+ 
++ 
+ 
+ 
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Electron microscopy. Scattered fibers showed a disturbed sarcomere pattern, 
with loss of myofilaments, enlarged intermyofibrillar spaces and Z-line stream-
ing. The mitochondria in the fibers used to be swollen. Crystalline inclusions 
were not observed. There were normal quantities of glycogen but the number of 
neutral lipid droplets was increased. Fibers with folded sarcolemma were 
suggestive for a repair mechanism after focal necrosis. 
Case 2 (at age 35 years) 
Light microscopy (Fig. 2). The biopsy (quadriceps muscle) of the father showed 
a dystrophic pattern. The ratio of the number of type I and type II fibers (type 
I/type II) was 0.52. Both types HA and IIB fibers were observed, but there were 
many intermediate fibers. The mean diameters of type I and type II fibers were 
about the same (type I: 41 urn ± 12 urn; type II: 43 um ± 15 um). About 25 
percent of the fibers of both types contained internal nuclei. There was no 
preference for a particular diameter-range. Ring fibers were present (2%); 
basophilic fibers were sporadically seen. Fiber fragmentation occurred only in 
one fiber. Phagocytosis was not observed. Some fibers had increased sub-
sarcolemmal succinic dehydrogenase activity, suggesting the presence of sub-
sarcolemmal mitochondrial aggregates. There were no ragged-red fibers. The 
checkerboard pattern was not disturbed and the terminal motor nerves in the 
biopsy were unbranched, which suggests a normal innervating pattern. 
Fig. 3. Electronmicrograph (x 30,000) of quadriceps muscle biopsy specimen of case 2. Severe 
fibrosis is present around many blood vessels and capillaries. Note the mitochondrial abnor-
malities such as crystalline inclusions (in type I fibers) and mitochondria with concentric 
cristae. 
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Electron microscopy (Fig. 3). Some fibers revealed a focal loss of cross-
striation. Many fibers showed mitochondrial abnormalities, such as crystalline 
inclusions (in type I fibers) and mitochondria with concentric cristae. Fibrosis 
was severe around blood vessels and the capillaries used to have thickened basal 
membranes. Many fibers showed small folds intruding formations consisting of 
basal membranes or connective tissue. 
Discussion 
Our two cases fulfil the clinical and morphological criteria of CMD, without 
CNS involvement (see Table 1). Dystrophic changes especially in case 1 are 
relatively mild. Remarkable is the absence or small increase in CK activity, 
which, however, has been described more often [8, 9, 12]. 
Kalyanaraman et al [17] described an autosomal dominant congenital muscu-
lar dystrophy (mother and son) with possible CNS involvement (see Table 1). 
Muscle biopsy showed mitochondrial abnormalities, such as duplication and an 
increased number of mitochondria of abnormal size and shape with distorted 
cristae. 
In our patients, EM examination of the muscle biopsy of the father showed 
mitochondria with crystalline inclusions in a large group of fibers and prolifera-
tion of concentric cristae. In contrast, EM examination of the muscle biopsy of 
the daughter revealed no mitochondrial abnormalities. In literature, several types 
of changes are mentioned in EM examination of muscle biopsies in CMD [18-
21]. All these changes, however, are not pathognomonic for CMD, but are 
interpreted as atypical degenerative characteristics. 
Fukuyama et al [13] found mitochondrial anomalies in EM examination of 
the muscle biopsy in F-CMD, i.e. disappearance of shape and structure. 
In 1960, Fukuyama et al [6] proposed an autosomal recessive heredity as the 
most likely mode of inheritance in CMD. Osawa [22] demonstrated that F-CMD 
is induced by homozygote conjugation of autosomal recessive genes. In 1980, 
Kalyanaraman et al [17] described an autosomal dominant type of CMD with 
possible CNS involvement. CNS involvement was a functional disorder, as in 
their case the mother had epilepsy with generalized tonic clonic and absence 
seizures from the age of 14 and her son had also spike and wave complexes in 
his EEG at the age of 9. Their CT scans were normal. Possibly dystrophy and 
epilepsy were unrelated. 
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Considering the mode of inheritance and the absence of CNS involvement in 
our family, a peculiar type of CMD is probable. Theoretically, the mother of 
case 1 (see Fig. 1) can be carrier of the autosomal recessive type of CMD. This 
hypothesis seems very unlikely because of the low frequency of carriers and 
lack of consanguinity in this family. We believe that our cases represent an 
autosomal dominant inheritance of CMD but without CNS involvement. 
The varying mode of inheritance and the differences in EM findings in CMD 
may suggest CMD is not one single nosological entity but rather a syndrome. 
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IV 1.2 
Congenital muscular dystrophy and severe central 
nervous system atrophy in two siblings 
Q.H. Leyten, P.G. Barth, F.J.M. Gabreëls, К. Renkawek, W.O. Renier, 
Α.A.W.M. Gabreëls-Festen, H.J. ter Laak, M.G. Smits 
Acta Neuropathologica 1995, in press 
Abstract 
Severe degenerative features of the nervous system of a hitherto unknown kind, 
associated with a neuromuscular disorder with histopathological features of 
congenital muscular dystrophy, are reported in two female siblings. The clinical 
profile was characterized by generalized hypotonia followed by spastic tetra-
plegia, contractures, polyneuropathy, lack of cognitive development and progres-
sive microcephaly. There was no involvement of the eyes. Neuropathological 
examination of the brain of one sibling, who died at the age of 30 months, 
revealed subtotal loss of neurons in the cerebral and cerebellar cortex and in the 
ventral pons, and secondary loss of myelin in the cerebral and cerebellar 
subcortical white matter. Sural nerve biopsy in the other sibling, who had a 
similar neurological affection, showed a lack of large myelinated fibers. 
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System atrophy of the central nervous system (CNS) with perinatal onset, and 
subtotal loss of neurons, predominating in the cerebral and cerebellar cortex and 
the ventral pons is extremely rare [15]. Congenital muscular dystrophy (CMD) 
has recently been classified into four categories (CMD I, II, III and IV) [7, 8]. 
In each category the CNS can be involved. This involvement is mild in a 
subtype of CMD I, which is associated with white matter hypodensities and 
deficient merosin status [7, 8, 25, 35]. In gene linkage studies the merosin locus 
was found on chromosome 6q [8]. CNS involvement is severe in CMD II, 
which is characterized by moderate neocortical and cerebellar cortical dysplasia 
as well as white matter abnormality, as in Fukuyama syndrome (F-CMD) [7, 8, 
10, 11]. The gene responsible for typical F-CMD was recently mapped to 
chromosome 9q31-33 [34]. CNS involvement is also present in CMD III, the 
Finnish type of muscle-eye-brain disease, which is characterized by hydrocepha-
lus and cobblestone (previously type II) lissencephaly, as in CMD IV, Walker-
Warburg syndrome, with similar but more severe brain abnormalities [4, 7, 8, 
19-21, 27, 29, 36]. 
We describe two siblings who had severe cerebral system atrophy together 
with CMD and a lack of large myelinated fibers in peripheral nerve. 
Case Reports 
Case 1 
A girl, the fourth child of healthy Turkish parents, was born after an uneventful 
pregnancy and birth. Consanguinity could not be proved. The older two children 
of the family - both girls - appeared to be healthy. The family history did not 
mention neuromuscular diseases or mental retardation. Birth weight was 3330 g. 
Head circumference at birth was 35 cm [50th percentile (P50)], but at the age of 
3 months 38 cm (<P2.5), indicating a secondary microcephaly. The postpartum 
period was not complicated by asphyxia. From birth, generalized muscle weak-
ness including facial muscles, head lag and atrophy of hypothenar were present. 
Deep tendon reflexes and the sucking reflex were absent. Further development 
was complicated by severe psychomotor retardation. The infant reacted to 
auditory and tactile stimuli, but not to visual ones. Ophthalmological examina-
tion revealed uncontrolled eye movements, but no structural eye abnormalities. 
In the first few months, hypertonia was noted, especially involving the legs. The 
infant did not reach any motor milestone. At the age of 30 months, she died 
from respiratory insufficiency. Autopsy was performed immediately after death. 
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Fig. 1. Magnetic resonance imaging (case 1) at the age of 7 months revealing severe cerebral 
and cerebellar cortical atrophy as well as hypomyelination (A) and ventricular widening (B). 
Biochemical investigations of serum and urine gave normal values except for 
increased creatine kinase (CK: 527 U/l, normal <90 U/l). In the CSF, no 
abnormalities could be found. Appropriate studies ruled out metabolic, endocri-
nological, immunological, and chronic infectious diseases, vitamin deficiencies, 
and disorders caused by toxic agents. Microbiological examination excluded 
infections such as toxoplasma, cytomegalovirus, herpes or rubella virus. Chro-
mosome analysis revealed a normal 46 XX karyotype. EEG showed a diffuse 
slowing of the background pattern with spike and wave paroxysms over the left 
hemisphere. EMG revealed myopathic characteristics and decreased motor nerve 
conduction velocities (MNCVs) of the median nerve (25 m/s at the age of 7 
months; normal 35-58 m/s). Brainstem auditory evoked potential (BAEP), visual 
evoked potential (VEP) and somatosensory evoked potential (SSEP) recordings 
at the age of 4 months were isoelectric. Cerebral computed tomography (CT) 
and magnetic resonance imaging (MRI) at the age of 7 months revealed 
ventricular widening and severe cerebral and cerebellar cortical atrophy as well 
as hypomyelination (Fig. 1). EMG performed in both parents did not show any 
abnormality. 
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Muscle biopsy 
Eight muscle samples were available for morphological study one sample was 
taken at 4 months from the quadriceps muscle and the others were taken at 
autopsy from the diaphragm, the intercostalis externus and rectus abdominis 
muscles, and from the left and right psoas and iliopsoas muscles Routine 
histochemical and histopathological stains were done on rapidly frozen sections 
from the biopsy specimen, including H&E, Gomon tnchrome, Ca-ATPase at pH 
10 3 and after preincubation at pH 4 6 and pH 4 3, NADH-tetrazohum oxido-
reductase, acid phosphatase, periodic acid Schiff (PAS), and Sudan black В 
Immunohistochemistry included stains for dystrophin, vimentin, desmin, and 
merosin Muscle samples taken at autopsy were prepared for paraffin sections 
The quadriceps biopsy showed a normal percentage of type I fibers, many 
fibers of both types, increase of muscle fiber diameter variation, and a moderate 
endomysial fibrosis (Fig 2A) Scattered small basophilic fibers with swollen 
nuclei showed an increased acid phosphatase activity There were some slightly 
hypertrophic type I fibers, but there was no bimodal fiber diameter distribution, 
nor type grouping, nor small or large group atrophy Immunohistochemistry with 
dystrophin, vimentin, and desmin antibodies revealed a normal pattern of 
expression However, antibodies against merosin did show a variable lmmuno-
reactivity The other seven muscle specimens taken at autopsy 2 years later 
showed essentially the same muscle fiber diameter variation and fibrosis, but 
now a moderate to heavy fat cell infiltration was present 
Pathological examination 
General autopsy revealed marked muscle atrophy and contractures of joints 
Organ malformations were not present Slight splenomegaly and microscopical 
infectious changes in the spleen and lungs were found 
Neuropathological examination 
Formalin-fixed, paraffin-embedded samples from frontal, central, parietal, 
temporal and occipital cortex, hippocampus, cerebellum, brain stem and spinal 
cord were cut at 6um sections and stained with hematoxyhn-eosin, Luxol fast 
blue, tnchrome, and Bodian methods Immunohistochemical reactions for 
neuron-specific enolase (NSE), neurofilaments, glial fibrillar acidic protein 
(GFAP), vimentin, carbonic anhydrase and myelin basic protein were performed 
according to the avidin-biotin complex (ABC) method [13] 
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Fig. 2. A Quadriceps muscle (case 1) at the age of 4 months demonstrating different size of 
the muscle fibers and endomysial fibrosis. Gomori trichrome. В Frontal lobe showing complete 
destruction of the neocortex and lack of subcortical myelin. Luxol fast blue-cresyl violet. 
С Cerebral cortex replaced by astrocytic cells. GFAP immunoreaction. D Temporal cortex. 
Scanty myelinated fibers in the white matter. Proliferating mesenchymal tissue of the vessels 
surrounded by glial cells. Staining for myelin basic protein. 
Bars A, C, D = 50 цт; В = 100 μπι. 
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Fig. 3. A Cerebellar foliae surrounded by thickened meninges. Loss of neurons and proli­
feration of glial fibrils. Phosphotungstic acid-hematoxylin staining. В Cerebellum. Narrow 
band of granular neurons, lack of Purkinje cells, myelin and lack of neurofilaments. Staining 
for the 60-kDa neurofilament. С Replacement of cerebellar neuronal layers by glial cells. 
GFAP staining. D Quadriceps muscle (case 2) at the age of 16 months showing variable 
muscle fiber sizes, endomysial fibrosis and a basophilic fiber. H&E stain. 
Bars A = 100 pm; B-D = 50 pm. 
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Gross examination revealed a brain weight of 225 g (normal for age 900 g). 
The leptomeninges were slightly opaque, particularly in the basal cisterns, over 
the cerebellum and along the fissures. Cerebral and cerebellar surfaces showed 
pronounced atrophy. Primary and secondary gyri were poorly distinguishable. 
The olfactory bulbs, tracts, optic nerves, mammillary bodies, cerebral peduncles 
and brain stem were reduced in size. Cranial nerves were macroscopically 
unremarkable. Cerebellar hemispheres and vermis were small but well shaped. 
On the coronal sections, poorly delineated gray and white matter, underdevel­
oped hippocampi, basal ganglia and thalami, thin callosal body, and dilated 
ventricles were seen. 
Cerebral cortex (temporal neocortex, hippocampal gyrus). Subtotal depletion of 
neurons was seen, with NSE only staining the fifth layer (Fig. 2B). Layers II, III 
and IV had virtually disappeared. Layer VI was partially preserved. Replace­
ment gliosis was found (Fig. 2C). The hippocampal cortex was only represented 
by the hippocampal gyrus, for which a number of neurons was identifiable. 
Other neocortical areas showed similar abnormalities, characterized by extreme 
depletion of neurons. In some areas, some preservation of NSE-positive cells in 
the area corresponding to the second layer was visible. The layer corresponding 
to the fifth layer and the one or two layers above it were affected by a sponge­
like change, but this was not evident in all the sections. The subcortical white 
matter showed a diffuse lack of myelinated fibers (Fig. 2D). No demyelinating 
lesions were found. 
Cerebellum. There was almost total depletion of the interior granular layer and 
total disappearance of the Purkinje cell layer (Fig. ЗА). A few remaining 
granule cells and cells of glial lineage could be easily differentiated by NSE. 
The molecular layer was curiously divided in a lower half which was GFAP 
positive and NSE negative, and an upper half which was GFAP negative and 
NSE positive. Therefore, an appreciable number of fibers in the molecular layer 
were lost and replaced by Bergmann glia. The intrafolial white matter was 
represented by large GFAP- and S-100 protein-positive fibrous astrocytes, and 
myelinated fibers were few (Figs. 3B, C). 
Basal ganglia. Basal ganglia showed undifferentiated structures and few neurons 
showed correctly preserved features of large neurons and positive reactions for 
NSE. The nucleus caudatus was poorly developed. There were abundant vessels 
in the basal ganglia and in the meninges. 
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Pons Myelin was present in the medial longitudinal fasciculus, lateral and 
medial lemnisci, and conjunctival brachia, but almost complete absent in the 
ventral pons The ventral pons also displayed severe loss of neurons 
Medulla oblongata The inferior olivary nucleus was depleted of neurons No 
reactive gliosis was encountered Well-developed myelin was present in the 
restiform bodies, medial lemnisci, and spinal trigeminal tracts, but was absent in 
and around the inferior olivary nuclei and the pyramidal tracts 
Cervical spinal cord The lateral corticospinal tracts could not be traced and 
were either unmyelinated or completely absent The dorsal spinocerebellar tracts 
were underdeveloped There was no reactive gliosis Only the medial group of 
motor neurons could be identified No sections of spinal ganglia were available 
In the brain stem and cervical spinal cord there were no other pathological 
changes 
Case 2 
The older sister of case 1, the third child of the parents, was bom after an 
uneventful pregnancy of 41 5 weeks in breech presentation Birth weight was 
3830 g (P60) Head circumference was 35 cm at birth (P50), but at the age of 3 
months was 38 cm (<P2 5) The postpartum period was not complicated by 
asphyxia The same clinical signs and symptoms as in case 1 occurred (head 
lag, atrophy of hypothenar, absent deep tendon reflexes, absent sucking reflex) 
The girl was also profoundly retarded She reacted to auditory and tactile 
stimuli, but not to visual ones Ophthalmological examination confirmed lack of 
control of eye movements and lack of structural eye abnormalities 
In the first few months, progressive pyramidal signs developed leading to 
contractures, especially in knee and ankle joints The muscular system appeared 
to be hypoplastic, especially in the distal muscles At the age of 21 months, she 
suddenly died, probably of a pulmonary infection Autopsy was not allowed 
Findings of biochemical investigations of serum and unne were similar to 
those in case 1, and all normal, except CK (904 U/l) Chromosome analysis 
revealed a normal 46 XX karyotype EEG showed a diffuse slowing of the 
background pattern EMG revealed an increased number of brief polyphasic 
potentials with small amplitude MNCVs of the median and peroneal nerve were 
markedly decreased (15 m/s at the age of 4 months, normal 37-48 m/s, and 18 
m/s at the age of 17 months, normal 39-54 m/s) BAEP, VEP and SSEP 
recordings at the age of 17 months were isoelectric Cranial CT showed en-
larged ventricles and cerebral and cortical cerebellar atrophy 
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Muscle biopsy 
Biopsy specimens from the quadriceps (two samples) and soleus muscle were 
taken at 6 and 16 months after birth. The picture (Fig. 3D) was clearly dystro­
phic with many small rounded fibers of both types, moderate endomysial 
fibrosis, some scattered basophilic fibers, and fibers with internal nuclei. The 
percentage of type I fibers was 80% (both quadriceps muscles) and 40%, 
respectively. Type grouping and small or large group atrophy were absent. The 
muscle fiber diameter distribution was unimodal and hypertrophy was only 
observed in the quadriceps muscles. In the latter two biopsies samples (taken at 
16 months) a heavy fat cell infiltration was found. Except for basophilic fibers, 
no other fibers were acid phosphatase positive; PAS stain was normal. Electron 
microscopy of the soleus muscle did not show abnormal lipofuscin or other indi­
cations for storage disease. Cross-striations were often disturbed. Dilated sarco­
plasmic reticulum, proliferating Τ tubules, autophagic vacuoles, and mitochon­
dria with poor cristae were found. Fibers were sometimes surrounded by col­
lagen. Basal lamina did not generally show redundant loops, the latter excluding 
fast volume decreases as seen in acute infantile spinal muscular atrophy. 
Immunohistochemistry with dystrophin, vimentin, desmin, and merosin antibod­
ies revealed a normal pattern of expression in the soleus muscle. 
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Fig. 4. Sural nerve (case 2). Distribution of diameters of myelinated fibers expressed in density 
per mm 2 (white area) compared with age-matched control (hatched area). 
182 
Sural nerve biopsy 
Qualitative light and electron microscopical examination did not reveal patho-
logy. However, quantitative examination of the nerve biopsy revealed some dif-
ferences from the normal. There was a slightly increased density of myelinated 
fibers (20,890 fibers/mm2, mean of age-matched controls 15,660 fibers/mm2, 
range 11,860-19,520 fibers/mm2). The total number of myelinated fibers was 
normal (8560 fibers, mean of age-matched controls 8050 fibers, range 4750-
10,540 fibers). Large-diameter fibers were almost lacking (Fig. 4). The propor-
tion of fibers with a diameter of greater than 6 urn was less than 0.5%. In five 
control nerves of children between 1 and 2 years of age, it was 27% (range 22-
30%). The myelinated fiber histogram showed a shift towards smaller diameter 
fibers and a peak of the histogram between 2 and 3 um. The thickness of the 
myelin sheath compared to axon diameter was normal [30], which rules out 
axon atrophy as possible explanation for the lack of large fibers. We found no 
signs indicative of a degenerating process; thus, we consider a maturation defect 
the most likely explanation of the pathological features. 
Discussion 
Both siblings presented an identical clinical, neurophysiological and neuro-
radiological profile. At birth, they had a generalized hypotonia, followed after 
several weeks by spastic quadriplegia and at later stages joint contractures. 
Further investigations revealed a reduction in nerve conduction velocities, a 
myopathic EMG pattern, and mildly increased CK. Both children developed a 
secondary microcephaly with large cerebral ventricles. They were severely 
mentally retarded. 
Histomorphological and histochemical examination of muscle biopsies of both 
patients revealed characteristics of CMD [5, 6, 10, 11, 18, 19, 22, 24, 31]. 
Immunohistochemistry with dystrophin, vimentin, desmin, and merosin anti-
bodies showed a normal pattern of expression, except for a variable immuno-
reactivity with merosin antibodies in case 1. 
A quantitative neuropathological examination of sural nerve showed a normal 
total number of myelinated fibers but a lack of large-diameter fibers. A patho-
genic mechanism for this lack of large-diameter fibers could not be established, 
but may be part of a global maturation defect of the peripheral nervous system. 
Neuropathological examination of the CNS in case 1 revealed a severe deple-
tion of cerebral and cerebellar neurons and fibrous gliosis, pointing to an early 
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degenerative process The ventral pons, the inferior olivary nucleus, and the 
lateral group of motor neurons in the cervical spinal cord were also depleted of 
neurons The myelin deficiency was restricted to the area around the inferior 
olivary nuclei and to the pyramidal tracts in the medulla oblongata and the 
lateral corticospinal tracts in the cervical spinal cord This was due to loss of 
corresponding cerebral and cerebellar neurons 
The present disorder, in as much as the brain is concerned, has characteristics 
of a primary and progressive neurodegenerative disorder of gray matter with 
very early onset In this regard there are parallels with earlier publications, such 
as the multisystem degeneration of prenatal onset described by Kaarsoo Hernck 
et al [15], and the pontocerebellar hypoplasias by Barth [2] However, in the 
cases of these authors no muscular dystrophy, or a lack of large-diameter fibers 
in sural nerve morphology was mentioned In the literature on CMD and other 
muscular dystrophies associated with pathological findings in the CNS (Table 
1), we could not find any similar cases Especially the severity of the brain 
pathology and the developmental defect of the peripheral nerve are striking 
Table 1. Muscular dystrophy associated to brain pathology in men 
- Myotonic dystrophy [12] 
- Duchenne's / Becker's muscular dystrophy [6, 28] 
- Congenital muscular dystrophy with severe impairment of intellectual development 
(Fukuyama type of CMD, Walker-Warburg syndrome and Finnish muscle-eye-brain 
disease) [4, 7, 8, 10, 11, 19-21, 27, 29, 36], Fowler's syndrome [3] 
- Muscular dystrophy in Marinesco-Sjogren syndrome [17] 
- Lethal congenital muscular dystrophy with cataracts and a minor brain anomaly 
[37] 
- Congenital adrenal hypoplasia, muscular dystrophy, and glycerol kinase deficiency 
[9] 
Comparing our patients with F-CMD (CMD II), the following differences are 
noted 
1 The neuropathological findings in our patient are more severe than those 
described until now in F-CMD [10, 11], especially the complete loss of normal 
cytoarchitecture of the cortex of cerebrum and cerebellum, and the myelin defi-
ciency In F-CMD, a mild gliosis or edema of the cerebral white matter or 
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myelin pallor in the centrum semiovale has been reported [16, 33], but in these 
series most F-CMD cases showed no remarkable abnormalities in the cerebral 
white matter. 
2. Microcephaly in our patients (<P2.5) is more severe. In the review article of 
Fukuyama et al. [11], microcephaly in 13 females amounts to the 'min SD' 
level. 
3. At birth our patients presented generalized weakness and hypotonia, but later 
on developed a progressive hypertonia in contrast to the generalized hypotonia 
in F-CMD patients [10, 11]. 
4. Neuroradiological findings on CT/MRI in our patients (i.e., enlarged ventri-
cles, cerebral atrophy and severe generalized decreased white matter lucency in 
the cerebrum) are different from those described in F-CMD patients by 
Yoshioka et al. [38-40], who described delayed myelination especially in the 
frontal lobes, which are the last areas to be myelinated [1]. Moreover, they 
mentioned that the low-density areas in the cerebral white matter were most 
apparent around the age of 1 year and that they decreased or disappeared by 2-3 
years of age [38, 39]. These observations suggest that the low-density areas 
found in F-CMD on CT/MRI are due to a delay in myelination rather than to a 
demyelination or a dysmyelination process [40]. 
5. Neurophysiological and neuromorphological studies of the peripheral nervous 
system of our patients manifest a lack of large-diameter fibers, a finding not 
described in F-CMD [10, 11]. Neuromorphological studies of spinal anterior 
roots and medullated nerve fibers in F-CMD did not show any deviation from 
those in the controls with respect to the total number as well as the distribution 
of fiber diameter, and no pathological findings such as segmental demyelination, 
myelin bulb formation or axonal degeneration could be found in nerve fibers by 
the teasing method [11, 14, 32]. However, one should be cautious about drawing 
conclusions from these differences because long-term follow-up of several 
F-CMD cases revealed marked individual and intrafamilial variability [26]. If 
our cases are considered as F-CMD, then they illustrate a most severe type. For 
further differentiation within the F-CMD variability, staining for dystrophin-
associated proteins [23] and molecular genetic studies ('genetic mapping'), 
especially on chromosome 9 [34], is necessary. 
In conclusion, the brain and sural nerve pathology of our patients essentially 
differ from those described previously in conjunction with CMD. We consider 
the pathological changes to be a very early multisystem degeneration of the 
CNS and a developmental defect of the peripheral nervous system. An auto-
somal recessive mode of inheritance is likely. 
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IV 1.3 
Association of congenital muscular dystrophy, 
hypoplasia of the lateral abdominal wall 
musculature and hypoplasia of the external genitalia 
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H.G. Brunner, H.J. ter Laak, R.A. Mullaart 
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Abstract 
We describe a girl with the rare association of congenital muscular dystrophy, 
hypoplasia of the lateral abdominal wall musculature and hypoplasia of the 
external genitalia. 
192 
'Pure' congenital muscular dystrophy (CMD type I) is an autosomal recessive 
muscular disorder that is present at birth or manifests itself during the first year 
of life. It is characterized by generalized muscle weakness with a non-progres-
sive or slowly progressive clinical course, (sub)normal cognitive development 
and muscle histology showing characteristic changes of fibre necrosis, fat cell 
infiltration and fibrous tissue infiltration [3, 10]. A subgroup of 'pure' CMD is 
associated with cerebral white matter hypodensity and merosin-negative staining 
of muscle biopsy specimens [12, 17, 18]. According to the new nomenclature, 
this condition is referred to as merosin M-chain-deficient or laminin-otj-deficient 
CMD [1]. The laminin-c^ gene is linked to chromosome 6q2 [4]. CMD can be 
associated with multiple joint contractures. Congenital joint contractures (arthro-
gryposis) also occur in amyoplasia [8]. Patients with amyoplasia have a higher 
frequency of non-limb anomalies, such as hypoplastic external genitalia [8] and 
defects in the lateral abdominal wall musculature [14]. 
We describe a girl with an association of CMD, hypoplasia of the lateral 
abdominal wall musculature and hypoplasia of the external genitalia. 
Case Report 
A girl, the first child of healthy non-consanguineous parents, was born after 40 
weeks of gestation. There was no family history of neuromuscular disorders. 
Pregnancy was complicated by breech position and the infant was delivered by 
Caesarian section. Apgar score was 9 after 1 min. Birth weight was 3530 g, 
birth length 50 cm, occipitofrontal head circumference 36.5 cm (60lh centile). At 
birth, the neonate was hypotonic and weak and had contractures of the neck, 
thumbs, elbows and hips and had slight campylodactyly. Deep tendon reflexes 
were absent and pathological reflexes could not be elicited. There was striking 
hypoplasia of the lateral abdominal wall musculature (obliquus abdominis) with 
obvious diastasis (Fig. 1). The genitalia were female with absent labia majora. 
There was no webbing of the skin (pterygium). 
On admission to hospital at 3 years of age, the child showed marked motor 
delay, generalized weakness, hypotonia, flexion contractures of the neck, 
thumbs, elbows and hips and slight campylodactyly. She was able to stand and 
walk, but only with support. Mental development was appropriate for her age. 
Examination of the eyes was normal. 
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Fig. 1. The patient at 2 months of age with striking hypoplasia of the lateral abdominal wall 
musculature (obliquus abdominis) and obvious diastasis. 
Fig. 2. Biopsy from the quadriceps muscle showing variation in fibre diameters, slight 
endomysial fibrosis and a dark staining regenerating fibre. Anti neonatal-myosin antibodies. 
Bar = 25 μιτι. 
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Investigations 
The following investigations were normal full blood count, urea, creatinine, 
electrolytes, creatine kinase, carnitine, ammonia, proteins (including electropho­
resis), lipids, ceruloplasmin, purines, pynmidines, thyroid function, organic and 
amino acid levels in plasma and unne, white blood cell (lysosomal) enzymes, 
blood and cerebrospinal fluid (CSF) lactate and pyruvate and CSF analysis 
Serology for toxoplasma, rubella, cytomegalovirus, herpes and syphilis was 
negative Chromosome analysis revealed a normal 46.XX karyotype 
Neurophysiological investigations revealed normal motor nerve conduction 
velocities of the peroneal and median nerves, but myopathic features, ι e an 
increased number of brief, polyphasic, small amplitude potentials in the deltoid, 
quadriceps and tibialis anterior muscles consistent with myopathy There was no 
evidence of denervation/reinnervation 
Magnetic resonance imaging (MRI) of the cerebrum, cerebellum, brain stem, 
medulla oblongata, spinal cord and cauda equina appeared normal MRI of the 
lateral abdominal wall musculature showed hypoplasia of the obhquus abdomi­
nis 
Muscle biopsy 
The needle biopsy obtained from the quadriceps muscle at the age of 22 months 
showed many type I fibres (67%) and wide variation in the fibre diameters 
caused by the presence of atrophic and hypertrophic fibres The muscle fibres 
were rounded and there was moderate perimysial fibrosis and extensive endomy-
sial fibrosis (Fig 2) The number of fibres with internal nuclei was normal and 
slight fat cell infiltration was observed Some regenerating fibres (positive with 
LEU 19 antibodies and antibodies against neonatal and developmental myosin) 
were present (Fig 2) The muscle fibres showed normal dystrophin, vimentin, 
desmin and merosin (or laminin-Oj) staining Carnitine content was within the 
normal range Electron microscopic examination did not reveal any additional 
information 
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Discussion 
Our patient's symptoms meet the clinical and morphological criteria for 'pure' 
congenital muscular dystrophy with normal mental development (CMD type I) 
[3, 10]. Her histopathological characteristics included extensive substitution of 
muscle tissue by endomysial fibrosis and some regenerating fibres. Necrosis was 
not observed, but it is usually less severe in CMD than in Duchenne dystrophy 
and limb girdle dystrophy, and it may even be absent in muscle specimens [5]. 
Fat cell infiltration was slight. This latter phenomenon has been found to 
increase with increasing age in 'pure' CMD [11] and usually differs from one 
site to another within one muscle [5]. The extracellular matrix protein laminin-
a2 was found to be present, which excludes the laminin-ctj-negative subgroup of 
'pure' CMD with cerebral white matter hypodensity [12, 17, 18]. Laminin 
variants are proteins that are expressed in muscle membranes as well as in 
Schwann cells [1, 18]. The normal mental development and normal cerebral 
MRI in our patient are additional arguments in favour of 'pure' CMD type I. 
Our patient with 'pure' CMD type I also had hypoplasia of the lateral 
abdominal wall musculature, as demonstrated by MRI, and hypoplasia of the 
external genitalia. Hypoplasia of the lateral abdominal wall musculature causes a 
prune belly aspect of the abdomen. The descriptive term 'prune belly' refers to 
the slack, lax abdomen alone and should be differentiated from the 'prune belly 
syndrome', a well-recognized entity consisting of deficient abdominal muscula-
ture, failure of testicular descent and structural urinary tract anomalies [6, 9, 13, 
15, 16]. Although our patient had hypoplasia of the external genitalia, structural 
abnormalities of the urinary tract were lacking, which excluded a true 'prune 
belly syndrome' [6, 9, 11, 14, 15]. Our case seemed to bear some resemblance 
to cases with amyoplasia. In amyoplasia, limb muscles are absent and are 
replaced by fibrous and fatty tissue. Congenital joint contractures (arthro-
gryposis) have been described in amyoplasia by Hall et al [8]. At the same 
centre, Reid et al reviewed 225 cases of amyoplasia and observed other associ-
ated anomalies: 12 cases (5.3%) with gastroschisis, 6 (2.7%) with bowel atresia 
and 4 (1.8%) with defects in the lateral abdominal wall musculature [14]. 
Summarizing, our patient had characteristics of 'pure' CMD, a prune belly 
due to hypoplasia of the lateral abdominal wall musculature and hypoplasia of 
the external genitalia. In an attempt to classify our patient, there are three possi-
ble diagnoses: (1) a coincidental association of CMD and hypoplasia/aplasia of 
the lateral abdominal wall muscles, because of the epidemiological rarity of the 
two entities, (2) a non-coincidental association of CMD and hypoplasia/aplasia 
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of the lateral abdominal wall musculature and (3) a 'new' CMD subtype with 
prominent involvement of the lateral abdominal wall muscles, that presents with 
a prune belly in the neonatal period. We are presently unable to differentiate 
between these three diagnoses. The first hypothesis receives some indirect 
support from observations in hereditary aplasia of specific muscles [2, 7]. The 
second hypothesis is in line with amyoplasia, in which lateral wall hypoplasia is 
commonly seen [8, 14]. Molecular genetic investigations may eventually reveal 
which of these hypotheses is correct. 
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IV 2 
LOCALIZED FORMS OF 
CONGENITAL MUSCULAR DYSTROPHY 

IV 2.1 
Dystrophie myopathy of the diaphragm in a neonate 
with severe respiratory failure during infectious episodes 
Q.H. Leyten, W.O. Renier, F.J.M. Gabreëls, 
H.J. ter Laak, L.H.A. Hinkofer 
Neuromuscular Disorders 1993;3:51-55 
Abstract 
In this study a boy is described who showed slight postnatal asphyxia related to 
isolated dystrophic diaphragmatic musculature. Development was complicated 
by several periods of bronchopneumonia necessitating artificial respiration each 
time. 
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Very few cases of respiratory insufficiency due to dystrophic diaphragmatic 
musculature have been reported [1-4]. Only two cases have been described with 
isolated dystrophy of the diaphragmatic musculature: in one case a 'dystrophy-
like' diaphragm was found [4] and in another well-documented case isolated 
dystrophy of diaphragmatic musculature was seen [2]. In this paper, we report 
the clinical and morphological characteristics of another case with isolated 
dystrophic diaphragmatic musculature which led to severe asphyxia in periods of 
bronchopneumonia necessitating artificial respiration. 
Case Report 
A boy, the second child of healthy non-consanguineous parents, was bom at 37 
weeks. Pregnancy was complicated by slight toxicosis, decreased antenatal 
movements and breech position, and was terminated by caesarian section. Apgar 
score was 8 after 5 min. Birth weight was 2,750 g. Occipitofrontal circum-
ference was 33.5 cm. The postpartum period was complicated by a short period 
of hypoxia and slight generalized hypotonia. Examination revealed upwards 
displacement of the right part of the diaphragm. No muscular atrophy, muscular 
weakness, talipes, tent-shaped mouth and no haematomas were observed. Deep 
tendon reflexes were present, pathological reflexes could not be elicited. Slight 
resistance to passive movements of the hips and elbows was noticed. Mild 
retrognathia and asymmetrical implant of the ears were seen. 
The family history did not mention neuromuscular diseases, such as dystro-
phic myotonia, myasthenia or congenital myopathies. Further development of 
the boy was complicated by periods of bronchopneumonia caused by Staphylo-
coccus aureus and Haemophilus influenzae, respectively, which led to severe 
asphyxia and febrile convulsions, necessitating artificial respiration for 2-3 days. 
Despite five periods of artificial respiration, the motor and mental development 
have proceeded normally so far. At the time of this study, he was 3 yr old. To 
correct the upwards displacement of the right diaphragm, restorative surgery was 
undertaken at the age of 19 months. At the operation, eventration was present. 
The diaphragm was hypotonic with a normal macroscopic aspect. A biopsy 
specimen was taken from the right diaphragm. Further investigations on the 
respiratory tract and cardiovascular system did not reveal any other abnor-
malities. 
205 
4 • < - ' - " , « > 
% 
Ai* 
φ •** 
•г 
ν 
У 
J*'«ι 
^ " 
Fig. 1. Muscle biopsy from quadriceps muscle at the age of 14 months showing a normal 
picture (HE, bar = 50 μπι). 
Fig. 2. Muscle biopsy from diaphragm muscle showing many rounded hypertrophic fibres with 
a clear increase in endomysial connective tissue (HE, bar = 50 μιτι). 
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Laboratory studies 
Results of the following laboratory tests were normal: complete blood cell count 
and urine analysis, renal function tests, determinations of serum electrolyte 
levels, serum protein content and electrophoretic pattern, serum lipid spectrum, 
ceruloplasmin, ammonia, purines, pyrimidines, organic and amino acid levels in 
plasma and urine, and lysosomal enzyme activities in leucocytes. Appropriate 
studies ruled out endocrinological diseases, especially hypothyroidism and dis­
orders caused by toxic agents. Lactate and pyruvate levels were normal in serum 
and the cerebrospinal fluid (CSF). Further studies on the CSF showed no abnor­
malities; leucocyte count, protein immunoelectrophoresis and ketone bodies were 
normal. Creatine kinase (CK) activity was normal (27 U Γ1). Myoglobin and 
carnitine content were normal. 
Microbiological examination excluded infections caused by toxoplasma, 
cytomegalovirus, herpes and rubella virus, and syphilis. 
Electromyographic studies revealed normal motor and sensory nerve conduc­
tion velocities in the arms and legs, and normal myographic patterns. Stimula­
tion of the right phrenic nerve was not attempted. Prostigmine test was normal. 
Muscle biopsies 
Needle biopsies from the quadriceps muscle (17 days and 14 months after birth) 
did not reveal any dystrophic characteristics (Fig. 1). Immunohistochemical 
localization of dystrophin, desmin and vimentin appeared to be normal. 
Contrary to the results of both biopsies from the quadriceps muscle, a muscle 
specimen from the diaphragm taken at 19 months of age, clearly showed a 
dystrophic aspect by the presence of many rounded hypertrophic muscle fibres 
embedded in a matrix of connective tissue (Fig. 2). Sporadically, a muscle fibre 
with a round vacuole filled with a basophilic substance was observed. The 
number of muscle fibres with internal nuclei was increased; fat cells and fibre 
splitting were absent. Enzyme histochemically, most of the fibres were type I 
fibres; some of the fibres showed gradations in staining intensity with ATPase 
(preincubated at pH 4.2) and thus resembled type IIC fibres. The 5'-nucleotidase 
activity of the connective tissue was clearly increased. Immunohistochemical 
localization of dystrophin, desmin and vimentin appeared to be normal. Ultra-
microscopic examination of the same specimen did not reveal any other abnor­
malities. Myoneural endplates were normal. Pyruvate oxidation, fatty acid 
oxidation and carnitine content of muscle tissue were within the normal ranges. 
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Discussion 
The boy in our study suffered from severe respiratory insufficiency, but only 
during infectious episodes. Obstructive upper airway pathology was excluded. 
The sole anomaly was isolated dystrophy of the diaphragmatic musculature. 
Despite five periods of artificial respiration, the boy is developing well. 
Neurological causes of diaphragmatic paralysis were excluded, such as 
pathology of the anterior horn (poliomyelitis, carcinomatous encephalomyelitis, 
amyotrophic lateral sclerosis, chronic proximal spinal muscular atrophy, 
Werdnig-Hoffmann disease [5-7]), or the roots of the cervical plexus (traumatic, 
tuberculosis, cervical disc hernia, cervical spine spondylarthrosis, birth injuries 
with Erb's palsy). Disturbances of the peripheral nerves (the Guillain-Barré 
syndrome, blastomatosis, phrenic nerve trauma [8] and neuritis by infections 
such as poliomyelitis, diphtheria, syphilis and herpes zoster, were excluded, as 
well as disturbances caused by toxic (lead), metabolic (acute intermittent 
porphyria, nutritional beriberi), allergic (vascular) and endocrinological agents 
(congenital hypothyroidism [9]). Muscle diseases such as primary infection of 
the diaphragm [10,11] by cytomegalovirus, neonatal myotonic dystrophy [12-
16], myasthenia gravis and polymyositis [17] were also excluded. 
With respect to the histological characteristics of the muscle biopsies taken 
from our patient, it should be emphasized that no changes were found in the 
quadriceps muscles. The diaphragmatic musculature revealed typical dystrophic 
changes, such as an increased variation in the fibre diameter, an increased 
number of fibres with internal nuclei, and rounded muscle fibres surrounded by 
increased quantities of collagen. Immature, myotube-like fibres as seen in 
Werdnig-Hoffmann disease [18] were not observed. Myotubes (very small fibres 
with swollen internal nuclei), as seen in muscles (including the diaphragm) from 
cases suffering from congenital myotonic dystrophy [16], were not present in the 
diaphragm of our case. 
Reports in the literature on respiratory insufficiency due to (isolated) dystro-
phy of the diaphragmatic musculature are scarce [1-4] and most of them are 
poorly documented [2]. Only Bergen et al. presented a well-documented case of 
a myopathic process in a neonate which solely involved the diaphragm [2]. In 
their study, isolated diaphragmatic dystrophy was found with typical dystrophic 
characteristics, such as an increased variation in the fibre diameter, increased 
amount of collagen, necrosis and hypertrophy. All the other muscles examined 
(psoas, deltoid, biceps, quadriceps, gastrocnemius, intercostal, neck and tongue 
muscles) were normal. The female infant in their study died at 3 months of age. 
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They emphasized that possible 'hypoplasia' or 'dysplasia' of the diaphragm was 
very unlikely, because the intercostal and abdominal muscles, which originate 
from the same myotomes as the diaphragm, did not reveal any similar changes. 
Bosman et al. [4] described a case of congenital diaphragmatic paralysis in an 
infant who died of respiratory failure at the age of 5 weeks. At autopsy they 
found dystrophy-like muscle pathology restricted to the diaphragm. The histolo-
gical findings included extensive thinning of the diaphragm, marked variation in 
muscle fibre size with random distribution, nuclei in rows in the more atrophic 
fibres and increased interstitial tissue, but without inflammatory infiltrates, fatty 
or fibrotic changes. They hypothesized hypoplasia of the diaphragm muscle, 
leading to compensatory hypertrophy of the remaining muscle fibres, conse-
quently determining a muscular dystrophy-like appearance of the diaphragm, 
with random distribution of large and small fibres. The female infant in their 
study died at the age of 1 month and 7 days. 
Lewis and Besant [1J reported two patients, a boy and a girl, in a family with 
two siblings with diaphragmatic weakness. The histological findings in the dia-
phragm did not reveal an increased amount of interstitial tissue. The variation in 
muscle fibre size was slight with respect to our case. The other striate muscles 
examined showed no changes, except for the pectoral muscle in one case, which 
also showed slightly increased variation in the size of the fibres and a rare vacu-
olated fibre. The boy died at the age of 8 weeks, the girl at the age of 6 weeks. 
De Reuck et al. [3] described a patient with progressive congenital myopathy, 
with initial involvement of the diaphragm with type I muscle fibre atrophy, but 
also involving the peripheral psoas and pectoralis major muscles. The histologi-
cal characteristics of the diaphragm included an increased amount of collagen, 
increased variation in the fibre diameter, but no hypertrophy. Fibres with 
internal nuclei were not observed. The boy in the study by De Reuck et al. [3] 
died at the age of 21 months. 
Our study of the literature led us to the conclusion that only Bergen et al. [2] 
described a case with isolated dystrophy of the diaphragm. Based on the histo-
logical data, we believe that our patient represents a second well-documented 
case. An important clinical difference is the clinical course. The female infant in 
Bergen's study died at 3 months of age, in contrast to our male patient who is 
still alive at the age of 3 yr. So far, our patient has had five periods of broncho-
pneumonia necessitating artificial respiration during each period. Whether our 
patient represents a new (variant) type of diaphragmatic muscular dystrophy 
with a milder clinical course, remains unclear. Despite the life-threatening 
events, he is still developing well. 
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IV 3 
LATE ONSET TYPE OF MUSCULAR DYSTROPHY 

IV 3.1 
Familial adult-onset muscular dystrophy with leukoencephalopathy 
B.G.M. van Engelen, Q.H. Leyten, P.L.J.A. Bernsen, F.J.M. Gabreëls, 
F. Barkhof, E.M.G. Joosten, B.C.J. Hamel, H.J. ter Laak, 
M.B.M. Ruijs, J.R.M. Cruysberg, J. Valk 
Annals of Neurology 1992;32:557-580 
Abstract 
We report on 3 siblings with an adult-onset, predominantly distal muscle weak-
ness. In the female index patient this was associated with epilepsy and a 
progressive spastic ataxic gait, while the 2 other siblings had no appreciable 
clinical nervous system involvement. Additional investigations revealed muscu-
lar dystrophy and leukoencephalopathy in all 3 siblings. We conclude that this 
familial adult-onset muscular dystrophy associated with leukoencephalopathy 
represents a newly recognized autosomal recessive syndrome. 
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An association between muscular dystrophy and leukoencephalopathy has been 
described in congenital muscular dystrophy (CMD) of the Fukuyama type 
(F-CMD); CMD of the so-called and less severe non-Fukuyama type (nF-CMD) 
or "Occidental type"; and the composite "muscle, eye, and brain disease" (MEB) 
[1-4]. Central nervous system (CNS) involvement may range from apparently 
asymptomatic leukoencephalopathy (nF-CMD) to widespread developmental 
abnormalities in the cerebral architecture (F-CMD, MEB). These three types of 
CMD appear immediately after birth and are always connected with severely 
delayed motor development. 
We present the cases of 3 siblings with a type of muscular dystrophy com-
bined with leukoencephalopathy in whom symptoms presented in adulthood. The 
relationship with CMD is discussed. 
Case Histories 
Patient I1I-3 (proband) 
The proband (Fig. 1) was a 29-year-old woman who had normal motor mile-
stones and intellectual development until the age of 18 years. Then she experi-
enced exercise-induced walking difficulties due to a mainly left-sided footdrop. 
At the age of 22, she had her first generalized tonic-clonic seizure. Afterward, 
walking difficulties due to muscle weakness in the lower part of the legs and 
spastic gait were found. Following each epileptic attack, her walking 
deteriorated further. At the age of 28 years, she became wheelchair dependent. 
Neurological examination showed bilateral myopia (- 2.0 diopters), slightly 
increased calf bulk, and bilateral pes cavus without muscle wasting. There was a 
diffuse weakness of all muscle groups that was more pronounced distally in the 
lower limbs. She had a bilateral predominantly right-sided pyramidal and 
cerebellar syndrome. Cognitive functions were normal. 
Patient III-4 (affected sib) 
This 25-year-old man has always been healthy. He admitted to having some 
exercise-induced pain in the upper leg muscles and calves. Neurological exami-
nations showed bilateral myopia (- 0.75 diopters), an increased calf bulk, and 
slight distal muscle weakness in the lower extremities. 
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Patient III-5 (affected sib) 
This 19-year-old man started to complain of abnormal muscle fatigue after 
exercise from the age of 16 years. At 18 years old, he sought medical attention 
because of slight exercise-induced muscle weakness and pain in the upper leg 
muscles and calves. Neurological examination revealed bilateral myopia (- 7.5 
diopters), increased calf bulk, pes cavus, and slight distal muscle weakness in 
the lower extremities. 
Family history 
The medical history and examination of Patients III-2, II-3, II-9, 1-1, 1-3, 1-4, 
II-l, II-2, II-4, II-5, II-6, II-7, 11-10, IV-1, IV-2, and IV-3 did not reveal any 
abnormalities. Pedigree analysis revealed no consanguinity in six generations. 
D 
IV 
Ο-Π0 
I . 
D-r-O 
1 2 3 4 
О D О G И О О 
4 5 6 7 SB Τ 9 
D - r - O C B B 
/ 
2 if 3 4 5 
<TS~ä 
1 2 3 
S proband 
?· 
I-J v_/ unaffected male and female 
Ш w muscular dystrophy 
LU v i/ leucoencephalopathy 
Fig. 1. Pedigree of the present family. Affected family members were Patients ΙΠ-3, III-4, and 
III-5. 
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Table. Summary of investigations in affected siblings 
Tests 
Laboratory 
Creatine kinase (unitsfliter; normal < 90) 
Dystrophy gene rearrangements 
Muscle biopsy (dystrophic changes) 
Neurophysiology 
Electromyography (myopathic) 
Nerve conduction velocity slowing 
Brainstem auditory evoked potential slowing 
Somatosensory evoked potential slowing 
Visual evoked potential slowing 
Electroencephalography 
Slowing 
Slow spike waves 
Patient III-3 
116-281 
NE 
+ 
+ 
-
+ + 
+ + 
-
+ + 
+ 
Patient III-4 
586-801 
NE 
NE 
+ + 
-
- + 
-
-
+ 
— 
Patient III-5 
791-1608 
— 
+ + 
+ + + 
— 
-
— 
— 
+ + 
+ + 
Neuroradiology 
Brain CT scan: white matter hypodensities + + + + + + 
Brain MRI 
Periventricular hyperintensities + + + + 
Deep white matter hyperintensities + + + + + + 
U fiber involvement + + + - + + 
Corpus callosum atrophy + + - + 
External capsule involvement + + + + + 
CT scan of muscles: fatty infiltrates - + + + 
- = absent; - + = borderline; + = mild; + + = moderate; + + + = severe; NE = not estimated. 
Results 
Laboratory investigations 
Creatine kinase values were clearly elevated and varied among the 3 affected 
siblings (Table). Unaffected family members (II-3, II-9, III-2, IV-1, IV-2, IV-3) 
had normal CK values. Results of the following laboratory tests were normal in 
Patients HI-3 and IH-5: in urine—organic acids, amino acids, purines, pyrimi-
dines, mucopolysaccharides, oligosaccharides, and neuraminic acid; in serum 
—amino acids, very-long-chain fatty acids, and lactate; in leukocytes—several 
lysosomal enzymes (including acid maltase, arylsulfatase A, galactocerebro-
sidase); and in cerebrospinal fluid—total protein, IgG, and lactate. Ischemic 
forearm exercise tests revealed normal findings. Acanthocytes were not found. 
Rearrangements of the dystrophy gene at Xp21 were not found in Patient III-5 
[5]. 
Neurophysiological and ophthalmological studies 
Electromyography (EMG) showed small polyphasic motor units, high-frequency 
discharges, fibrillations, and positive spikes mainly in the distal musculature in 
all 3 affected siblings (Table). Unaffected family (II-3, II-9, III-2) had normal 
EMG findings. Varying degrees of electroencephalographic (EEG) abnormalities 
were detected in all 3 affected siblings and consisted of diffuse slowing, focal 
hypofunctional, and irritative activity and generalized slow spike waves. 
Corrected visual acuity was 20/20 in all 3 siblings. Slit-lamp microscopy and 
ophthalmoscopy revealed no abnormalities, especially no cataracts. Results of 
color vision tests were normal and the electroretinogram was not disturbed. 
Radiological studies in brain and muscle 
Leukoencephalopathy was defined as confluent, not well-demarcated areas of 
high-signal intensity on long repetition time (TR; 2,500 msec), long echo time 
(TE; 60 msec), spin-echo magnetic resonance images (MRIs) (0.6 tesla), corre-
sponding with areas of low attenuation on the computed tomogram (CT). Leuko-
encephalopathy with mild ventricular enlargement was present in the proband 
(III-3, Fig. 2A) and to a lesser degree in both other affected siblings (III-4, 
IH-5) (Table), whereas brain MRI showed no abnormalities in the asymptomatic 
sister (III-2) and in both parents (II-3, II-9). No progression of white matter 
abnormalities in Patient III-3 was seen on CT during the past 7 years. Short TR, 
spin-echo images were obtained after the injection of gadolinium diethylenetri-
aminepentaacetic acid (Gd-DTPA) in Patients III-3 and III-4, but no signal 
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enhancement was seen. There were no gyral disorders or calcifications, and no 
abnormalities of the anterior commissure, the internal capsule, the basal ganglia, 
the brainstem, or the cerebellum. 
Fatty infiltrates were seen on the CT scan of the gastrocnemius and soleus 
muscles and to a lesser extent in the quadriceps muscles of Patients III-4 and 
III-5. 
Fig. 2. (A) Increasing signal intensity of all the supratentorial white matter on MRI of the 
brain of Patient III-3. (B) Soleus muscle biopsy from Patient III-3 showing fiber splitting and 
fragmentation, an increased number of fibers with internal nuclei, and slight endomysial 
fibrosis. 
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Histopathological studies 
Histopathological studies on frozen sections (quadriceps muscle) from Patients 
III-3 and III-5 showed characteristic findings of muscular dystrophy (Fig. 2B): 
increased variation of the muscle fiber diameter, fiber splitting and fragmenta­
tion, atrophic basophilic fibers, increased number of fibers with internal nuclei, 
replacing fat cells, and slight endomysial fibrosis. Enzyme histochemical studies 
on frozen sections including succinate dehydrogenase and cytochrome oxidase 
were normal. No ragged red fibers and no basophilic and rimmed vacuoles were 
found. In Patient III-3, a combined biopsy specimen of the soleus muscle and 
sural nerve showed more pronounced dystrophic changes in the soleus as 
compared to the quadriceps muscle. Morphological and morphometrical analysis 
of the sural nerve revealed no abnormalities using standard techniques [6]. 
In Patient III-5, immunostaining with monoclonal antibodies against the 
C-terminus of dystrophin (DYS 2, Novocastra Laboratories, Newcastle-upon-
Tyne, UK) showed a normal pattern. 
Biochemical studies in muscle 
Substrate oxidation and ATP production studies were performed in 600-gm 
supernatants of the fresh muscle material obtained from the quadriceps. These 
studies, and the measurement of the activities of citrate synthase, cytochrome с 
oxidase, NADH:Q1 oxidoreductase, pyruvate dehydrogenase complex, and 
succinatexytochrome с oxidoreductase and of the concentrations of carnitine 
and protein were performed as previously described [7]. A defect in oxidative 
metabolism was not found. 
Discussion 
The clinical features and results of additional investigations in our 3 patients do 
not correspond with any known neuromuscular syndrome in adulthood. Becker's 
muscular dystrophy is clinically unlikely because of the predominance of distal 
muscle weakness, the only moderately elevated CK levels, and the leukoenceph-
alopathy. It is also genetically unlikely because of the female proband, the lack 
of rearrangement of the Xp21 gene, and the normal dystrophin level. Our 
patients could be compared to the type of distal muscular dystrophy described 
by Miyoshi and colleagues [8]. In the present family, however, the clinical 
findings included a more generalized form of muscular dystrophy, an only 
moderately elevated CK level, and no or only slight progression. In addition, no 
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association has been described between distal muscular dystrophy and leuko-
encephalopathy. 
Leukoencephalopathies could, in our patients, correspond with either demye-
lination or dysmyelination due to developmental disturbances. Fluid accumula-
tion in the white matter without demyelination or dysmyelination seems unlikely 
because of the lack of signs of brain swelling and the presence of mild ventricu-
lar enlargement. Known demyelinating leukoencephalopathies, including those 
due to mitochondrial diseases, were excluded on clinical and biochemical 
grounds. The lack of progression of leukoencephalopathy on successive CT 
scans suggests a dysmyelinating condition. 
Recently, the familial occurrence of asymptomatic periventricular leuko-
encephalopathy with myopathy starting in early childhood was reported as a 
new syndrome [9]. In this myopathy, changes resembling inclusion body 
myositis were observed. In biopsy specimens from our patients, no basophilic 
vacuoles, an indication of inclusion bodies, were observed. 
The clinical picture and associated CNS abnormalities of CMD show a 
marked heterogeneity, but no doubt exists about the congenital character of 
CMD [1]. "Adult-onset CMD" has not been hypothesized in the literature. 
CMD, nevertheless, is the only clinical syndrome comparable to that of the 
reported patients. Their clinical features and MRI findings do, however, not 
correspond to the severe neuromorphological alterations and functional or 
structural eye changes known to occur in F-CMD and MEB. The syndrome in 
the reported family shows remarkable similarities with, and might therefore 
possibly be, an adult-onset variant of nF-CMD. In the latter syndrome there is 
no correlation between the extent of leukoencephalopathy and the clinical signs 
of CNS involvement or the severity of the myopathy. nF-CMD may even 
present with asymptomatic leukoencephalopathy. Similar findings have been 
demonstrated in our patients, although it must be stated that leukoenceph-
alopathy is most pronounced in the only sibling with clinically evident CNS 
involvement. 
Similar to CMD, the mode of inheritance in the present family is most likely 
autosomal recessive with variable expression. The occurrence in siblings of both 
sexes from normal parents is sufficient evidence of an autosomal recessive trait. 
We conclude that there is a type of muscular dystrophy associated with 
leukoencephalopathy which starts in adulthood and represents a newly recog-
nized autosomal recessive syndrome. Provided CMD is not heterogenetic, the 
reported syndrome might be due to allelic mutation at the putative CMD locus. 
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Chapter V 
GENERAL DISCUSSION 

This study opens with a review of the literature and presents the clinico-
pathological results in our own material on 34 patients with the diagnosis of 
congenital muscular dystrophy (CMD). Nearly 1 % of all the patients who under-
went a muscle biopsy at the Centre for the Investigation of Disorders of the 
Neuromuscular System at the University of Nijmegen in the period 1977-1994 
had CMD. We discuss our findings in the light of the new classification for 
CMD as proposed at two recent international workshops on this topic, in which 
the author of this thesis was one of the participants.1,2 
CMD type IA. Classical or 'pure' CMD without white matter hypodensity 
The clinico-pathological observations in our patients3"7 were all in accordance 
with those reported in the literature.1,2,8'24 
CMD type IB. Classical or 'pure' CMD with white matter hypodensity 
In seventeen patients with classical or 'pure' CMD, the neuroradiological 
examination (CT/MRI) showed three with hypodense white matter areas.4 Two 
out of these three patients had epilepsy, but none were mentally subnormal. In 
the literature, the occurrence of epilepsy was mentioned in 13 out of 64 patients 
with a combination of CMD, (sub)normal intelligence and hypodense white 
matter areas.'25"37 Based on these data, it can be concluded that the frequency of 
epilepsy in CMD patients with (sub)normal intelligence and with white matter 
hypodensities is significantly higher (1 : 4.5) than in the normal population (1 : 
150). The nature and significance of the white matter changes remain obscure. 
Informative neuropathological data are scarce. Egger et al27 found patchy de-
my elination of the white matter of the centrum semiovale; Echenne et al28 
described a spongy appearance of the white matter on necropsy; and Malik et 
al38 mentioned a case with significantly decreased myelin staining. The lack of 
progression of white matter hypodensities on successive CT/MRI scans4,27,32,34·39 
and normal myelin basic protein findings in CSF4 are arguments in favour of hypo-
or dysmyelination. Recently, Voit et al40 postulated that the white matter 
hypodensities on CT/MRI are due to dysmyelination of the central nervous 
system. However, long-term follow-up studies with neuropathological, 
biochemical and magnetic resonance spectrometry (MRS) investigations are 
necessary to provide a definite answer to this question. 
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Severely decreased merosin expression was also observed in two of our 
patients with white matter changes in whom merosin investigation was possible. 
Until now, no direct relation has been demonstrated between hypodensities in 
the white matter and a merosin (merosin M-chain or laminin-ctj) deficient 
muscle status . 
Based on neuroradiological and immunohistochemical investigations, the 
patients with 'pure' CMD can be subdivided into two subtypes: (1) CMD 
without white matter changes and normal merosin (merosin M-chain or laminin-
oti expression and (2) CMD with white matter changes and a deficient merosin 
status.19 
CMD type II. Fukuyama type of CMD 
In the light of the recent classification for CMD,1,2 we reviewed the data on our 
eight patients with CMD and impaired intellectual development, who were clas-
sified in 19891 and 19936 as having the Fukuyama type of CMD (F-CMD).41"45 
Two patients were described by Krijgsman et al in 1980.46 The pathological 
findings in the central nervous system (CNS) were identical to those in the 
Japanese cases of F-CMD.4M5 Four other patients were classified as F-CMD 
because of their clinical features, i.e. histologically proven congenital muscular 
dystrophy, mental retardation, neurological defects, EEG and neuroradiological 
(CT/MRI) abnormalities and lack of structural eye abnormalities. 
In our study, normal merosin expression was found in 3 F-CMD patients. 
These merosin findings contrast with the findings in 17 Japanese F-CMD 
patients.47 In these patients, there was on average a 74% reduction. As the gene 
for Japanese F-CMD has been localized on chromosome 948 and the merosin 
gene on chromosome 6, the low levels of merosin in Japanese F-CMD seem 
secondary to another as yet unknown defect. Thus, our results show phenotypic 
heterogeneity of merosin expression in F-CMD. The normal merosin results in 
our F-CMD patients are in agreement with a merosin gene that is functioning 
normally. Our findings indicate that different primary defects may be involved 
in F-CMD. However, according to Dobyns et al49 another explanation for the 
merosin discrepancy might be that most non-Japanese F-CMD patients should 
be diagnosed as having muscle-eye-brain disease (Finnish type of muscle-eye-
brain disease, F-MEB-D, or Walker-Warburg syndrome, WWS) because of their 
more severe anomalies. Gene localization studies in non-Japanese F-CMD 
families are needed to clarify this. 
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In two female siblings who did not have eye abnormalities, we found severe 
degenerative features in the CNS and a neuromuscular disorder with histopatho-
logical features of CMD 50 Neuropathological examination of the brain of one 
sibling who died at the age of 30 months, revealed subtotal loss of neurons in 
the cerebral and cerebellar cortex and in the ventral pons, and secondary loss of 
myelin in the cerebral and cerebellar subcortical white matter These neuro-
pathological findings are more severe than those described until now in F-
CMD 4 '45 Moreover, neurophysiological and neuromorphological studies on the 
peripheral nervous system of our patients revealed a lack of large diameter 
fibres, a finding not described m F-CMD4 '45 Also the clinical picture was 
qualitatively and quantitatively more severe than any described in the classical 
Fukuyama type of CMD We could not prove that our cases had F-CMD, 
because we could not examine dystrophin-associated proteins (DAPs), especially 
43 DAG which are known to be abnormally low in F-CMD patients,51 or 
molecular genetic studies, especially on chromosome 94 8 For further differentia-
tion within the F-CMD group, molecular genetic studies are necessary 
CMD type III, or the Finnish type of muscle-eye-brain disease (F-MEB-D) 
and CMD type IV, or the Walker-Warburg syndrome (WWS) 
The Finnish type of muscle-eye-brain disease (F-MEB-D) and the Walker-
Warburg syndrome (WWS) represent rare autosomal recessive disorders in 
which muscles, the eyes and brain are affected Both have congenital muscular 
dystrophy, cobblestone (previously type II) lissencephaly and white matter 
changes The latter are diffuse and severe in WWS, but patchy in F-MEB-D 
Most WWS patients have hydrocephalus and anterior chamber malforma-
t i o n s ' 2 4 9 " " High myopia can be present in both In F-MEB-D retinal 
abnormalities associated with reduced or absent responses to electroretinography 
(ERG) and very high amplitude responses to visual evoked potentials (VEPs) 
are present by 2 years of age ' 2 49 52 55 Microphthalmia, typical retinal dysplasia 
and corneal opacities, present in WWS, have not been observed in F-MEB-D49 
F-MEB-D and WWS are usually classified separately because the clinical 
features and the neuropathological findings in WWS are more severe than in 
F-MEB-D12495557 and the eye abnormalities are somewhat different in both 
diseases Progressive ERG and VEP changes have been reported in F-MEB-D 
but not in WWS The differences in central nervous system abnormalities all 
appear to be quantitative, especially the seventy of the gyral malformation and 
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the white matter changes. In F-MEB-D patients, the gyral malformation usually 
consists of pachygyria over the frontal region and polymicrogyria posteriorly. 
The white matter changes are present but patchy in about half of the F-MEB-D 
patients. Most WWS patients have more severe gyral changes, consisting of 
agyria or mixed agyria-pachygyria with some areas of polymicrogyria. All have 
severe and diffuse white matter changes. Cerebellar hypoplasia might be 
somewhat more severe in WWS. Also the occipital cephaloceles which occur in 
about 30% of patients with WWS, have been reported very rarely in F-MEB-D. 
All these elements constitute a qualitative difference, but Dobyns is of the 
opinion that there is also a quantitative difference. Thus, severity forms the main 
difference between F-MEB-D and WWS, but this is not a reliable way to 
differentiate between these two genetic syndromes.1,2,49,55 
Our six patients with congenital muscular dystrophy and involvement of the 
central nervous system and eyes, who we classified as 'muscle-eye-brain 
disease' (MEB-D) in 1992,5 correspond with what now is called the (more 
severe) WWS and not with F-MEB-D, which is milder. According to the litera-
ture,49,55,58"6' progression of the disease is rapid in most WWS patients; this was 
also the case in five out of our six patients.5 In contrast, the patients in 
Santavuori's study showed slow progression, typical for F-MEB-D.57 Consider-
ing the clinical and neuropathological expression and progression patterns, our 
study supports the notion that the disease exists in different levels of severity, 
ranging from a milder type in the F-MEB-D group to a more severe type in the 
WWS group.49,55 
Creatine kinase (CK) values 
In agreement with literature reports,1,2,8"24 most of our patients with 'pure' CMD 
without white matter hypodensity, had normal or moderately increased serum 
CK values (up to 4 times the upper limit of the reference range). The patients in 
the study by Topaloglu et al37 with 'pure' CMD and white matter hypodensity, 
had significantly higher values of CK (ranging from normal up to 17 times the 
upper limit of the reference range) in comparison with their group of 'pure' 
CMD patients without white matter hypodensity (ranging from normal up to 4 
times the upper limit of the reference range). Our patients with 'pure' CMD and 
white matter hypodensity also had normal or moderately increased CK values 
(up to 13 times the upper limit of the reference range).4 In the literature, the CK 
values in F-CMD were significantly elevated in all cases (10 to 50 times the 
upper limit of the reference range).41,42 Our F-CMD patients had normal or 6 to 
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7 times the normal CK values.3·6 In the literature, CK values in F-MEB-D were 
significantly elevated in all cases (3 to 20 times the upper limit of the reference 
range),16,57 as well as in WWS (variable values, ranging from 3 to 60 times the 
upper limit of the reference range)55 and could vary greatly between patients or 
over time in an individual patient. Our WWS patients also had elevated CK 
values (10 to 16 times the upper limit of the reference range).5 Considering the 
CK values in CMD, it is our impression that the more organs involved, the 
higher the CK value. 
Muscle biopsy 
The histomorphological findings in the muscle biopsy specimens from our 
'pure' CMD patients with and without low density areas in the white matter and 
in the F-CMD and WWS patients, did not differ essentially.6 It was only 
possible to observe increasing fat cell infiltration with increasing age in our 
'pure' CMD series without white matter hypodensity. Immunohistochemistry 
with dystrophin, vimentin and desmin antibodies showed a normal expression 
pattern.6 Merosin (merosin M-chain or laminin-o^) expression was normal in 
eleven patients (six had 'pure' CMD without white matter hypodensity, three 
were considered to have F-CMD and two had WWS), was severely decreased in 
two cases with 'pure' CMD with white matter hypodensity and showed variable 
expression in one of two exceptional F-CMD-like cases.50,62 Tomé et al63 and 
Mercuri et al19 were the first authors to report the absence of merosin in some 
cases of 'pure' CMD, whereas Hayashi et al47 reported near-normal values by 
quantitative immunofluorescence in 'pure' CMD. All 10 merosin-positive cases 
in the study by Mercuri et al39 had normal MRI of the CNS, whereas all the 
merosin-negative cases had moderate to severe diffuse white matter changes on 
MRI. The study by Mercuri et al39 was the first to make a clear distinction 
between patients with 'pure' CMD without white matter hypodensity but with 
normal merosin expression and 'pure' CMD with white matter hypodensity plus 
a deficient merosin status. In our material on 'pure' CMD,62 only two cases had 
merosin deficiency; they also had white matter hypodensity, which is in agree-
ment with the findings in the study by Mercuri et al.39 
In the study by Hayashi et al,47 quantitative immunofluorescence showed that 
the merosin content in F-CMD was reduced to a mean of 26%. However, 
merosin (merosin M-chain or laminin-o^) expression was normal in intrafusal 
fibres, which suggests a secondary change.40 In contrast, in our study, normal 
merosin (merosin M-chain or Іатіпіп-оц) expression was found in the three 
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patients considered to have F-CMD As the gene for Japanese F-CMD has 
been localized on chromosome 9q31-3348 and the merosin gene on chromosome 
6q2,2 6 4 these low levels of merosin in Japanese F-CMD should be considered as 
secondary to another as yet unknown defect Thus, the differences in merosin 
expression between Japanese and non-Japanese F-CMD suggest genetic hetero­
geneity However, another explanation is that some of our F-CMD patients may 
have F-MEB-D or a mild form of WWS Dobyns et al49 believe that most non-
Japanese patients diagnosed as having F-CMD have more severe anomalies 
typical of F-MEB-D or WWS, or less severe anomalies consistent with CMD 
with mental retardation In a recent study, consistently preserved merosin 
(merosin M-chain or laminin-a2) expression was found in five patients with 
WWS, as detected by immunofluorescence in skeletal muscle4 0 This is in 
accordance with our findings The authors claimed that merosin can be used as 
an immunocytochemical marker to distinguish WWS from F-CMD 
Electron microscopy examination of the muscle biopsy of the father in our 
family with possible dominant 'pure' CMD6,5 showed mitochondria with 
crystalline inclusions in a large group of fibres and proliferation of concentric 
cnstae 6S Both patients in the study by Kalyanaraman et al66 had mitochondrial 
abnormalities in their muscle tissue (biopsy), ι e an increased number of 
mitochondria of abnormal size and shape with distorted cnstae Although this 
may be an unspecific or age-related finding, these observations indicate that in 
the future, more attention should be paid to the exploration of mitochondria in 
CMD 
Genetic aspects 
In general, it is agreed that CMD, F-CMD, F-MEB-D and WWS have an 
autosomal recessive pattern of inheritance ' 2 8 2 4 4 1 4 5 4 9 5 2 " Recent studies have 
indicated that in 'pure' congenital muscular dystrophy, a proportion of cases are 
merosin-negative The locus for the merosin gene is on chromosome 6q2 2 M The 
gene responsible for typical F-CMD has recently been mapped to chromosome 
9q31-334 8 Linkage studies on ten Finnish families with F-MEB-D excluded the 
F-MEB-D gene from this region6 7 Toda et al68 claimed that F-CMD and WWS 
are genetically identical Their findings were based on microsatellite marker 
analysis of two siblings, one presumed to be suffering from F-CMD, one from 
WWS Both cases showed the same alleles for the flanking markers of the F-
CMD locus on 9q31-33 No statistical analysis or lod score calculation of these 
results were provided and no mutation of the F-CMD gene was demonstrated40 
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Many explanations can account for this observation. However, these findings 
contrast with the different merosin (merosin M-chain or laminin-a2) expression 
in the skeletal muscle of F-CMD versus WWS.40 
Kalyanaraman et al66 are the only authors to have reported on a family with 
CMD and possible CNS involvement (i.e. seizures in the mother and poor 
reading ability with an abnormal EEG (spike and wave complexes) in the son), 
which suggests an autosomal dominant pattern of inheritance. We examined a 
family (father and daughter) with 'pure' CMD in which inheritance was possibly 
autosomal dominant.65 Theoretically, the mother in our family could be a carrier 
(heterozygote) of an autosomal recessive type of CMD. 
In conclusion, for definite delineation of the nosological entities of CMD, 
further molecular genetic research is necessary. 
Particular forms 
In our series, there were two particular forms of congenital muscular dystrophy 
which we could not classify. One child had a combination of congenital muscu-
lar dystrophy, hypoplasia of the lateral abdominal wall musculature (especially 
of the oblique abdominal musculature) and hypoplasia of the external genitalia. 
This case illustrates a rare combination of a muscular dystrophic process and a 
muscular developmental defect.69 The other patient, a boy, had unilateral isolated 
dystrophic diaphragmatic musculature.70 In the literature, only Bergen et al71 
described a neonate with isolated congenital dystrophy of the diaphragm. 
Severe degenerative features of the central nervous system were reported in 
two female siblings with CMD. Brain pathology differed essentially from that 
described previously in conjunction with CMD, i.e. subtotal loss of neurons in 
the cerebral and cerebellar cortex and in the ventral pons, and secondary loss of 
myelin in the cerebral and cerebellar subcortical white matter. Sural nerve 
pathology showed a lack of large diameter fibres, a finding not described in F-
CMD. There was a marked variability of merosin (merosin M-chain or laminin-
ct2) expression in the skeletal muscle fibres in one of these two patients, as is 
also found in Japanese F-CMD. Within the spectrum of F-CMD these cases may 
illustrate a more severe type or they may represent a distinct entity. 
In our latest report, we described three siblings (one sister and two brothers) 
with an adult-onset of predominantly distal muscle weakness.72 In the female 
index patient, this was associated with epilepsy and a progressive spastic ataxic 
gait, while the two other siblings had no appreciable clinical nervous system 
involvement. Additional investigations revealed muscular dystrophy and leuko-
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encephalopathy in all three siblings. After the publication of this article, merosin 
expression was found to be normal in the one patient we examined. Only by 
excluding abnormalities in the merosin (merosin M-chain or laminin-ctj) (6q2) 
gene, can we conclude that this is a different type of muscular dystrophy. 
Conclusion 
This study indicates how fast research into CMD has developed in recent years. 
Molecular genetic research ('genetic mapping') has contributed greatly to 
research into dystrophinopathies. Associating clearly delineated clinical signs 
and symptoms with morphological and genetic data will help to establish a 
better defined classification for syndromes with congenital muscular dystrophy. 
Our study supports the recent CMD classification (see Table), but suggests that 
more subtypes may be identified in the future. 
Table. The 1995 CMD classification according to the literature and two ENMC 
sponsored workshops'2 
CMD I Classical or 'pure' CMD without severe impairment of intellectual 
development: 
A. Without white matter hypodensity and with normal merosin (merosin 
M-chain or laminin-OL·,) expression (McKusick, no. 23667), 
B. With white matter hypodensity and with deficient merosin (merosin 
M-chain or lanunin-Oj) status. 
CMD II CMD with mental impairment due to structural brain abnormality: the 
Fukuyama type (McKusick, no. 253800). 
CMD III CMD with eye and brain abnormalities: the Finnish type (McKusick, no. 
253280). 
CMD IV CMD with eye and brain abnormalities: the Walker-Warburg syndrome 
(McKusick, no. 236670). 
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SUMMARY 

This study on congenital muscular dystrophy (CMD) focusses on the clinical 
and morphological aspects of the disorder. 
In Chapter II, the literature is reviewed within the framework of recent CMD 
classification. This study aims to evaluate and delineate the clinical and morpho-
logical characteristics of the different types of CMD by comparing our findings 
to data reported in the literature. 
In the past, CMD was often used as a 'catch-all' diagnosis owing to its 
imprecise delineation and the confusing overlap of conditions. Furthermore, 
there were several forms of CMD, with a wide range of clinical findings and 
variable prognoses, which shared similar histological muscle changes. The 
clinical expression of CMD was determined by the presence or absence of 
anomalies of the brain and eyes. The prognosis was variable and depended on 
the severity of the disease. 
The myopathological manifestations of congenital muscular dystrophy were 
clear, but there were no differentiating histological and electron microscopic 
aspects. The changes were variable and included features like variation in fibre 
size, the presence of necrotic and basophilic fibres, an increased number of 
fibres with internal nuclei and the substitution of muscle tissue by endomysial 
fat and connective tissue. 
Signs and symptoms, clinical course, laboratory, neurophysiological, radiolog-
ical, morphological and genetic characteristics are outlined for each subcategory. 
Histological characteristics of muscle biopsy specimens and neuropathological 
findings in the central nervous system (CNS) and the eyes are described for 
each subcategory. The present-day discussion about whether the Fukuyama type 
of CMD (F-CMD), the Finnish type of muscle-eye-brain disease (F-MEB-D) 
and the Walker-Warburg syndrome (WWS) should be considered to represent a 
spectrum of one disease, is continued at the end of this Chapter. Although there 
is consensus that the same or a similar basic pathological process is involved, 
there are also several consistent and mainly quantitative differences between 
these entities. Especially merosin (merosin M-chain or laminin-Oj) has accentu-
ated the discussion. 
Chapter III section 1.1 reviews eighteen patients with congenital muscular 
dystrophy. Six of them also have involvement of the central nervous system that 
corresponded with the Fukuyama type of congenital muscular dystrophy. In four 
patients, both the CNS and the eyes are involved, so the diagnosis of 'muscle, 
eye and brain disease' has been made. With reference to the 1995 proposal for 
the classification of CMD, our four patients described as having muscle-eye-
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brain disease in 1989, should now be classified under the Walker-Warburg syn-
drome. 
Chapter III section 1.2 presents the clinical signs, symptoms and central 
nervous system characteristics (intelligence, cerebrospinal fluid, especially 
myelin basic protein, EEG and neuroradiological findings (CT/MRI)) of 17 
patients with classic or 'pure' congenital muscular dystrophy. In three patients, 
neuroradiological examinations (CT/MRI) indicate hypodense white matter 
areas. Two out of the three have epilepsy. In our opinion, the classic or 'pure' 
form can be subdivided into two subtypes, i.e. those with and those without 
white matter hypodensities. Based on our study and the literature data, a mild 
form of epilepsy or an epileptic predisposition on the EEG can be part of the 
subtype with white matter hypodensities. 
In Chapter III section 1.3, six patients with muscle, eye and brain disease 
(WWS according to the 1995 classification) are reported on. Progression of the 
disease has been rapid in five out of the six patients. Our data are in agreement 
with those recently published in the literature. 
Chapter III section 2.1 describes the morphological variability in muscle 
specimens obtained from thirty patients with congenital muscular dystrophy 
(fifteen with 'pure' CMD, two with 'pure' CMD with hypodense white matter 
on CT/MRI, six with F-CMD, two exceptional cases with Fukuyama-like CMD 
and five with WWS). No morphological hallmarks were found to differentiate 
between these subgroups. Fat cell infiltration was only found to be increased 
with increasing age in 'pure' CMD. Immunohistochemistry with dystrophin, 
vimentin and desmin antibodies in fourteen patients showed a normal expression 
pattern. Immunohistochemistry with merosin (Chapter III section 2.3) in thirteen 
patients revealed a normal expression pattern in eleven of them (6 'pure' CMD, 
3 F-CMD, 2 WWS), but there was little or no expression in two patients with 
'pure' CMD and white matter hypodensity. 
In Chapter III section 2.2, neuropathological findings are described in two 
sisters with muscle, eye and brain disease (WWS type). Pathological examina-
tion demonstrated muscular dystrophy, hydrocephalus, cobblestone (previously 
called type II) lissencephaly, dysplasia of the cerebellum, agenesis of the vermis, 
Dandy-Walker cyst and defective eye development of fetal origin. 
In Chapter IV, particular forms of CMD are presented which cannot be 
classified within the new classification system. In Chapter IV section 1.1, a 
family is described with a (probable?) autosomal dominant type of congenital 
muscular dystrophy. This report concerns a father and daughter suffering from 
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CMD without CNS involvement. The histological findings, especially some 
mitochondrial abnormalities in the muscle biopsy of the father, are remarkable. 
In Chapter IV section 1.2, severe degenerative features of the central nervous 
system are reported in two female siblings, associated with a neuromuscular 
disorder with histological features of CMD. Brain pathology differed essentially 
from that described previously in conjunction with CMD, i.e. subtotal loss of 
neurons in the cerebral cortex, cerebellar cortex and in the ventral pons and 
secondary loss of myelin in the cerebral and cerebellar subcortical white matter. 
These pathological changes are considered to reflect very early multisystem 
degeneration of the CNS. Sural nerve pathology manifested a lack of large 
diameter fibres, a finding not described in F-CMD. Within the spectrum of 
F-CMD, these cases may illustrate an extremely severe type. 
In Chapter IV section 1.3, a Dutch girl is presented with congenital muscular 
dystrophy associated with hypoplasia of the lateral abdominal wall musculature 
and hypoplasia of the external genitalia. 
In Chapter IV section 2.1, a Dutch boy is presented with an isolated dystro-
phic diaphragmatic musculature, who showed slight postnatal asphyxia and later 
on, episodes of respiratory insufficiency when viral infections occurred. 
In Chapter IV section 3.1, three siblings are reported with adult-onset, 
predominantly distal muscle weakness. In the female index patient, epilepsy and 
a spastic ataxic gait are present, while the two other siblings show no apprecia-
ble clinical central nervous system involvement. All three siblings have muscu-
lar dystrophy and leukoencephalopathy. 
In Chapter V, General Discussion, our results are reconsidered in the light of 
the most recent classification of CMD from 1995. 
245 

SAMENVATTING 

Deze studie over congenitale spierdystrofie (CMD) richt zich vooral op de 
klinische en morfologische aspecten van de aandoening. 
In Hoofdstuk II wordt een overzicht gegeven van de literatuur in het kader 
van de recente CMD classificatie. Met deze studie hebben wij getracht te komen 
tot een evaluatie en beschrijving van de klinische en morfologische kenmerken 
van de verschillende typen van CMD middels vergelijking van onze resultaten 
met de literatuurgegevens. 
In het verleden werd CMD vaak gebruikt als een 'alles omvattende' diagnose, 
aangezien de verschijningsvorm niet nauwkeurig was en de 'overlap' van de 
criteria verwarrend. Bovendien bestonden er verscheidene vormen van CMD met 
en breed scala aan klinische bevindingen en wisselende prognose, welke gelijk-
soortige histologische spierveranderingen deelden. De klinische expressie van 
CMD werd bepaald door de aan- of afwezigheid van afwijkingen aan hersenen 
en ogen. De prognose was wisselend en afhankelijk van de ernst van de ziekte. 
De aanwezigheid van spierafwijkingen bij CMD was duidelijk, maar onder-
scheid in histochemische en electronenmicroscopische kenmerken ontbrak. De 
afwijkingen waren variabel en omvatten kenmerken als variatie in vezelgrootte, 
de aanwezigheid van necrotische en basofiele vezels, een toegenomen aantal 
vezels met interne nuclei en vervanging van spierweefsel door endomysiaal vet-
en bindweefsel. 
Van elke afzonderlijke categorie worden de klachten en verschijnselen, 
klinisch beloop, laboratorium, neurofysiologische, radiologische, morfologische 
en genetische kenmerken uiteengezet. De histologische kenmerken van de spier-
biopten en de neuropathologische bevindingen in het centrale zenuwstelsel en de 
ogen worden voor elke categorie achtereenvolgens beschreven. De huidige 
discussie of Fukuyama type CMD (F-CMD), het Finse type van 'muscle-eye-
brain disease' (F-MEB-D) en het Walker-Warburg syndroom (WWS) als een 
spectrum van één ziekte dienen te worden beschouwd, wordt besproken aan het 
eind van dit hoofdstuk. Ofschoon er consensus bestaat over het feit dat er sprake 
is van eenzelfde of gelijksoortig fundamenteel pathologisch proces, bestaan er 
ook verscheidene consistente, voornamelijk kwantitatieve verschillen tussen deze 
entiteiten. Vooral merosine (merosin M-chain or laminin-otj) heeft de discussie 
geaccentueerd. 
Hoofdstuk III paragraaf 1.1 bevat een overzichtsverslag van achttien patiënten 
met congenitale spierdystrofie, waarvan er zes ook een aandoening hebben van 
het centrale zenuwstelsel, overeenkomend met Fukuyama type CMD. Bij vier 
patiënten zijn zowel het centrale zenuwstelsel als de ogen aangedaan; op grond 
waarvan de diagnose 'muscle-eye-brain disease' is gesteld. Onder verwijzing 
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naar het voorstel uit 1995 met betrekking tot de classificatie van CMD dienen 
onze vier patiënten welke in 1989 werden beschreven als 'muscle-eye-brain 
disease', thans te worden geclassificeerd als Walker-Warburg syndroom. 
In Hoofdstuk III paragraaf 1.2 worden de klinische verschijnselen alsook ken-
merken van het centrale zenuwstelsel (intelligentie, liquor cerebrospinalis, met 
name het basisch myéline eiwit, electroencephalogram en neuroradiologische 
bevindingen) gepresenteerd van zeventien patiënten met klassieke of 'pure' 
CMD. Neuroradiologisch onderzoek (CT/MRI) laat bij drie patiënten hypodense 
gebieden in de witte stof zien. Twee van deze drie patiënten hebben epilepsie. 
We zijn van mening dat de klassieke of 'pure' vorm kan worden onderverdeeld 
in twee subtypes, namelijk één met en één zonder hypodense gebieden in de 
witte stof. Op grond van onze studie en de literatuurgegevens kan een lichte 
vorm van epilepsie of een epileptische predispositie op het EEG deel uitmaken 
van het subtype met hypodense gebieden in de witte stof. 
In Hoofdstuk III paragraaf 1.3 worden zes patiënten beschreven met 'muscle-
eye-brain disease' (WWS volgens de classificatie van 1995). Bij vijf van de zes 
patiënten heeft de ziekte een snel progressief beloop. Onze gegevens zijn in 
overeenstemming met die van de recente literatuur. 
In Hoofdstuk III paragraaf 2.1 wordt de morfologische variabiliteit bestudeerd 
in de spierbiopten van dertig patiënten met congenitale spierdystrofie (vijftien 
met 'pure' CMD, twee met 'pure' CMD en hypodense gebieden in de witte stof 
op CT/MRI, zes met F-CMD, twee uitzonderlijke patiënten met CMD gelijkend 
op Fukuyama type CMD, en vijf met WWS). Er werden geen morfologische 
kenmerken gevonden welke deze subgroepen van elkaar kunnen onderscheiden. 
Alleen een met de leeftijd toenemende vetcel infiltratie werd aangetroffen bij 
'pure' CMD. Immunohistochemie met dystrofine-, vimentine- en desmine- anti-
lichamen toonde bij veertien patiënten een normaal patroon. Immunohistochemie 
met merosine (Hoofdstuk III paragraaf 2.3) toonde een normaal patroon bij elf 
van de dertien onderzochte patiënten (zes met 'pure' CMD, drie met F-CMD en 
twee met WWS) en was nagenoeg afwezig bij twee patiënten met 'pure' CMD 
en hypodense gebieden in de witte stof. 
In Hoofdstuk III paragraaf 2.2 worden de neuropathologische bevindingen 
beschreven van twee zusters met 'muscle-eye-brain disease' (WWS type). Patho-
logisch onderzoek toonde spierdystrofie, hydrocefalie, 'cobblestone' (voorheen 
type II) lissencefalie, dysplasie van het cerebellum, agenesie van de vermis, 
Dandy-Walker cyste en een in aanleg gestoorde oogontwikkeling. 
In Hoofdstuk IV worden bijzondere vormen van CMD beschreven welke niet 
in het nieuwe classificatiesysteem kunnen worden ondergebracht. In Hoofdstuk 
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IV paragraaf 1.1 wordt een familie beschreven met een (waarschijnlijk?) auto-
somaal dominante vorm van congenitale spierdystrofie. Dit verslag betreft een 
vader en dochter met CMD zonder aandoening van het centrale zenuwstelsel. De 
histologische bevindingen, vooral enige mitochondriële afwijkingen in het spier-
biopt van de vader zijn opmerkelijk. 
In Hoofdstuk IV paragraaf 1.2 worden twee zusters beschreven met ernstige 
degeneratieve kenmerken van het centrale zenuwstelsel, in samenhang met een 
neuromusculaire aandoening met histologische kenmerken van CMD. De patho-
logie van de hersenen verschilde wezenlijk met die van de reeds eerder in 
verband met CMD beschreven patiënten, namelijk een subtotaal verlies van 
neuronen in de cerebrale en cerebellaire schors alsook in het ventrale deel van 
de pons, en een secundaire teloorgang van myéline in de subcorticale witte stof 
van cerebrum en cerebellum. Deze afwijkingen worden beschouwd als een zeer 
vroegtijdig optredende degeneratie van meerdere systemen binnen het centrale 
zenuwstelsel. De nervus suralis vertoonde afwijkingen in de zin van een tekort 
aan vezels met een grote diameter, hetgeen niet wordt beschreven bij F-CMD. 
Binnen het spectrum van F-CMD zouden deze twee patiënten mogelijk aan een 
zeer ernstige vorm kunnen lijden. 
In Hoofdstuk IV paragraaf 1.3 wordt een Nederlands meisje beschreven met 
congenitale spierdystrofie gecombineerd met hypoplasie van de laterale buik-
wand musculatuur en hypoplasie van de uitwendige genitaliën. 
In Hoofdstuk IV paragraaf 2.1 wordt een Nederlandse jongen beschreven met 
een geïsoleerde dystrofie van de diafragma musculatuur, die een lichte post-
natale asphyxie vertoonde en later perioden van insufficiënte ademhaling bij het 
doormaken van virale infecties. 
In Hoofdstuk IV paragraaf 3.1 worden drie familieleden beschreven met een 
op volwassen leeftijd beginnende en voornamelijk distale spierzwakte. Bij de 
vrouwelijke patiënt was sprake van epilepsie en een spastisch-atactische gang, 
terwijl de twee andere familieleden geen waarneembare aandoening van het 
zenuwstelsel hadden. Bij alle drie was sprake van spierdystrofie en leukoence-
phalopathie. 
In Hoofdstuk V, Algemene Discussie, hebben we onze resultaten opnieuw 
afgezet tegen de achtergrond van de meest recente classificatie van CMD van 
1995. 
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Instituut voor Neurologie van het Academisch Ziekenhuis Nijmegen (opleider: 
Prof.Dr. B.P.M. Schulte t)· In het tweede deel van 1986 was hij werkzaam als 
neuroloog op de afdeling Neuro-Intensieve Zorg in voornoemde kliniek. 
De aantekening Klinische Neurofysiologie werd in 1987 behaald (opleider: 
Prof.Dr. S.L.H. Notermans). 
Van 1 januari 1988 tot 1 januari 1994 was hij werkzaam als neuroloog in het 
Streekziekenhuis Midden-Twente te Hengelo. Sedert 1 januari 1994 is hij werk-
zaam als neuroloog en B-opleider in Ziekenhuis Rijnstate te Arnhem. 
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STELLINGEN 
behorende bij het proefschrift 
CONGENITAL MUSCULAR DYSTROPHY 
Clinical and morphological studies 
in het openbaar te verdedigen 
op 19 januari 1996 
des namiddags te 1.30 uur 
door 
Q.H. LEUTEN 
1 De classificatie van congenitale spierdystrofie berust primair op de klinische 
Symptomatologie De definitieve indeling zal in de toekomst door het mole­
culair genetisch onderzoek worden bepaald 
- dit proefschrift 
2 Bij kinderen met een ernstige cerebrale aandoening en structurele oogafwij­
kingen verdient het aanbeveling CK te bepalen ter opsporing van een moge­
lijke spierdystrofie 
- dit proefschrift 
3 Patienten met congenitale spierdystrofie en structurele afwijkingen van de 
ogen en van de hersenen kunnen worden onderscheiden in een groep met 
ernstige klinische presentatie en progressief beloop (Walker-Warburg syn­
droom) en in een groep met mildere klinische presentatie en minder 
progressief beloop (Finse vorm van 'muscle-eye-brain disease') Het is niet 
bekend of deze groepen genetisch heterogeen zijn of niet 
- dit proefschrift 
4 Een vorm van epilepsie of een epileptische predispositie bij EEG-registratie 
kan deel uitmaken van de merosine-negatieve congenitale spierdystrofie met 
witte stof afwijkingen in het centrale zenuwstelsel 
- dit proefschrift 
5 'Times are changing' "Een geneesheer vraagt in Zeitschr f Krankenanstal­
ten, of hij schadevergoeding kan eischen van een patiente, die bij het onder­
gaan van een tandheelkundige bewerking een krampaanval had gekregen en 
hem een instrument in het oog had geslagen, zoodat hij enige dagen niet 
had kunnen werken " 
- Pinkhof H, Ned Tijdschr Geneeskd 1919, Eerste helft, No 22, Ы 1973 
6 "Retinal - or ophthalmic - artery vasospasm should be considered as the 
cause of amaurosis fugax when thromboembolic disease and carotid-artery 
hypoperfusion have been carefully excluded as causes In such cases, a 
calcium-channel blocker may be effective treatment " 
- Winterkorn JMS, et al N Engl J Med 1993,329 396-398 
7. De verklaring van het ministerie van WVC dat dihydroergotamine en 
ergotamine 'goed werkende en veilige alternatieven voor sumatriptan' zijn, 
is onjuist en niet gebaseerd op wetenschappelijk aangetoonde feiten. 
- Ferrari MD, et al. Ned Tijdschr Geneeskd 1993;137:846-855 
8. Het is onjuist dat het 'numerus fixus' systeem voor geneeskunde zich in 
Nederland al meer dan 20 jaar op cijfers fixeert, en volledig voorbijgaat aan 
sociale - en andere - vaardigheden. 
9. Indien het vermoeden bestaat op een spieraandoening, verdient het aanbeve-
ling een spierbiopsie te laten verrichten in een centrum dat gespecialiseerd 
is in neuromusculaire aandoeningen. 
10. Een gevolg van de invoering van de Algemene Maatregel van Bestuur van 
1 februari 1993 met betrekking tot het aantal werkuren voor arts-assistenten 
is de discontinuïteit, waardoor de kwaliteit van de zorg en van de opleiding 
wordt bedreigd. Door de opgelegde beperking in aanwezigheid ervaart de 
assistent in opleiding niet voldoende de verantwoordelijkheid voor de aan 
hem toevertrouwde patiënt. 
- Roos, RAC. In "Statistisch dynamisch, neuron en neuroloog", inaugurele rede, 3 maart 
1995, Rijks Universiteit Leiden 
11. "There are lies, damned lies and statistics, in this order." 
- Benjamin Disraeli (1804-1881) 
12. De jeugd eindigt daar, waar men relaties gaat maken in plaats van vrienden. 



